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CHAPTER 1  
1.1 Evolutionary perspectives of transcriptional regulation 
In the early nineties, the H. sapiens genome was estimated to encode around 
100,000 genes, and this extensive number was used to explain the apparent difference 
in complexity between humans and simpler organisms like yeast (S. cerevisiae, 6,000 
genes) and fruitfly (D. melanogaster, 13,000 genes). The estimated number of human 
genes has later consecutively decreased from 100,000 to 80,000 to 40,000. The latest 
reports from the human genome project (end 2003) estimate that a human genome 
contains 20,000-25,000 genes. Not only is this number four to five times lower than 
the original estimate but it also instigates the somewhat sobering idea that we are, 
from a genomic perspective, not far from either D. melanogaster or roundworm (C. 
elegans, 9,000 genes). Obviously, gene numbers alone do not reflect the 
sophistication of nature; other factors must explain how a modest increase in gene 
number from yeast to human can create such a different physiology.  
The human genome has been called “the blueprint of life” because it carries all 
information necessary for a single fertilized egg cell to transform into a human being. 
Though all cells in one organism contain identical “blueprints”, cells are able to 
develop and specialize because the transcription regulation machinery controls the 
precise expression of a subset of these genes in each cell. In effect, some genes 
(house-keeping genes) are expressed in all cells all the time, providing common 
routine metabolic functions. Other genes are expressed as a cell enters a particular 
pathway of differentiation or stage in the cell cycle and yet others are continuously 
expressed in a cell that has differentiated into a specialized state. Lastly, genes can be 
expressed as a direct consequence of a conditional change, for instance upon the 
presence of a hormone. Needless to say, one would expect a highly complex and 
dynamic machinery necessary to conduct such an elaborate task. 
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1.2 Historical preview 
Thirty years ago, Jacob and Monod described how genes are selectively 
switched on and off in bacterial cells1. According to their paradigm for gene 
regulation, trans-acting regulatory proteins interpret and mobilise specialized DNA 
sequences called cis-regulatory elements. Human cells share considerable functional 
and structural characteristics with simpler organisms, and genes of eukaryotic 
organisms are controlled largely the same way as in prokaryotic cells, although in 
eukaryotic cells cis-regulatory DNA sequences are named enhancers and silencers 
whereas trans-acting regulatory proteins are collectively termed transcription factors. 
The two largest eukaryotic RNA pol II subunits, Rpb1 and Rpb2, are homologous to 
the β and β’ subunits of bacterial polymerase, whereas a third subunit, Rpb3, is 
related to the α subunit of bacterial polymerase, and although there is no eukaryotic 
equivalent to the bacterial σ subunit family, structural and functional similarities 
between σ and certain general transcription factors have been postulated. 
In contrast to prokaryotes, multi-cellular eukaryotes comprise hundreds of 
different cell types, performing a specific role that contributes to the overall being of 
the organism. To facilitate this, eukaryotes possess, compared to prokaryotes, a huge 
number of transcription factors and accessory factors, cofactors, modifying enzymes 
and bridging factors.  
 
1.3 The core promoter 
           Core promoters are defined as the minimal DNA sequences required to recruit 
the appropriate RNA polymerase and initiate transcription2, and can be divided into 
core elements and regulatory elements. Core promoter elements define the site for                          
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assembly of the preinitiation complex (PIC) and a classical core promoter for RNA 
pol II can include a TATA box (at –20 to –30 relative to the transcription start site), 
an initiator element (at the transcription start site) and a downstream promoter 
element (DPE at +30 relative to the transcription start site) (figure 1). Regulatory 
elements control the rate of transcription initiation in a gene-specific manner, either 
from near-by start sites (upstream activating and repressing sequences) or from great 
distances (enhancers and silencers).  
 
1.4 The basal transcription machinery 
Eukaryotic transcription is carried out by three polymerases; RNA polymerase 
I (RNA pol I) which is responsible for transcription of rRNA genes, RNA polymerase 
II (RNA pol II) transcribing all protein-coding genes and most snRNAs, and finally 
RNA polymerase III (RNA pol III), transcribing 5S rRNA, tRNAs and the U6 
snRNA2,3. The earliest in vitro transcription experiments that were performed in the 
late 1970s and early 1980s showed that RNA pol II is unable to recognise promoter 
sequences and initiate RNA synthesis by itself4,5, and this observation provided the 
basis for characterizing the general transcription machinery3,6,7. Originally, the general 
transcription factors that reconstituted efficient selective transcription by purified 
RNA pol II in vitro were identified by fractionation of cellular extracts and include 
TFIIA, TFIID, TFIIE, TFIIF and TFIIH (see table 1).  
TFIID, which in fact is a multi-subunit complex comprising TATA-binding 
protein (TBP) and more than ten TBP-associated factors (TAFs) can bind directly to 
the TATA box and nucleates formation of the initiation competent complex8-10. In 
TATA Inr DPE Figure 1: A classical RNA pol II core promoter 
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addition to TBP binding to the TATA box, certain TAF subunits can interact directly 
with initiator or downstream promoter elements. Whereas TBP is sufficient for basal 
in vitro transcription, it must be complemented by the TAFs to respond to 
transcriptional activators (see 1.5).  
Table 1 Human class II general transcription initiation factors 
Factor                          Subunits    Function 
  
TFIID   
      TBP 1 Core promoter recognition  
TFIIB recruitment 
      TAFs 14 Core promoter recognition/selectivity (non-TATA 
elements), regulate TBP function, co-activator, kinase, 
ubiquitylase and acetylase activities 
TFIIA 3 Stabilising TBP-DNA interaction 
Anti-repressor and co-activator 
TFIIB 1 Stabilising TBP-DNA interactions, recruiting TFIIF/RNA 
polII, 
start site selection 
TFIIF 2 Recruiting RNA polII to DNA-TBP-TFIIB complex, 
destabilizing non-specific RNA polII-DNA interactions, 
facilitates RNA polII elongation 
RNA pol II 12 RNA polymerase (pre-mRNA synthesis), recruiting TFIIE, 
CTD domain, interacts with Mediator complex, Elongator 
complex and processing factors 
TFIIE 2 TFIIH recruitment, TFIIH helicase ATPase and kinase 
modulating actitvity,  
Promoter melting 
TFIIH 9 Promoter melting, helicase, CTD kinase, role in nucleotide 
excision repair 
                                                Taken from 2,3,11,12 
TFIIA was initially identified as one of the general transcription factors but 
was later found to be dispensable for basal transcription2,11,13-18. Partially purified 
systems that were used to categorize the general transcription factors contained 
negative factors like NC1 or NC2 and may have necessitated the action of TFIIA to 
reverse their inhibitory effect on basal transcription3. TFIIA is now known to displace 
transcription repressors like NC2/Dr1-DRAP1, PC3/Dr2, HMG1 and BTAF1 and 
stabilize TBP-DNA association (see figure 2), and it can function as a co-activator for 
a number of activators. In highly purified systems, TFIIA is therefore dispensable 
because these systems are presumably devoid of regulators that are normally 
antagonized by TFIIA, in contrast to systems assessing crude extracts where TFIIA is 
essential for full transcriptional activation. However, TFIIA, like the TAFs, has many 
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characteristics of a co-activator rather than a basal transcription factor. TFIIA is 
discussed in detail in chapter 2. 
                                            
Figure 2: Crystal structure of TBP and TFIIA binding to the promoter19,20 
                         
TFIIB enters the PIC after TFIID and TFIIA and is a pre-requisite for RNA 
pol II recruitment in vitro21. It interacts with TBP and binds to DNA upstream and 
downstream of the TATA box22, is a target for a number of activators and is probably 
involved in start site selection23,24. TFIIB also interacts with and recruits RNA pol II 
and TFIIF. TFIIF is in many ways reminiscent of the bacterial σ factor; it binds 
tightly to RNA pol II and prevents non-specific binding of the polymerase to DNA, in 
addition to having an overall stabilizing effect on the PIC25-27. TFIIF also suppresses 
transient pausing of the polymerase and thus operates as an elongation factor28.  
Even with RNA pol II stably bound to the promoter, transcription can not be 
initiated before the last two general transcription factors, TFIIE and TFIIH, join the 
PIC and provide open complex formation, i.e. promoter melting. The function of 
TFIIE is closely linked to TFIIH function, recruits and stimulates its activity. TFIIH 
consists of nine subunits, including a DNA-dependent ATPase, two DNA helicases 
and a CTD kinase25-27. TFIIH is essential for promoter opening in vitro and both 
TFIIE and TFIIH are required for the ATP-dependent formation of the open promoter 
complex prior to formation of the first RNA phosphodiester bond. In addition, TFIIE, 
TFIIH and TFIIF cooperate to suppress promoter-proximal stalling, thus facilitating 
the transition of RNA pol II to productive elongation29.  
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A basal transcription factor was originally defined as “a factor that is 
important for initiation of transcription from a core promoter by RNA pol II”, whereas 
a general transcription factor was “essential for initiation of transcription at all 
promoters”30. From these definitions follows that all general transcription factors are 
basal factors, but the use of these terms today is more complicated than the original 
models prompted. Despite the name, it appears that many general transcription factors 
do not necessarily function at all genes in vivo and several other members of the 
transcription apparatus are as generally employed as the general transcription factors, 
as will be discussed later. 
                   
                                                                Figure 3 Assembly of the preinitiation complex on the promoter. Originally, the general transcription factors necessary for selective transcription by purified RNA pol II included TFIIA, 
TFIID, TFIIE, TFIIF and TFIIH. (See text for details)  
 
1.4.1 The TAFII components of the TFIID complex 
 Whereas purified TBP stimulates basal and not activated transcription in cell-
free systems, the TFIID fraction mediates both due to the so-called TBP-associated 
factors (TAFs) (see table 2) 8,31-34.  In the context of TFIID, some TAFs can contact 
initiator or downstream promoter elements50,51. These interactions are particularly 
important for promoters lacking a conventional TATA element; in this case the 
initiator element of the core promoter can be contacted by TFIID subunits dmTAF1 
and dmTAF2, whereas the DPE has been shown to interact with dmTAF6 and 
dmTAF98,52-55. The TAFs are believed to be essential for linking the preinitiation 
complex to a diversity of transcription factors35, thereby defining the TAFs as co-
activators. Direct contact has been demonstrated for example between the activator 
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p53 and dmTAF9/6, VP16 and dmTAF9, SP1 and dmTAF4 and the nuclear estrogen 
receptor and hsTAF108,56-59. 
Table 2: The TBP-Associated factors 
Name Complex Characteristics 
 
                 TAFs with enzymatic activities 
TAF1 TFIID Protein kinase, phosphorylates Rap74 and TFIIA 
Acetylates H3 and H4 in vitro 
Contains Bromo domains and HMG boxes 
Contacts DNA and associates with TBP 
Cell cycle progression through G1/S boundary 
Repression of Apoptosis 
 
BTAF1 B-TFIID ATP-dependent inhibitor of TBP-mediated 
transcription 
                 Histone-like TAFs 
TAF3 TFIID Histone fold motif 
TAF6 TFIID, hTFTC, ySAGA            Histone fold motif 
Contacts TFIIEa, Rap74 and TBP 
TAF9 TFIID, hTFTC, ySAGA, 
hPCAF      
Histone fold motif 
Contacts DNA, TFIIB, acidic activators 
TAF11 TFIID Histone like 
Contacts VP16, TFIIB 
TAF12 TFIID, hTFTC, ySAGA, 
hPCAF     
Histone fold motif 
Required for the HAT activity of SAGA 
TAF13 TFIID Histone fold motif 
                 Others 
TAF2 TFIID Downstream promoter contact (specific)  
Contacts TBP 
TAF4 TFIID, hTFTC                           Q-rich 
contacts DNA, hTFIIA, SP1, NFATp 
TAF4b  Specific for gonads 
TAF5 TFIID, hTFTC, ySAGA            WD40 repeats 
Contacts DNA and Rap74 
promoter-specific and complex stabilizing function 
TAF7 TFIID, hTFTC                           contacts DNA (hTAF55) and many activators 
TAF10 TFIID, hTFTC, ySAGA            contacts the estrogen receptor 
Progression through the G1/S boundary 
Repressor of Apoptosis 
TAF15 TFIID RNA or ssDNA-binding domain 
contacts hRNAP 
might have a role in driving the preinitation 
complex in an open conformation and in RNA 
chain initiation 
TAF43 TFIID  
                                                              Taken from   8-10,35-49 
 TAF1 is the largest TAF and has historically been regarded as the key scaffold 
upon which the other TAFs assemble, because D. melanogaster, S. cerevisiae and 
human TAF1 bind both TBP and several other TAFs in vitro39. Amongst the many 
known protein domains harboured by TAF1 are two bromodomains40 that bind 
acetylated lysines, two kinase domains reported to phosphorylate Rap74 (TFIIF) and 
TFIIA37,47, a histone acetyl transferase domain that can acetylate histones H3, H4 and 
H2A41 and a Ubiquitin-activating/conjugating activity ubiquitylating histone H144. 
This considerable number of enzymatic activities is consistent with a broad role of 
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TAF1, which has been associated with regulation of the cell cycle, cell differentiation, 
cell proliferation and cell survival46,60,61. Studies have shown that the presence of 
TAF1 can decrease activated transcription in a promoter-dependent manner, and that 
TAF1 and (co-)activators like VP16 or TFIIA compete for binding to TBP38,62-65. 
It has been known for a time that TAFs are essential for basal transcription in 
vitro from TATA-less promoters33,35. In yeast, two active forms of TBP, one TAF-
dependent and one TAF-independent, have been shown to be involved in 
transcription66,67. These results suggested that the TAFs are not involved in 
transcription on all promoters, and genome-wide studies in yeast have estimated that 
TFIID pre-dominates at ~90% of the promoters68. 
 
1.4.2 TAF-containing complexes without TBP 
According to their definition, TAFs exist in association with TBP, but the 
validity of the definition of TAFs has been challenged by the identification of the 
TBP-free-TAF containing complexes like hTFTC, hPCAF, hSTAGA and 
ySAGA42,49,69,70. These discoveries suggested that TBP might be dispensable for 
transcription at least on some promoters. Common to these complexes are intrinsic 
HAT activities, they contain homologues of ADA (adaptor) proteins and SPT 
(suppressor of Ty insertion) proteins and subsets of TAFs but no TBP. The hTFTC, 
ySAGA and hPCAF components were shown to be essential for in vitro and in vivo 
activated transcription, but not much is known about the mechanism of their function. 
They might change the acetylation state of chromatin by their intrinsic HAT activity, 
thereby potentiating initiation and activation of transcription (see 1.5.2.1), and 
secondly, they might contact TBP or other general transcription factors and co-
activators such as p30036. 
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Recent studies addressing the roles of TFIID and SAGA in transcriptional 
regulation in yeast found that mutation of shared SAGA and TFIID subunits affected 
as much as 99% of all yeast genes68. TFIID predominates at 90% of the measurable 
promoters and is responsible for transcribing house-keeping and non-regulated genes, 
whereas SAGA predominates at the remaining 10% at what appears to be largely 
stress-induced genes. Though some gene targets may be shared between the two 
complexes, they therefore appear to have separate roles in expression of certain sets of 
genes.  
 
1.4.3 Diversity in the general transcription machinery   
Being involved in transcription by all three polymerases, TBP has been 
considered a universal transcription factor, but this dogma has been challenged by the 
recent discoveries of other TBP family members. Homologues of other basal 
transcription factors have subsequently been found as well, demonstrating that higher 
eukatyotes express cell and tissue-specific core promoter recognition factors that 
presumably exert their transcriptional effects at separate subsets of genes. The TBP 
family contains the apparently insect-specific TRF1 that acts in transcription of the 
tudor gene and the tRNA genes, and that associates with a novel set of associated 
factors (nTAFs)71,72. The TLF/TRF2 is found in all metazoan genomes examined so 
far, is required for spermatogenesis in mice73-75 and is essential for early 
embryogenesis in frogs, worms and fish76-78. A third member of the vertebrate TBP 
family, TBP2/TRF3, has an essential, specialized role in embryonic gene regulation in 
fish and X. laevis79,80. Some tissue-specific TAFs have also been identified; TAF4b is 
exclusively expressed in male germ cells and in granulosa cells of the ovary, and is 
essential for female fertility81. TAF1L is up-regulated during male germ cell 
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development to compensate for the silencing of its somatic counterpart on the X 
chromosome (i.e. TAF1)82 and dmTAF5 has a spermatocyte-specific homologue in 
the cannonball gene83. TFIIA also has a vertebrate homologue, the TFIIA-Like Factor 
(ALF) that is expressed predominantly in testis85-88. An additional complexity in the 
gene regulation by TFIIA may be gained by the association of uncleaved form of 
TFIIA αβ/γ in the complex TAC as discovered in P19 EC cells89.  
 
e
enhancer-binding factors but also by extensive variation within the basal transcription 
machinery. In contrast to S. cerevisiae, many of the general transcrip
higher eukaryotes have diverged considerably, likely 
of gene regulatory pathways.  
                    
1.5 Activation and Repression of transcription 
Gene-specific transcriptional activation is gen
transcriptional activators to upstream activating sequences (see 1.3) where they recruit 
Figure 4: Diversity in the general 
transcription machinery. A variety of 
transcription complexes may compete 
for the same target genes or regulate 
distinct sets of genes. TBP can 
assemble with the TAFs into the 
TFIID complex, and some of the TAFs 
in TFIID can be replaced by variant 
TAFs. Conversely, both TAFs and 
related variant TAFs can participate in 
histone acetyl transferase (HAT) 
complexes such as TFTC. Both TFIIA 
and the unprocessed form of TFIIA in 
the TAC complex are capable of 
binding TBP. Similarly, TFIIA-like 
factor (ALF) can substitute for TFIIA 
in binding to TBP. TBP is not only 
found in TFIID and TAC, but also in 
the BTAF1 and NC2 complexes. So 
far TBP-like factor (TLF) has not been 
found in TFIID, TAC, BTAF1 or 
NC2. However, TLF can compete with 
TBP for TFIIA binding (modified 
from84).
cificity is regulated not only by The model emerging is one in which gene sp
tion factors in 
reflecting the greater complexity 
erally effected by the binding of 
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or regulate activities of co-activators and the basal transcription machinery. 
Regulation of transcription often involves interplay between activators and 
repressors25 and genes may be regulated by mixing and matching different types of 
activators and repressors in a coordinated fashion. The activators can function in 
several manners90; some (for example Gal4, Pho4, E2F-4 and Swi5) can bind to the 
packaged nucleosomes and perturb chromatin structure by recruiting chromatin 
remodelers activator, some (for example the E2Fs and SBF) can bind nucleosomes 
only after their conformational change. Many activators (for example Rap1) can 
recruit basal transcription factors directly.  
Co-activators are required for transcriptional activation but are dispensable for 
low-level basal transcription in vitro, and they do not bind DNA specifically91 as 
opposed to activators. Generally, co-activators are divided into four groups and the 
first group includes TFIIA and the TAFs that function by bridging activators and the 
preinitiation complex (1.4).  The second group is composed of the Mediator 
complexes, the third group contains the histone modifying complexes and finally the 
fourth group includes the ATP-dependent remodelers (see below). 
 
1.5.1 The Mediator Complex 
In the search for factors that could imitate the in vivo effects of activators in an 
in vitro setting, Kornberg and co-workers discovered the yeast Mediator complex that 
was required for stimulation of transcription in highly purified systems92,93. The 
Mediator complex transduces both negative and positive regulatory information from 
gene-specific activators and repressors to the basal transcriptional machinery94,95. The 
metazoan Mediator complexes have been reported to be holoenzymes with 
components ranging from DNA repair proteins to splicing and polyadenylation 
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factors96,97, in addition to homologues of the yeast SRB/Mediator proteins98. 
Purification methods generally produced two predominant complexes; one large 
complex variously named TRAP, DRIP, ARC, SMCC or NAT99-104 and a smaller 
complex named PC2/CRSP91,105. Both complexes were shown to mediate activator-
dependent transcription in vitro, and the NAT and SMCC complexes were 
additionally shown to repress activator-dependent as well as basal transcription106,107. 
The best-described metazoan Srb/Mediator-like complex is SMCC which was isolated 
from human cells through epitope-tagged components of the complex. SMCC 
contains 25 polypeptides including human homologues of yeast SRB10, SRB11, 
SRB7, MED6, MED7, NUT2 and RGR1 as well as TFIIB and subunits of RNA pol 
II. In addition, SMCC contains TRAP240, TRAP230, TRAP220 and several other 
subunits found in the thyroid-hormone-receptor-associated protein co-activator 
complex TRAP that was purified on its ability to mediate activation with thyroid 
hormone receptor100,101.  
The composition of metazoan (as well as yeast) Mediator thus varies 
according to the biochemical tools and the strategy used for its isolation, and the cell 
type and growth conditions as well as promoter-specific requirements may influence 
the composition. The functional significance of the range of documented Mediators is 
still unclear. This issue was recently addressed in a study where HeLa cell lines 
expressing FLAG-tagged subunits of several Mediator subunits were analysed by 
multi-dimensional protein identification technology108. All the isolated forms of 
Mediator were found to contain a consensus set of subunits, in addition to a variety of 
certain subunits, suggesting functional differences in the complexes. For example, a 
Mediator complex lacking the Med220 subunit is unable to serve as a co-activator at a 
subset of promoters109. 
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Mediator was initially believed to function by recruiting the preinitiation 
complex to the promoter. This is supported by observations from yeast where the 
Mediator is required for stability of preinitiation complexes that are dependent on a 
functional activator protein66,67,110,111 and Mediator–dependent activators like Gal4 
and GCN4112,113. The activator-dependent association of human Mediator to the 
promoter in vivo bridges the activator to members of the basal RNA pol II 
machinery114, and interaction of a number of activators with Mediator has directly 
been shown to stimulate preinitation complex assembly on the promoter115. On the 
other hand, in yeast the association of Mediator and RNA pol II occurs independently 
at the HO promoter and at other cell cycle regulated promoters like CLN1, CLN2 and 
PCL1114. This has lead to the suggestions that the Mediator performs different roles at 
different promoters. Several functions have been suggested; purified yeast Mediator 
stimulates the RNA pol II CTD-kinase activity of TFIIH, facilitating the transition 
from initiation to elongation106 and Mediator may contribute to recruiting other 
transcription co-activators like chromatin remodeling complexes, histone acetylase 
and methylase complexes and elongation factors116,117. Recently, it has been shown 
that Mediator functions at a post-recruitment step by enhancing the rate of 
transcription initiation by a preinitiation complex118. The mechanism behind is not 
clear but is suggested to be promoter melting or promoter clearance. 
 
1.5.2 Chromatin as a substrate for transcriptional regulation 
An important factor for the overall outcome of transcription regulation is the 
structure in which the chromatin is stored in a eukaryotic cell.  The basic unit of 
chromatin is the nucleosome particle, containing 147 bp of DNA wrapped nearly 
twice around an octamer of core histones119. The genetic material containing all 
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information necessary for development, differentiation and cell plasticity is thus 
packaged to fit the limited confines of the cell nucleus, and this dense, non-accessible 
substrate represents a significant barrier to the basal transcription machinery120,121. To 
facilitate access to DNA, eukaryotes have evolved multi-subunit protein complexes 
that alter chromatin structure by either covalently modifying nucleosomes or utilising 
ATP to remodel nucleosomes and mechanically restructure chromatin (SNF2-type 
ATPases)19,20,90,120-123. 
 
1.5.2.1 Covalent modifications 
Histones are subjected to a large number of post-translational modifications, 
including acetylation, methylation and ubiquitylation of lysines, methylation of 
arginines and phosphorylation of serines, tyrosines and threonines. The best studied is 
acetylation, the transfer of an acetyl side chain from an acetyl-Coenzyme A moiety to 
a lysine. This transfer effectively neutralizes the positively charged lysine, possibly 
reducing its affinity for the DNA backbone and releasing the compactness of the 
nucleosomal arrays by disrupting the inter-nucleosomal interactions made by the 
histone tails. In addition, by establishing different combinations of histone tail 
modifications (the ‘histone code’), different proteins recognizing such signature 
through for example bromodomains (acetylated residues) or chromodomains 
(methylated residues) can be recruited121,124-126. The first activator of transcription 
found to possess histone acetyl transferase (HAT) activity was the yeast Gcn5p127,128, 
and this was later found to be the catalytic subunit of the yeast complexes ADA and 
SAGA129 (see table 3). Besides this, yeast contains many other HAT containing 
complexes, like the NuA3, NuA4 complexes and the SAS complex. As this multitude 
of different HAT complexes already suggests, HATs are required for a broad 
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spectrum of biological functions ranging from transcriptional activation and silencing 
to DNA damage response and chromosome segregation69,99,128,130,131. 
Mammalian cells contain at least two proteins related to yGCN5; p300/CBP-
Associated Factor (PCAF) and hGCN5. Both human proteins have been shown to 
play key roles in transcriptional activation, for example for the function of p53 
mediated activation in response to DNA damage and MyoD-mediated activation 
during muscle differentiation132. The requirement of hPCAF as a histone acetyl 
transferase and transcriptional co-activator has been described, among others, for 
myogenesis133, growth factor signaling pathways134 and nuclear receptor mediated 
transcription135. In addition to acetylating histones, hPCAF has been shown to 
acetylate proteins like the HMG17136, HMGI(Y)137 and p53138 and the general 
transcription factors TFIIE and TFIIF139. Evidence is mounting arguing that the 
‘histone code’ is not restricted to histones, but that it in fact includes many other 
proteins that are subjected to posttranslational modification signatures, introducing the 
more general term ‘protein code’132,140-142. 
Table 3: Representative HAT complexes and their composition 
HPCAF hTFTC ySAGA yADA         yNuA4 yNuA3 
    
PCAF GCN5 GCN5 GCN5 Esa1 Sas3 
  Ada1    
Ada2  Ada2 Ada2   
Ada3 Ada3 Ada3 Ada3   
  Ada5/Spt20    
Spt3 Spt3 Spt3   Spt16 
  Spt7    
  Spt8    
 TAF2     
 TAF4     
 TAF5     
 TAF6     
PAF400 TRRAP Tra1  Tra1  
TAF5L TAF5L TAF5   TAF14 
TAF12 TAF12 TAF12    
TAF6L  TAF6    
TAF10 TAF10 TAF10    
TAF9 TAF9 TAF9    
  Sin4    
   Ahc1   
    Act3/ARP  
    Act1  
    Ep11  
    Eaf3  
Taken from 120
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Other fundamental HAT-containing proteins are CBP and p300; these proteins 
are highly homologous and often considered a unity. CBP/p300 is ubiquitously 
expressed and has critical roles in cellular processes like heart, lung and small 
intestine formation, cell cycle control, differentiation and apoptosis143,144. Like 
hGCN5, CBP/p300 can act as a co-activator for a wide variety of transcription factors 
including nuclear receptors and other activators like c-Fos, c-Jun and c-Myb. 
CBP/p300 affects transcription by serving as molecular scaffolds to bridge activators 
to co-activators and RNA pol II, by acetylating histone tails or they can acetylate 
transcriptional activators to directly affect their activity145. Accumulating evidence 
indicates that CBP and p300 are not completely redundant but also have unique roles 
in vivo, may be due to association with different proteins or slightly different substrate 
specificities146.  
Besides acetylation, histone phosphorylation has been shown to have a role in 
transcriptional induction of immediate early genes in mammalian cells like c-Fos147. 
Phosphorylation of H4Ser1 may have a role during DNA damage148 and the DNA 
damage checkpoint kinase ATM is recruited to a DNA double-break where it 
phosphorylates H2AX in mammals121. Histone phosphorylation of H3Ser10 has a 
dual function and has been shown to be involved in both transcriptional activation and 
chromosome condensation during mitosis149-151.  
In line with the proposed complexity of the ‘histone code’, also histone 
methylation of lysine and arginine residues has been linked to both activation of 
transcription and silencing of chromatin152,153. Transcriptionally active euchromatin 
can be methylated at H3Lys4, H3Lys36, and H3Lys79, and histone 
methyltransferases move along with elongating RNA pol II complexes, thus spreading 
H3Lys36 methylation through transcribed open reading frames154. In contrast, 
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transcriptionally repressed euchromatin can be methylated at H3Lys27 and H4Lys20, 
as well as H3Lys9154. Recently, several groups demonstrated that the yeast Set1 and 
Set2 enzyme complexes that mediate histone lysine methylation functionally interact 
with the PAF complex, a specific elongating RNA pol II complex155,156.  
In yeast, this interplay includes another covalent histone modification, namely 
ubiquitylation of lysine residues. It was shown that recruitment and activity of the 
Rad6-Bre1 ubiquitin ligase complex ubiquitylates H2BLys123 and this modification 
was required for sequential recruitment of the 19S proteasomal cap, the PAF complex 
and the various SET complexes. Histone ubiquitylation most likely can regulate gene 
transcription in a positive and negative fashion, depending on its genomic location and 
timing of occurrence. The ubiquitin hydrolase Ubp8 is a stable component of SAGA 
and biochemical and genetic evidence indicates that Ubp8 targets H2B for 
deubiquitylation prior to transcriptional initiation. The dynamic balance of H2B 
ubiquitylation/deubiquitylation was shown to be important for GAL1 transcription 
and further, this balance of ubiquitylation appears to set the balance of histone H3 
methylation at Lys4 relative to Lys36157. Both phosphorylation and methylation of 
histone tails have been shown to regulate HAT activity and crosstalk among the 
different histone marks appears to be extensive, not only between adjacent 
modifications in the same histone tail, but also inter-nucleosomal158. 
Most known histone modifications can be enzymatically removed. 
Complementary to the HAT complexes, cells contain protein complexes like Sir2, 
Sin3/HDAC or the Mi-2/NuRD complex and the complexes containing the N-
CoR/SMRT that are able to deacetylate nucleosomes159,120. As with the HAT 
complexes, the different subunit compositions of the HDAC complexes imply that 
they are involved in separate biological functions and that they have different 
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substrate specificities. The HDAC complexes have been shown to be targeted to 
specific promoters by repressors, like the recruitment of yeast Sin3-Rpd3 complex by 
the transcription repressor Ume6p160. The Sin3/HDAC complex can be recruited by 
the Mad1 protein161, while the N-CoR/SMRT complex is recruited by unliganded 
nuclear hormone receptors162. N-CoR and SMRT can interact with nuclear receptors 
and have been implicated in repressing activities of factors like SRF, AP-1 and NF-
κB163 as well as the POU homeodomain factor Pit-1164,165 and the bHLH protein 
MAD161,165.  
HDACs can deacetylate core histones in vitro and in vivo166,167 and several 
observations suggest that the deacetylase activity of HDACs is responsible for the 
transcriptional repression; single amino acid mutations in the catalytic core of the 
HDACs RPD3 and HDAC1 demonstrated a direct correlation between its enzymatic 
activity and its repressive ability168-170. Additionally, nuclear receptor dependent 
repression can be inhibited by the deacetylase inhibitor trichostatin A130,171. It has 
been shown that whereas the Sin3/HDAC complex can deacetylate both histone H3 
and H4, the N-Cor/SMRT complex only deacetylates H3, demonstrating that the 
different complexes have distinct histone tail specificities172. Analogous to HDACs, a 
histone demethylase LSD1 has recently been identified173. LSD1 is found to be a 
transcriptional co-repressor participating in the silencing of neuron-specific genes and 
has specificity for histone H3Lys4.  Thus, like acetylation, methylation appears to be 
a dynamic process that is regulated by a balance between HATs and HDACs, 
methylases and demethylases, kinases and phosphatases and so on. 
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1.5.2.2 ATP-dependent Chromatin Remodeling Complexes   
Complexes like ySWI/SNF, yRSC, dNURF, dCHRAC, dACF, dBrahma, 
hSWI/SNF, hNURD and hRSF represent the fourth and last group of co-activators174. 
These chromatin remodeling complexes function by promoting nucleosome disruption 
or displacement in an ATP-dependent manner and can alter the structure of large 
segments of chromatin. In yeast, the known nucleosome remodelers are grouped 
based on the functional domains present in their catalytic subunit resulting in three 
main groups; the SWI/SNF group is characterized by a C-terminal bromodomain 
(Swi2/Snf2 and Sth1), the ISWI group containing a SANT domain (Isw1 and Isw2), 
the Mi-2 group harbouring a chromodomain (Chd1), leaving Ino80p, Swr1p, Rad54p, 
Rdh54p and Yfr038wp116,119,120,122,129,175-177. Genome-wide expression studies using 
mutant of the well-characterized ySWI/SNF complex revealed that this complex is a 
key transcriptional regulator involved in activation or repression of 6% of yeast 
genes178 including a subset of highly inducible genes179. Furthermore, it is known that 
ySWI/SNF functionally collaborates with the SAGA complex to drive transcription of 
many (mitotic) genes, showing that ATP-dependent nucleosome remodelers and 
histone modifying complexes seamlessly cooperate. This intersection extends beyond 
mere recruitment of ATP-dependent chromatin remodelers by PTMs deposited by 
HATs and SETs, as examples have been described (such as the homothallic switching 
endonuclease HO180) where the ATP-dependent remodelers precedes and is required 
for recruitment of HATs prior to transcriptional activation. 
A diversity of transcription factors like the glucocortoid receptor, Myc, MyoD, 
HSF-1 and C/EBPb have been shown to recruit hSWI/SNF to specific 
promoters122,181. Further, the D. melanogaster SWI/SNF-like Brahma complex 
appears to be required for the Wingless signaling pathway and the E2F cell-cycle 
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regulator function182,183 and hSWI/SNF is required for full function of several 
activators, including the glucocorticoid receptor184, the estrogen receptor185 and the 
retinoid receptors186. Intriguingly, mammalian SWI/SNF complexes appear to be 
essential for mouse development187,188 and expression of key pRb-dependent cell 
cycle regulators189 and contain the known tumour suppressors Brg1 and Snf5. Mice 
heterozygous for Brg1 or Snf5/Ini1 deletions are prone to a variety of tumor types, 
including glandular epithelial tumors and malignant rhabdoid tumors187,188,190 and it 
has been shown that mutations in hSNF5 induce chromosome loss and polyploidy191. 
Other ATP-dependent chromatin remodelers play key roles in transcriptional 
regulation as well, as exemplified by the repressor Ume6p recruiting yeast Isw2p192 or 
the recruitment of Mi-2/NuRD by the DNA binding transcription factor Ikaros of the 
NuRD complex to heterochromatin regions upon T cell activation193, proposed to 
maintain an inactive chromatin state.  
Besides well-established roles in transcription regulation, ATP-dependent 
nucleosome remodelers play roles in a wide range of physiological functions, ranging 
from histone deposition (Isw2, Swr1) to DNA damage response (Ino80, Sth1, Rad54, 
Rdh54) and chromosome segregation (Sth1)119,131,160,176,177,188,190,191,194. 
 
1.5.3 Other repressors of transcription   
Repressors of transcription can functionally be divided in two classes, and one 
class is functionally linked to chromatin and includes histones, histone-related 
proteins, histone deacetylases and histone demethylases (discussed in chapter 1.5.2). 
The other class operates through promoter elements and affects TBP binding, and 
includes for example BTAF1, which represses transcription at a subset of genes by 
binding TBP-DNA complexes and causing TBP to dissociate from the DNA43. 
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BTAF1 (hTAFII170/Mot1) was identified in a screen for mutants with enhanced basal 
transcription and is an ATP-dependent inhibitor of TBP binding; however Mot1 has 
also been shown to function as an activator195. Another example is Dr1-DRAP1/NC2 
which is a general negative regulator of class II and class III genes, and functions by 
preventing TBP binding to TFIIA and TFIIB and thus assembly into a preinitiation 
complex196.  
 
1.5.4 The ubiquitin system and transcription 
Eukaryotes contain a highly conserved multi-enzyme system that covalently 
links ubiquitin to a variety of proteins with degradation signals (degrons) recognized 
by this system, followed by degradation of the tagged protein in the 26S proteasome. 
This system has mainly been associated with cellular degradation of discarded 
proteins, but an increasing compilation of data suggests that it also is linked to 
transcription and regulation thereof.  
A protein substrate, recognised through a degron, is conjugated to Ubiquitin 
through the mechanism of the three enzymes E1, E2 and E3197. UBR1, an E3 of the 
N-end rule pathway, can recognize both the so-called N-degrons198 and internal (non-
N-terminal) degrons199. Most degrons are poorly defined, but amongst the known ones 
are N-end rule degrons200,201 cyclin destruction boxes202 and regions rich in proline, 
glutamic acid, serine and threonine (PEST sequences)203. Destabilising N-terminal 
amino acids may be generated through proteolysis and involve modifications like de-
amidation of asparagine and glutamine or arginylation of aspartic acid, glutamic acid 
or cysteines. The N-end rule has a hierarchical organization, where Asp (and Glu and 
Cys) are secondary destabilizing residues that must undergo conjugation by arginine-
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tRNA transferase (ATE1) to Arg, one of the primary destabilising residues to be 
recognized by the ubiquitin ligase204-206.  
 
 
 
 
 
Figure 5: The N-end rule pathway for the type 1 substrates Asp and Glu. N-terminal residues are denoted by 
single letter abbreviations for amino acids. The ovals represent the rest of a protein substrate. Primary 
destabilising residues are recognised by functionally overlapping E3s that include UBR1 and UBR2204-206.  
Ubiquitin-dependent pathways have been shown to play major roles in 
numerous processes, including cell differentiation, the cell cycle progression, 
embryogenesis, apoptosis, signal transduction, DNA repair and stress responses197,207. 
In addition, several pieces of evidence suggest that the transcription process is closely 
linked to the cellular protein degradation machinery. The largest subunit of RNA pol 
II is ubiquitylated during transcription in vitro208,209 and the yeast 19S proteasome is 
required for efficient transcription elongation by RNA pol II210. Ubiquitin mediated 
processing of p105211,212, IκBα (168), the SREBP family, VP16, the estrogen receptor 
and Ci-155213-217, has been shown to regulate the transcriptional activity of these 
factors. Importantly, many transcriptional regulators are conditionally short-lived 
proteins, and their cellular levels are largely determined by the rate of proteasomal 
degradation, rather than the rate of de novo synthesis218. Transcription-dependent 
degradation of transcription factors constitute a feedback mechanism to regulate the 
stability of transcription factors and, thereby, the dynamics of the transcriptional 
responses. 
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1.6 The recruitment models 
The general transcription factors and RNA pol II were purified and identified 
as independent, chromatographically distinct factors, and reconstitution of 
transcriptional activity in vitro occurred by step-wise addition of these factors2,7,11, 
arguing that one functions after the other. This step-wise model was challenged by the 
purification of preassembled complexes (holoenzymes) from yeast and human 
containing subsets of GTFs, Mediator subunits and SWI/SNF chromatin remodeling 
complex subunits97,219,220. Collectively, these reports suggested that some transcription 
factors associate with RNA pol II prior to promoter binding. Later, this view was yet 
again questioned by reports of holoenzyme components being recruited to promoters 
in the absence of RNA pol II114,221, in addition to the relative abundance of the yeast 
general transcription factors being more compatible with the step-wise model222.   
This brings about a central question in eukaryotic transcription regulation; 
how is the recruitment of the multitude of necessary factors orchestrated?   This issue 
has been addressed by a number of recent studies assessing the architecture of 
transcription components on various promoters in vivo over time. The now classical 
example of the HO promoter in yeast shows that the activator Swi5 transiently binds 
during telophase and recruits SWI/SNF, leading in turn to SAGA recruitment, histone 
modifications and binding of the activator SBF. Subsequent to that, and after Swi5 
removal, SBF recruits the Mediator, followed by the binding of RNA pol II and the 
GTFs114. The mammalian IFN-β locus, on the other hand, is activated upon 
recruitment of GCN5, subsequent histone acetylation and binding of RNA pol 
II/CBP223,224. RNA Pol II/CBP in turn recruits hSWI/SNF, followed by remodeling 
and binding of TBP, TFIID recruitment and finally transcription initiation. As 
classical is the mammalian example of estrogen-responsive genes, demonstrating the 
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cycling of ER and p300, subsequent histone acetylation and binding of PBP, CBP, 
PCAF and RNA pol II upon estrogen stimulation225. These types of experiments have 
also led to a reconsideration of the common view that basal transcription factors and 
RNA pol II can only associate with nucleosomes after remodeling; on the α1-AT 
promoter, TBP and TFIIB bind long before the CBP/PCAF complex and the 
remodeling complex Brm are recruited to the promoter226.   
The important insight emerging from these studies is that the steps leading to 
chromatin remodeling and assembly of the preinitiation complex vary extensively, 
depending on the gene and its biological context. This variability may be interpreted 
as an additional level of regulation at a particular gene; any given promoter can 
dictate its individual recruitment patterns, and thereby obtain a more tailored 
regulation.  
                            
Figure 6: Eukaryotic transcription regulation. Mediator facilitates integration of multiple activities into 
the preinitiation complex formed at the eukaryotic promoter. The Mediator can be recruited by specific 
promoter and or enhancer bound activators.  
 
 
 
Concluding remarks 
The compilation of data following the identification of RNA pol I, II and III 
almost four decades ago revealed that eukaryotic transcription is regulated in a 
manner far more complex than many anticipated. As in bacteria, gene transcription is 
achieved by factor recruitment, but the mechanism critically depends on the order of 
the recruited factors, the timing, the histone code and the selection of the available 
factors in the cell. Nevertheless, the composition of the general transcription 
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machinery is largely conserved between yeast and man, as are the mechanisms by 
which it functions194. As far as we know at this point, all the difference appears to be 
gained by a more intricate use of this machinery in humans, the more effective use of 
activators and signaling pathways as well as differential splicing.  
 
 
AIM AND OUTLINE OF THIS THESIS 
 The aim of the research presented here was to gain insight into the function of 
TFIIA cleavage and thus the protein complex TAC. To accomplish this, we undertook 
to 1) identify the residues of TBP involved in formation of the TAC complex, 2) to 
identify the cleavage site of TFIIAαβ and 3) characterize it, to 4) identify the protease 
responsible for cleavage of TFIIA and ultimately 5) understand the function of 
cleavage of TFIIA.    
 Chapter 1 is a summary of the eukaryotic transcription regulation.  Data that 
has been obtained in the last four decades revealed that eukaryotic gene regulation 
requires distinct multi-protein complexes to modulate chromatin structure, bind to 
enhancers, bind to promoters, to communicate between the basal transcription 
machinery and activators, to modify the nucleosomal structure and to generate 
transcripts. Global ChIP-on-chip profiling is now widely used to assess how 
transcriptional control is orchestrated on individual promoters in a whole genome 
context.  
 The general transcription factor TFIIA is reviewed in chapter 2. This chapter 
represents, in fact, an outline of the results, conclusions and perspectives presented in 
this thesis. In chapter 3, the identification of the contact residues between TBP and 
TFIIA in TAC is described. The results show that the helix 2 of TBP is essential for 
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formation of TAC and that residues in the stirrup region contribute to its stability. To 
begin investigating the role of TFIIA cleavage we identified the N-terminus of 
TFIIAβ, as described in chapter 4. Mutational analysis of the adjacent region was 
undertaken to assess the cleavage region, and this revealed the cleavage recognition 
sequence (CRS), a string of four residues that are essential for cleavage. Whereas no 
functional difference in transcriptional competence could be detected between wild-
type TFIIA and the uncleavable CRS mutants, cleavage of TFIIA was found to affect 
its stability. The uncleavable forms of TFIIA were considerably more stable than 
wild-type TFIIA. The data described in this chapter suggest that TFIIA is a substrate 
for proteasomal degradation subsequent to cleavage through the N-end rule.  The 
identification of the protease responsible for TFIIA cleavage is described in chapter 5. 
The TFIIA CRS was identical to the recently identified cleavage site of MLL, which 
is cleaved by Taspase1. Subsequently, Taspase1 was found to cleave TFIIA, revealing 
an exciting connection between two until then unrelated proteins. The hypothesis that 
TFIIA is a substrate for degradation through the N-end rule is elaborated upon in 
chapter 6. Over-expressing ATE1 leads to increased degradation of TFIIA, and 
consistently, the half-life of TFIIA is prolonged in ATE1-/- cells. This study indicates 
that TFIIA degradation follows the N-end rule, making TFIIA the first physiological 
substrate of ATE1 through an aspartic acid. Chapter 7 summarises the data presented 
in this thesis and discusses its implications. 
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CHAPTER 2 
Abstract 
TFIIA was originally identified as one of the general transcription factors, and 
activates transcription by stabilizing TBP binding to DNA and by working as a co-
activator and anti-repressor. Newly obtained data show that TFIIA instead of being a 
general transcriptional regulator is involved in transcriptional activation at a subset of 
promoters.  In addition, recent studies concerning the proteolytical cleavage of TFIIA 
reveal unexpected layers of complexity in TFIIA regulation. This review will focus on 
functional characteristics of TFIIA and discuss novel insights in the role and 
regulation of this revived basal transcription factor. 
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Introduction 
 In one of the groundbreaking discoveries in eukaryotic transcription, nuclear 
RNA polymerase I, II and III were identified and found to transcribe large ribosomal 
genes, protein coding and some small nuclear RNA genes and most small structural 
RNA genes, respectively1-3. The complexity and variability of the general 
transcription machinery in Eukarya was further extended through the discovery of 
specific accessory factors4-7. The inability of RNA polymerases to initiate 
transcription by themselves provided the basis for characterizing the basal 
transcription machinery, i.e. the general transcription factors (GTFs) that reconstitute 
efficient and selective transcription initiation. For RNA pol II, these GTFs were 
identified by fractionation of cellular extracts and include TFIIA, TFIID, TFIIE, 
TFIIF and TFIIH8-11. Despite the complexity conferred by the composition of the 
basal transcription machinery, subsequent research has unveiled an unexpected 
multitude of activators, repressors, multi-protein complexes mediating communication 
to the basal transcription machinery, and last but not least variation within the basal 
transcription machinery itself. It has also lead to the understanding that the highly 
compact nucleoprotein or chromatin structure in which the DNA is organised plays a 
central role in orchestrating transcription regulation12,13. 
One of the general transcription factors whose precise role in transcription has 
remained elusive is TFIIA. The TFIIA-containing fraction was originally found 
necessary to reconstitute basal transcription in vitro14. TFIIA has since been counted 
amongst the general transcription factors, though this classification has been debated, 
largely because of the contradicting results as to how general it actually is for basal 
transcription. Recent data suggest that promoters vary widely in their requirement for 
TFIIA for transcriptional activation, and it appears that TFIIA may not be generally 
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involved in transcription, but rather have a role in transcription of a subset of genes. 
An enigmatic feature of TFIIA is its proteolytic cleavage. Recent observations that 
TFIIA cleavage appears to be a regulated event together with the discovery that the 
MLL protease Taspase1 is also responsible for TFIIA cleavage have revealed 
unexpected aspects of TFIIA biology.  
 
The role of TFIIA in general transcription 
     Role in vitro  
The HeLa-derived Phosphocellulose (PC) A fraction, or Trancription Factor 
Pol II in PC A (TFIIA) has been shown to stimulate transcription and TBP binding to 
the TATA box15 but does not stimulate TBP-mediated transcription from a core 
promoter using highly purified factors16-19. In assays using partially purified factors, 
however, TFIIA stimulates transcription by reversing the inhibitory effects of negative 
co-factors like NC1, Dr1/NC2, Dr2/Topo1, HMG1 and DSP1, as well as by 
counteracting the effects of BTAF1 and TAF1 present in the extracts16,20-27. 
TFIIA is crucial for basal and activated transcription from TATA-less 
promoters in vitro, suggesting it has a core promoter-specific role beyond the binding 
of TBP to DNA28. TFIIA functions as a co-activator for several activators (AP-1, 
Gal4-AH, Zta, VP16, CTF, NTF, Sp1)16,17,29-31 and promotes co-activators like PC4 
and HMG218,32. In addition, TFIIA has been reported to regulate TBP or TFIID 
dimerization and thus accelerate DNA binding33. Some observations have lead to the 
implication that TFIIA is also involved in RNA pol III transcription, for example on 
the 5S and U6 RNA promoters34,35, whereas this has been contradicted by other 
results36-38.  
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The initial classification of TFIIA as a general transcription factor has been 
debated because of contradictory observations9,16,17,19,39, and the inconsistent 
categorisation of TFIIA as essential40,41, stimulatory8 and dispensable42,43 for 
transcription are generally believed to originate from variations in the transcription 
factor composition employed in the respective studies.   
 
     Role of TFIIA  in vivo  
TFIIA can activate RNA Pol II transcription by a variety of mechanisms, but 
one question that remains open is to what extent TFIIA is generally involved in RNA 
Pol II transcription. Various approaches have been employed to study its function in 
transcription by disrupting the TBP-TFIIA-DNA interaction. By employing a yeast 
TBP mutant unable to interact with TFIIA, Stargell and Struhl demonstrated a specific 
impairment in the response to acidic activators, but no effect on RNA Pol II 
transcription in general44 and by diminishing the interactions between TFIIA and TBP 
using yeast TOA2 mutants, Ozer et al. observed selective transcriptional effects and a 
partial inhibition of cell-cycle progression45. Ten times depletion of TFIIA leads to a 
modest decrease in RNA Pol II transcription from both TATA-containing and TATA-
less promoters37 and a variety of genes is affected when TFIIA is reduced to less than 
1% of the wild-type level36. The effects on individual genes can be seen as minor (2-3 
fold), but the fact that cells arrest specifically at G2/M argues that TFIIA has an 
important role in controlling genes related to cell cycle progression. This moderate 
effect contrasts with depletion of other general transcription factors like TBP, TFIIB, 
TFIIH subunits and RNA Pol II subunits which in all cases leads to a total elimination 
of RNA Pol II transcription in yeast36. Hitherto, the data support the notion that TFIIA 
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acts as a co-activator more than a general factor and that promoters vary considerably 
in the extent to which they require TFIIA. 
Based on its co-activating features and association with TBP, TFIIA has been 
proposed to be a TBP-associated factor (TAF) that dissociates from the TFIID 
complex more readily than the other TAFs46. This classification is, however, not fully 
supported; recent in vivo studies in yeast have shown that the TBP/TAF ratio varies 
significantly amongst different promoters in contrast to the TBP/TFIIA ratio47. This 
suggests that some genes are TFIIA-dependent but TAF-independent, whereas other 
genes are both TFIIA- and TAF-dependent. Geisberg and Struhl recently proposed a 
novel mechanism based on yeast studies addressing the occupancy of Mot1 on 
promoters before and after stress48. These data suggested that in stressed cells Mot1 
functionally replaces TFIIA in preinitiation complexes in vivo. The authors argued 
that this may explain the moderate effects on transcription upon TFIIA depletion. It 
has indeed been shown that Mot1 can assist in recruiting TBP to promoters during 
gene activation, much in the same way TFIIA is thought to do49,50. 
A large number of factors have been reported to genetically or physically 
interact with TFIIA (summarised in table 1). TFIIA has been shown to interact with 
Gcn5, Swi2 and Nhp6 suggesting that histone acetylation, chromatin regulation and 
architectural gene modulation contribute to the formation of a TBP-TFIIA-DNA 
complex61, but the overall characteristics of these factors support the notion that 
TFIIA modulates the activities of the TFIID- or SAGA-components, communicates 
between activators and the basal transcription machinery and counterbalances the 
effects of repressors.  
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Table 1: TFIIA-interacting proteins 
Factor Function Reference 
  
AP-1 Activator of transcription 51 
Zta Activator of transcription 17,51 
VP16 Activator of transcription 51,52 
CTF Activator of transcription 51 
NTF Activator of transcription 29,46 
SP1 Activator of transcription 29 
GAL4 Activator of transcription 53 
PC4 Co-activator of transcription 54 
HMG2 Co-activator of transcription 32 
scTAF11 TBP-Associated Factor 55 
dmTAF4 TBP-Associated Factor 46,56 
TBP TATA-Binding Protein 55,57,58 
TRF2 TBP-Related Factor 2 59 
CREM Activator of transcription in germ cells 60 
GCN5 Histone acetylase, component of SAGA 61 
SWI2 Chromatin remodeling 61 
NHP6 Archetectural gene modulation 61 
TAF1 TBP-Associated Factor 23,25,27 
BTAF1 Repressor of transcription 48,62 
NC2 Repressor of transcription 63,64 
HMGB1 Repressor of transcription 65 
RBP Repressor of transcription 56 
SPT3 Component of SAGA 62 
SPT8 Component of SAGA 56,66 
 
 
  
 
The architecture of the TFIIA subunits 
Yeast TFIIA was originally purified as two polypeptides with molecular masses of 32 
and 13.5 kDa67. The subsequent cloning of the polypeptides identified two genes, 
TOA1 and TOA2, that are both essential in yeast40.  In contrast to yeast, TFIIA was 
found to be composed of three polypeptides, α, β and γ, in H. sapiens and D. 
melanogaster16,46,68. Cloning of TFIIA revealed that the two larger subunits, α and β, 
are encoded by a single gene and post-translationally processed. Toa1 and Toa2 are 
the respective homologues of the TFIIAαβ and TFIIAγ subunits of higher 
eukaryotes16,46,68 (figure 1). he high sequence- and function conservation of TFIIA 
from yeast to human underlines the importance of TFIIA in fundamental aspects of 
eukaryotic transcription. Besides the highly conserved and essential N- and C-
terminal domains of TOA1, a significant portion of the non-conserved middle region 
can be removed without loss of viability37, leading to the suggestion that this domain 
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functions as a non-specific spacer region. Introducing the human acidic region or the 
very C-terminal region of TFIIAαβ has severe effects on yeast growth, arguing that, 
despite their conservation, some protein functions are not conserved across species69. 
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I II III IV
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1
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54% 72%
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Figure 1. Sequence comparison of yeast 
and human TFIIA and human ALF. The 
four-helix barrel (FHB) domain and the β-
barrel domain identified in the crystal 
studies are depicted, as are the spacer 
domain, the acidic fomain the the CRS.   
 
The general transcription machinery 
The general transcription factors were long believed to be unique and essential 
for transcription of all RNA Pol II promoters. This view has been challenged by the 
discovery of TBP-free TAF-containing complexes like hTFTC, hPCAF, hSTAGA 
and ySAGA and the isolation of cell-and tissue specific paralogues of several basal 
transcription factors. TBP was originally defined as a universal transcription factor70, 
but is in fact supplemented with at least three paralogues in metozoans; the insect-
specific TRF171-73, TLF/TRF2 which is found in all metozoan genomes examined74-78 
and the vertebrate TBP279,80.  
Subsequent to the identification of the TBP paralogues, the TFIIA-Like Factor 
(ALF) was isolated81,82. ALF is homologous to TFIIAαβ (figure 1), and like 
TFIIAαβ, it is able to interact with the small TFIIA subunit (γ) to form a 
heterodimeric complex that stabilizes binding of TBP to promoter DNA. ALF 
undergoes proteolytical cleavage like TFIIAαβ83-85. The expression of ALF is 
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restricted to testis (X. laevis and M. musculus), and oocytes (X. laevis), where it 
probably replaces TFIIAαβ during meiosis. Hitherto, only subunits of TFIID and 
TFIIA are complemented with cell-specific paralogues whereas RNA Pol II, TFIIB, 
TFIIE TFIIF and TFIIH are all present as a single gene in the D. melanogaster, 
mammalian and C. elegans genomes. An archeal homologue of TFIIA is missing, and 
similarly, the protozoa P. falciparum expresses no apparent subunits of TFIIA and no 
TAFs86. One way to interpret this is that TFIIA has evolved in organisms where 
activated transcription is more widely employed and requires more complex 
regulation. 
 
Regulation of TFIIA by cleavage 
The TFIIAαβ precursor could originally not be detected in SDS-treated cell 
extracts from HeLa cells, leading to the assumption that cleavage of TFIIA is not 
regulated and occurs simultaneously with or directly after or during translation, and 
implying that functional cellular TFIIA is cleaved17,68. This common view was 
reconsidered years later when studies in P19 embryonal carcinoma (EC) cells 
demonstrated that these cells contain considerable levels of the uncleaved form of 
TFIIAαβ.  In P19 EC cells, the uncleaved form of TFIIA interacts strongly with TBP 
in a TAF-free complex termed TAC that supports transcription87. Furthermore, over-
expression of the co-activator p300 facilitates formation of TAC also in other cell 
lines88. These observations provided the first hint that cleavage of TFIIAαβ is a 
regulated event that may be linked to the differentiation state of cells. This 
observation motivated new efforts to identify the TFIIA cleavage site and the 
responsible protease(s). The mapping and characterisation of the TFIIA cleavage site 
lead to the discovery of the cleavage recognition sequence (CRS), a string of four 
residues (272-275) that are essential for TFIIA cleavage85. The importance of the CRS 
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is underscored by its strict conservation between higher eukaryotes and S. pombe 
(figure 2). 
Inhibition of cleavage through a single mutation in the CRS significantly 
prolonged the half-life of TFIIA85. These and other results suggested that cleavage of 
TFIIA is linked to its degradation; cleaved TFIIAα and -β  are substrates for 
proteasomal degradation, but uncleaved TFIIAαβ appears not to be, indicating that 
the level of TFIIA is regulated by cleavage. Several reports conclude that cellular 
TFIIA levels fluctuate; it has for example been shown that TFIIA expression declines 
dramatically upon HSV virus infection, suggesting that regulation of TFIIA levels is 
part of a cellular program enabling the transition from early to late viral gene 
transcription during infection, consistent with a requirement for TFIIA in transcription 
of early but not late genes89. Furthermore, inactivation of TFIIA during terminal 
differentiation of avian erythroid cells contributes to a general repression of gene 
activity in these cells90, and TFIIAγ expression is up- regulated during Ras-mediated 
photoreceptor induction in D. melanogaster91. Collectively, these results suggest that 
regulation of TFIIA levels contributes to the regulation of gene expression 
concomitant with cell differentiation and transformation. Regulating TFIIA stability 
through cleavage seems to be one way to achieve this.  
Figure 2. Alignment of the CRS 
and the cleavage site of TFIIA and 
MLL from different organisms, 
human (h), mouse (m), Xenopus 
(x), pufferfish (p) and Drosophila 
(d). The conserved CRS is boxed. 
Cleavage of TFIIA and MLL by 
Taspase1 is at D/G, indicated with 
an arrow. D278 marked with ◊ is 
the identified N-terminal end of 
the β subunit of TFIIA purified 
from mammalian cells. The acidic 
stretch (residues in blue and 
purple) is relatively conserved in 
TFIIA and MLL. 
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 The identification of the protease responsible for TFIIA cleavage was 
facilitated by the observation that the CRS of TFIIA is identical to the protease 
cleavage site of the proto-oncogene Mixed-Lineage Leukemia (MLL)92, and 
consistent with that, MLL and TFIIA were shown to be cleaved by the same protease, 
Taspase193 (Zhou et al., manuscript in preparation). Whereas the N-terminus of the 
TFIIAβ-subunit purified from stable FM3A cells was identified as D27885, N-terminal 
sequencing of in vitro Taspase1-cleaved TFIIA revealed that its cleavage site was 
between D274/G275, identical to the cleavage site determined for MLL (Zhou and 
Stunnenberg, unpublished observations). The inconsistencies in the cleavage sites as 
determined in the two studies may be a result of a secondary cleavage event in vivo by 
either an endo- or an exopeptidase activity. The strict conservation of D278 in TFIIA 
across species and in the TFIIA homolog ALF together with the fact that mutations of 
D278 strongly impair cleavage argues that it is important for cleavage. D278 
represents a potential N-terminal degron in TFIIA, and one of the implications of 
TFIIA cleavage could be the generation of a destabilising N-terminus that activates 
the destruction pathway and thus regulates the level and transcriptional activity of 
TFIIA in the cell.  
Transcriptional regulation in higher eukaryotes displays a much higher degree 
of complexity than in unicellular Eukarya and this is exemplified by the existence of 
cell- and tissue-specific paralogues of various general transcription factors. The 
occurrence of TFIIA (and ALF) cleavage adds additional complexity to the collection 
of transcription factors. From an evolutionary point of view, the cleavage process 
appears to have evolved subsequent to the divergence of S. cerevisiae which does not 
contain cleaved TFIIA, consistent with the absence of a CRS in its TFIIA and the 
absence of a Taspase1 like L-asparaginase. In contrast, the TFIIA of fission yeast (S. 
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pombe), A. thaliana and C. elegans all contain a CRS and their genomes encode a 
Taspase1 like factor. It is therefore likely that TFIIA undergoes cleavage in these 
organisms.   
 
Developmental role of TFIIA cleavage 
During X. laevis development, TFIIA cleavage is tightly regulated and 
correlates closely with Taspase1 activity (Spicuglia and Stunnenberg, unpublished 
observations), suggesting that in X. laevis, TFIIA cleavage is largely regulated by 
governing Taspase1 activity. In P19 EC cells, the higher ratio of uncleaved to cleaved 
TFIIAαβ does not correlate with reduced cellular protein levels of Taspase1 (Zhou et 
al., manuscript in preparation). Thus in these cells, regulation of TFIIA cleavage may 
occur either by regulating the Taspase1 activity itself or by post-translational 
modification of TFIIA that interfere with cleavage. In line with the latter, a fraction of 
TFIIAαβ/γ present in HeLa nuclear extracts appears uncleavable even when exposed 
to high levels of Taspase1 suggesting that human TFIIA may indeed be modified to 
prevent cleavage (Zhou and Stunnenberg, unpublished observations). With this in 
mind, it is interesting to note that mimicking phosphorylation by the mutation T276D 
located in a putative phosphorylation site adjacent to the CRS renders TFIIA 
uncleavable, whereas T276A behaves like wild-type TFIIA (Høiby and Stunnenberg, 
unpublished observations). Furthermore, putative phosphorylation sites in the 
cleavage region seem to regulate TFIIA stability85.  The sites are potential GSK-3 
(T276) or casein kinase II (CKII) (T276, T279, S280, S281) sites, and notably, CKII 
has been implicated in promoter selection and in the regulation of a number of 
transcription factors, including IκBα, c-Jun, IRF-1, RNA pol II and the phosphatase 
FCP1 which is involved in recycling of RNA Pol II for transcription elongation94-96.  
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Additionally, phosphorylation of TFIIA by TAF1 has been reported to stimulate TBP-
TFIIA-DNA interaction and to contribute to transcriptional activation in yeast and 
human97,98.  
In addition to phosphorylation, TFIIA may be acetylated, because the role of 
p300 in TAC formation is dependent on the presence of its HAT domain, and 
consistently, preferentially the uncleaved form of TFIIAαβ is acetylated88. The exact 
role of p300 in regulation of TFIIA cleavage can only be speculated upon at present, 
but it is possible that it affects the efficacy of cleavage, either directly on the substrate 
TFIIA or by modulating the Taspase1 activity.  
TFIIA appears to be subjected to a relatively complex array of regulation steps 
involving several factors, including well-known co-activators like p300 as well as 
recently identified factors like Taspase1.   
 
Perspectives 
The basal transcription machinery, once viewed as conserved and stoical, 
varies extensively in a promoter- and cell-type specific fashion. The classical TBP-
containing complex TFIID is complemented by tissue- and cell-specific TAFs, TBP-
like factors and an array of TBP-free complexes. This diversity in the general 
transcription machinery extends to TFIIA; the TFIIA-like factor ALF is expressed in a 
cell type specific manner in higher eukaryotes and probably takes over the role of 
TFIIA during meiosis. Evolution of the CRS together with Taspase1-like proteases, 
suggests that cleavage of TFIIA occurs in most eukaryotic systems and may have 
evolved subsequent to the divergence of S. cerevisiae, likely resulting in additional 
complexity of transcriptional control. The assembly of the uncleaved form of 
TFIIAαβ and TBP into TAC suggests that it may be required for expression of a 
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specific set of genes that are not receptive to cleaved TFIIA-containing complexes. In 
line with this notion are the observations that TFIIA cleavage is tightly regulated 
throughout development of X. laevis, and it seems that the uncleaved TFIIAαβ exists 
predominantly during early embryonal stages. A comprehensive analysis of the 
function of cleaved and uncleaved TFIIA will require genome-wide localization 
studies using organisms where wild-type TFIIA is replaced by an uncleavable form of 
TFIIA and antibodies that specifically recognize cleaved or uncleaved forms of 
TFIIA.  
The unexpected finding that TFIIA and MLL are substrates of the same 
protease, Taspase1, raises intriguing questions concerning a link between these 
proteins. Is cleavage of TFIIA and MLL a functionally co-regulated process during 
development or is their interconnectedness limited to sharing a protease? Insights into 
the role of p300, E1A and CKII in MLL processing could shed light on this issue. The 
facts that the two substrates for Taspase1 identified so far (TFIIA and MLL) are 
transcription factors and that Taspase1 associates with chromatin may argue that 
Taspase1 mediated cleavage is linked to the transcription process.  
Over the years, TFIIA has transformed from a basal transcription factor 
involved in general transcription to a co-activator affecting only a specific subset of 
genes. The role of its most notable feature, the posttranslational processing, remains a 
complicated matter. TFIIA cleavage seems to be tightly regulated during development 
suggestive of a specific role for uncleaved TFIIA on developmentally regulated genes. 
However, cleavage does not seem to affect the transcriptional competence of 
TFIIA and the only apparent distinction is the difference in half-life. The role for 
cleavage in determining promoter recognition specificity and/or attenuating the 
turnover of TFIIA will require a multifaceted mechanistic analysis involving 
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Figure 3. Model of function and 
regulation of TFIIA. Uncleaved 
TFIIAαβ/γ can assemble with TBP into 
TAC and this is facilitated, directly or 
indirectly, by p300. TAC is responsible 
for the transcriptional activation of 
hitherto unknown embryo-specific 
promoters. TFIIAαβ/γ can be cleaved by 
Taspase 1 into TFIIAα/β/γ that can 
assemble with TFIID and activate 
general transcription. Ultimately, 
TFIIAα/β/γ is a substrate for 
proteasomal degradation, possibly 
through the N-end rule 
transcriptional co-activators such as p300 and CKII, Taspase1 and the co-factors 
involved in TFIIA degradation. In an age of high-throughput functional screening, it 
is remarkable that the biology of a single basal transcription factor continues to unveil 
unexpected layers of complexity decades after its identification. 
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CHAPTER 3 
The general transcription factor TFIIA facilitates assembly of the preinitiation 
complex (PIC) by stabilizing TBP binding to the DNA, by operating as a co-activator 
and by counteracting negative effects from factors like NC2 and BTAF1. TFIIA 
consists of three subunits, α, β and γ, of which α and β are transcribed from one gene 
and post-translationally cleaved. The processed form of TFIIA associates with the 
TFIID complex, whereas the unprocessed form of TFIIA can associate with TBP in a 
complex (TAC) devoid of classical TAFs.  
 To learn more about the TAC-specific interactions, we tested the ability of a 
large number of TBP mutants for their ability to form TAC. Similarly, we studied the 
binding affinity of these respective mutants to TAF1.  Our data demonstrates that the 
convex surface of TBP is essential for TAC formation, whereas residues in the stirrup 
region contribute to its stability. Consequently, the TBP binding sites of TAF1 and 
TFIIA largely overlap, indicating that formation of TAC is incompatible with TBP-
TAF1 interaction. Since TAF1 is suggested to function as a scaffold for the other 
TAFs in TFIID, it could also explain why no TAFs have been found in TAC.  
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Introduction 
 Classically, the general transcription factors necessary for the assembly of the 
preinitiation complex (PIC) on an RNA pol II promoter ending in transcription 
initiation include TFIIA, -B, -D, (containing TATA-binding protein (TBP) and a 
number of TBP-associated factors (TAFs)), -E, -F and –H1. TBP has affinity for the 
TATA element, and has long been held to be crucial for transcription because of its 
involvement in the function of RNA pol I, RNA pol II and RNA pol III2. This dogma 
was challenged by the identification of the TBP-free complexes, like hTFTC (TBP-
free-TAF-containing complex) that supports in vitro transcription from TATA-
containing promoters as well as TATA-less promoters3. Genome-wide analyses in 
yeast do in fact confirm that most of the genes are TFIID-dominated (90%) and these 
genes have a strong tendency towards being house-keeping and non-regulated. In 
contrast, the ySAGA complex, a TBP-free protein complex that share some TFIID 
subunits, generally control genes that are stress-induced and highly regulated4, though 
a marginal overlap between these two complexes exists.  
The classification of TFIIA as a general transcription factor is already long 
debated. In general, TFIIA stimulates and stabilises association of TBP to the 
promoter5,6, and it can operate as an anti-repressor as well as a co-activator7-10. Most 
probably, the contradicting effects of TFIIA in transcription are due to differences in 
the experimental setup. TFIIA consists of the subunits TOA1 (yeast) or TFIIAαβ 
(higher eukaryotes) and TOA2 (yeast) or TFIIAγ (higher eukaryotes)11-14. In contrast 
to yeast TOA1, TFIIAαβ in higher eukaryotes is post-translationally cleaved to yield 
the two subunits α and β that are highly homologous to TOA1 N- and C–terminus, 
respectively10,15,16, whereas TFIIAγ and TOA2 are conserved throughout the protein. 
The major interactions between TFIIA and TBP are between the TOA2 and the N-
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terminal stirrup region of TBP, as demonstrated by crystallographic17-19 and genetic 
studies20-22. In addition, genetic studies have indicated that the N-terminal helix 2 
region of TBP is important for TFIIA interaction, probably through a strongly acidic 
domain of TFIIAβ.  
The largest subunit of the TFIID complex, TAF1, is suggested to serve as a 
binding scaffold for the other TAFs23. TAF1 has two bromo domains24, two kinase 
domains reported to phosphorylate Rap74 (TFIIF)25,26 and TFIIA26, a histone acetyl 
transferase domain that acetylate histones H3, H4 and H2A27 and a Ubiquitin-
activating/conjugating activity shown to ubiquitylate histone H128. TAF1 has been 
associated with regulation of the cell cycle, cell differentiation, cell proliferation and 
cell survival29-31. Although TAF1 in general is seen as a co-activator, it negatively 
regulates transcription by sequestering TBP away from DNA, and by competing with 
TFIIA binding to TBP32-35. The N-terminal domain of dmTAF1 has been dissected 
into two main TBP-interaction domains, dmTANDI and dmTANDII (TAND for 
TAF1 N-terminal Domain), binding to the concave and the convex side of TBP, 
respectively32,36,37.  
In contrast to yeast TBP, which is largely monomeric, mammalian TBP does 
not exist as a free molecule2. A protein complex consisting of TBP and the uncleaved 
form of TFIIAαβ together with TFIIAγ (named TAC), originally identified in 
embryonal carcinoma (EC) cells, has been hypothesized to supplement complexes like 
hSTAGA, hPCAF or hTFTC with TBP38,39. TAC mediates transcription in P19 EC 
cells and its cell-specific assembly suggests a link between the proteolytical state of 
TFIIAαβ and cell differentiation. Whereas the TFIIA-TFIID interaction can be 
disrupted under low-stringent conditions12, TAC is remarkably stable and can be 
purified from cell extracts under high stringency conditions. This suggests that 
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interactions between TFIIA and TBP in TAC are fundamentally different from 
interactions between TFIIA and TBP in TFIID. Recent studies have found that 
whereas the TBP/TAF ratio varies significantly between different promoters, the 
TBP/TFIIA ratio is constant40. This implies that some promoters are TFIIA-dependent 
but TAF-independent.  
We set out to study the biochemical characteristics of the TAC complex, and 
the properties that distinguish it from a TFIID-TFIIA complex; furthermore, to 
investigate how TBP is distributed between various protein complexes in cells. By 
employing a large set of TBP surface mutants, we have shown that residues found to 
be essential for TFIID-TFIIA interaction and activation of transcription play a less 
important role in the formation of TAC. This suggests that the ‘classical’ TFIID-
TFIIA interactions are supplemented by additional interactions in TAC, consistent 
with its remarkable stability under high-stringency conditions. Explicitly, our data 
demonstrate that the helix 2 domain of TBP is essential for TAC formation whereas 
residues in the stirrup region contribute to its stability. 
 
Results 
Competition between TFIIA and TAF1 for TBP binding 
A number of studies has demonstrated that TFIIA and TAF1 can bind 
competitively to overlapping surfaces of TBP but that TBP in the context of TFIID 
accommodates binding of both TAF1 and TFIIA33,41. The absence of TAF1 in TAC 
could imply that binding of TAF1 to TBP interferes with TAC formation. To address 
this question we set up a competitive assay by co-expressing TAF1, TBP and TFIIA 
in P19 EC cells. Figure 1B shows the expression of TBP, TFIIAαβ and increasing 
amounts of transfected TAF1. Both TFIIAαβ and TAF1 are detected through an HA-
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pronounced TBP stabilisation (fig. 1D, compare lane 1 with lane 4) indicating TAC 
epitope to enable direct comparison in a Western blotting analysis. However, the 
results showed that obtaining sufficiently high levels of expressed TAF1 was difficult 
(compare the levels of TFIIAαβ and TAF1 in lanes 5, figure 1B). To facilitate this, 
two deletion mutants of TAF1 were generated; TAF1∆1 contains the two TBP-
interacting domains TANDI and TANDII (residues 1-156), whereas TAF1∆2 in 
addition contains the N-terminal protein kinase domain of TAF1 and most of the 
histone acetylase domain (residues 1-894) (see figure 1A for a schematic depiction of 
TAF1 and its mutants). TAF1∆2 was readily expressed in P19 EC cells and TBP is 
stabilised upon co-expression of TAF1∆2 (Figure 1C, compare lane 2 with lane 5), 
confirming that the interaction between the two proteins is intact. Co-expression of 
TFIIA did not affect the overall level of TBP or TAF1∆2 in these experiments 
(compare lanes 4 and 5 with lane 6). Co-expression of TBP and TFIIA resulted in 
Figure 1 Co-expression of TAF1, TFIIA and TBP (A) Schematic picture of TAF1 and the deletion mutants TAF1∆1 and 
TAF1∆2. The known protein domains are depicted in the figure (B) Extracts of P19 EC cells transfected with TBP, TFIIA and 
increasing amounts of TAF1 were subjected to Western blot analysis with the HA-antobody (C) Extracts from P19 EC cells 
transfected with TBP, TFIIA and the TAF1 deletion mutant TAF1∆2 were analysed as in (B) (D) Extracts from P19 EC cells 
transfected with TBP, TFIIA and the deletion mutant TAF1∆1 were immunopricipitated using the anti-TBP antibody SL39. 
Peptide elution with the SL39 synthetic peptide was followed by analysis as in (B). Lanes 1-7 represent whole cell extracts and 
lanes 8-14 represent the eluted proteins.
TBP SURFACE AND TAC FORMATION 
complex formation, consistent with previous results38. The shortest deletion mutant 
TAF1∆1 containing only the two TBP interaction domains TANDI and TANDII was 
expressed at high levels in P19 EC cells (Figure 1D, lane 3). The level of TBP 
increased dramatically upon co-transfection of TAF1∆1, similar to what occurs when 
TFIIA and TBP are co-expressed (compare lane 4 with lane 5). This suggests that the 
TBP interaction site is contained within the smallest mutant of TAF1 (Figure 1B).  
To extend the above data and to test whether TFIIA and TAF1 compete for the 
same i
immunoprecipitated from the cells where TBP was not transfected (Figure 1D, lane 
13), most likely due to interaction between TAF1∆1 and endogenous TBP. In a 
competitive setting when all three proteins (TFIIA, TAF1∆1 and TBP) were co-
expressed, both TFIIA and TAF1∆1 were co-immunoprecipitated by TBP (Figure 1D, 
lane 14). The amount of TFIIA in the precipitate was moderately less than in the 
absence of TAF1∆1 (Figure 1D, compare lane 11 with lane 14). Although these 
results do not prove that complexes are formed with either TFIIA or TAF1 and not 
both, they suggest that the interaction between TBP and TAF1∆1 is affecting the 
f
 
 
 
nteraction domain on TBP, extracts from P19 EC cells co-transfected with 
TFIIA, TAF1∆1 and TBP were used for immunoprecipitations with antibodies against 
TBP. TFIIAαβ and TFIIAγ were readily co-precipitated with TBP (Figure 1D, lane 
11 and data not shown) confirming the formation of a genuine TAC complex. 
Similarly, the presence of TAF1∆1 in the precipitate established that a complex was 
formed between TAF1∆1 and TBP (Figure 1D lane 12).  Some TAF1∆1 was 
ormation of TAC.  
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Helix 2 in TBP is important for TAC formation 
To systematically study the potentially overlapping interaction sites of TAF1 
and TFIIA on TBP, we employed a large number of TBP surface mutants in a set of 
experiments designed to identify single residues involved in the formation of the 
respective complexes. These mutants have previously been used to map TBP epitopes 
important for TFIIA-TBP-DNA complex formation (DA complex) and tested for their 
response to activated and basal transcription . Bryant and colleagues showed that the 
main interaction lies in the so-called stirrup region of TBP, specifically residues 
A184, N189, A190, E191, R203 and R205, consistent with the crystallographic data 
, and
21
of yeast TBP17,18,21  these residues are also important for activated transcription in 
vivo.  
Fourty-seven TBP surface mutants were chosen for their structural proximity 
ain and used in this study. The TBP mutants were 
analysed by co-transfection with TFIIA in U2-OS and P19 EC cells, followed by 
Western blotting analysis. The extent to which TAC was formed was monitored by 
the observed stabilization of TBP upon co-transfecting TFIIA (Figure 2A and 2B). Of 
the fourty-seven mutants, five (R188E, Y192E, I201D, G223R, F253E) were 
expressed at very low level, or not at all. These mutants were probably unable to fold 
properly and were not considered further in the analysis. The results showed that 
mutants A190E, N193R, E227A, L244E, G245E, F246E, K249E, F250E, L251E and 
K254E modestly affected the formation of TAC, whereas the most severe effect was 
observed with the triple mutant R231E/R235E/R239E (named H2 for helix2) that was 
not able to fo igure 2B and 2C). This is consistent with previous data, 
except for mutants N193R, G245E, K249E, F250E and L251E that have been 
reported to behave like wild-type TBP in DA complex formation21. In converse, a 
to the TFIIA interaction dom
rm TAC at all (F
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number of mutants (A184E, E191R, R203E, R205E, S216R) that have previously 
been shown to severely undermine DA complex formation, behaved as TBP wild-type 
in the TAC assay (Figure 2B and Table 1). 
This suggests that the critical interactions involved in ‘classical’ TFIIA-TFIID 
formation are complemented by additional interactions in TAC. However, the 
relatively modest effects obtained in these experiments needed further verification. To 
confirm the data, extracts from P19 EC cells transfected with TFIIA and TBP (wild-
type or a subset of the mutants; A184E, E191R and the triple helix 2 mutant H2) were 
used for immunoprecipitations. A184E and E191R are in the stirrup region of TBP 
Figure 2 Effect of single mutations on TBP for formation of TAC and TAF1∆1-TBP (A, B) Extracts from P19 EC cells 
transfected with TBP wild-type or mutants, as depicted, (A) alone or (B) together with TFIIA were subjected to Western blot 
analysis using the HA antibody. (C) Extracts from P19 EC cells transfected with TFIIA and TBP wild-type or mutants as 
depicted, were subjected to immunoprecipitation using the Myc antibody against Myc-tagged TFIIAαβ. Peptide elution with 
the Myc synthetic peptide was followed by Western blot analysis using antibodies Myc (for TFIIAαβ and TFIIAα) and SL39 
(for TBP). (D) Extracts from P19 EC cells transfected with TBP wild-type or mutants as depicted and the TAF1 deletion 
mutant TAF1∆1 (see figure 1A) were analysed as in 2A.
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and were chosen because they fail to support transcription in vivo21. Figure 2C shows
le to form exogenous TAC, though to a 
 TAC cannot be formed with the mutant
monstrate that helix 2 is essential for TAC 
contribute to the stability of TAC but
x, whereas they are essential for formation 
anscription. In addition, TAC appears to 
193, G245, K249, F250 and L251 as
formation of TAC and interaction with TAF1∆1 
 
that TBP mutants A184E and E191R are ab
lesser extent than wild-type TBP. However,  
TBP H2. 
Taken together, the above results de
formation. Amino acids in the stirrup region  
appear to be less important in this comple
of a DA complex and to support activated tr
employ an additional contact surface including N  
compared to TFIIA-TFIID. 
Table 1: The effect of single TBP mutations on 
Mutation EMSA with TFIIA 
 
TAC formation TAF1∆1 interaction 
S159E + + + 
I161R +/- + + 
+ V162R + + 
G175R + + + 
+ C176R + + 
K177E + + + 
+ K179R + + 
K181E +/- + + 
A184E - + + 
L185E + + + 
R186E + +/- + 
A190E - + +/- 
E191R - +/- +/- 
N193R + + + 
P194E + + + 
K195E + + + 
R203E - + +/- 
R205E - + + 
E206R + + + 
R208E + + + 
S215E + + + 
S216R +/- + + 
E227R - +/- + 
E228A + + + 
R231E + + + 
L232E + + + 
R235E + + + 
K236Q + + + 
R239S + + + 
V240Q + + +/- 
L244E +/- +/- + 
G245E + +/- + 
F246E +/- +/- + 
K249E + + + 
F250E + +/- +/- 
L251E + +/- +/- 
D252R + + + 
K254E + +/- + 
+ + S261E + 
R231A R235A R239A - - - 
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The bi
ded from the analysis. Our results are partly consistent with the study of the 
Berk g
utants, namely A184E, N193R, R231E, R235E, K236Q, 
R239E and L244E gave conflicting results
aken together, our results w that there are several overlaps in the binding 
of T αβ/γ (TAC-specific) and TAF1 to TBP. The triple mutant H2 completely 
prohibits formation of TAC, and has also been shown to reduce the interaction 
between TAF1 and TBP with 98% compared to the wild-type TBP42 hus, these 
three residues are critically involved in both form n of TAC an BP-TAF1. 
Fur ore, residues L244, F250 and L251, which all seats at the top of the saddle 
stru of TBP, near helix 2 (see , contribute to the stability of AC as well 
as TAF1-TBP. 
nding surface between TBP and TAF1 
To determine which surface of TBP is involved in TAF1 interaction, TBP and 
the mutant TAF1∆1 were co-transfected into P19 EC cells or U2-OS cells, followed 
by Western blotting analysis. The extent to which the proteins interact was monitored 
by the stabilization of the proteins; both TBP and TAF1∆1 were stabilized upon co-
expression (Figure 1D, compare lanes 1, 3 and 5). Of the fourty-seven mutants tested, 
6 mutations affected the stability of TBP-TAF1∆1, namely A190E, E191R, R203E, 
V240Q, F250E and L251E (Figure 2D and Table 1). As previously mentioned, 
R188E, Y192E, I201, G223R and F253E were probably unable to fold properly, and 
were exclu
roup42 that reported TBP residues A184, N189, N193, R205, R231, R235, 
K236, R239, V240, Q242, K243, L244, F250, L251 and K254 were critically 
involved in TAF1 interaction. Mutation of either one of these residues leads to a 
binding efficacy reduced with 50% or more. Whereas the study of Berk did not test 
the mutant R203E, this work did not include mutants of residues N189, Q242 and 
K243. Nonetheless, seven m
 in the two studies (see discussion). 
T  sho
FIIA
. T
a iot d T 
therm
cture figure 3)  T
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Figure he TBP binding surfa r TFIIA and 
TAF1∆ rlap (A) Crystal structure of TBP binding 
to DNA. Residues involved in form n of TAC are 
depicted in dark. (B) As in (A), bu sidues in dark 
are involved in interactions with TA 1 
3. T ce fo
1 ove
atio
t re
F1∆
A   B 
Discussion 
In this study, we have mapped the TBP residues that are crucial for formation 
face mutants and testing them for 
interac
s under 
low-sal
of TAC by employing fourty-seven TBP sur
tion with TFIIAαβ/γ (into TAC) in vivo in P19 EC cells. The mutants cover 
most of the N-terminal region of TBP, including the domains that have been shown to 
be important for the formation of a TFIIA-TFIID-DNA complex in vitro and for 
activated transcription in vivo 21,42. It has earlier been shown that TFIIA can interact 
with TBP in the context of TFIID, but unlike the TAFs, TFIIA disassociates from 
TFIID at low-stringent conditions12. This is in strong contrast to the stability of TAC 
that survives high-salt conditions. We have found that ten single mutations in TBP 
reduced TAC formation (∼two-fold), and most of these residues are essential for 
optimal activated transcription by TFIID-TFIIA21. No TBP residues were found to be 
critically and exclusively involved in TAC formation, although four mutants that 
behaved like wild-type TBP in earlier studies, modestly affected TAC formation. On 
the other side, a number of the mutants that were critically impaired in their ability to 
form a TFIID-TFIIA complex and activate transcription readily formed TAC. An 
explanation for this is that interactions that are essential for ‘classical’ TFIIA-TFIID 
are complemented by additional interactions in the TAC complex. This could explain 
why TAC survives high-stringent conditions whereas TFIID-TFIIA dissociate
t conditions. It also offers an explanation for why no single residues are 
critically and specifically important for TAC formation; individual/single mutations in 
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TBP have less effect on TAC formation because more residues are involved in the 
binding. However, the strategy using single TBP mutations only is probably not 
sufficient to identify all the residues that are involved in TAC formation.  
The most severe effects on TAC formation were obtained with a triple 
mutation, R231E/R235E/R239E in the helix 2 sitting on top of TBP and residues 
clustered close to it (L244E, K249, F250E, L251E, V240Q). This domain has been 
yp A binding based on several arguments; its basicity 
complements the acidic stretch of TFIIA (residues 280-300 in humans)17,18, in 
addition, genetic studies have suggested that  
binding20,22. The acidic region of TFIIA did n on is not 
clear. In this context, it is interesting to note that the cleavage-exposed N-terminus of 
TFIIAβ has been identified as D278, immediately N-terminal of the acidic stretch43. 
Cleavage of TFIIA may have consequences for the structural flexibility of this region. 
Therefore, cleavage may change, directly or indirectly, the nature of the interaction 
between TFIIAαβ and TBP in TAC. It is likely that the uncleaved TFIIAαβ present in 
TAC makes additional contacts with TBP as compared to the interactions made 
between cleaved TFIIA and TFIID. Given that TFIIAαβ has been shown to be 
acetylated in TAC38,39, it is tempting to speculate that modified TFIIAαβ has different 
affinity for TBP than non-modified, cleaved TFIIA. 
Berk et al have shown that important contributions to TAF1-TBP interaction 
in vitro are made by the residues A184, R231, R235, K236 and R23942; however these 
results could not be confirmed in our studies. The inconsistencies in the two studies 
are likely due to the different experimental setups; the former study was performed 
using in vitro GST pull-downs and a protein is likely to bind differently in the context 
of a full set of transcription factors in vivo. Another explanation may be that the small 
h othesised to be involved in TFII
 this domain is involved in TFIIA
ot crystallise and its functi
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TAF1 fragment (∼30kD) generated in this study lacks domains that contribute to the 
TBP-TAF1 interaction. Consistent with the latter, Martel et al suggest an interaction 
between the first TBP repeat and residues 1172-1344 (the HMG box) of TAF1 and 
this region is not present in the deletion mutant TAF1∆1.  
Taken together, this study shows that there are overlaps in the binding sites of 
TAF1 and TFIIA to TBP, consistent with previous reports. These overlaps indicate 
that formation of TAC is incompatible with the assembly of a TAF1-TBP complex, 
and may offer an explanation for why none of the classical TAFs have been observed 
in TAC. The co-existence of TAF-dependent and TAF-independent forms of 
transcr
 site of pSG5-new. TAF1∆2 was 
iptionally active TBP are well-known in yeast40,44, and the occupancy of TFIIA 
correlates with TBP, suggesting that some promoters bind TBP and TFIIA but no 
TAFs. Whether the TAC complex present in mammalian cells represents the TAF-
independent form of TBP in higher eukaryotes or whether TAC complements TBP-
free complexes like PCAF or STAGA remains to be seen. 
 
Materials and Methods 
Plasmids, mutagenesis and antibodies, protein extracts, SDS-PAGE, 
immunoprecipitation, immunoblotting  
Expression plasmids encoding hTBP (pSG5-hTBP), Myc-tagged hTFIIAαβ 
(pSG5-Myc-hTFIIAαβ) and hTFIIAγ (pSG5-hTFIIAγ) have been described38. HA-
TAF1 was cloned by excising the BglII-BglII fragment (4241bp) fragment from pSV-
CMVTAF1 and ligate it into the BamHI site of pSG5-new (step1). In step 2, the PstI-
BamHI fragment from pSV-CMVTAF1 was excised and ligated into the PstI-BglII 
site of pSG5-new-TAF1 from step 1. TAF1∆1 was generated by placing the BglII-
SmaI fragment from pSV-CMVTAF1 into the SmaI
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generat
Ackno
4. Huisinga, K. L. & Pugh, B. F. A genome-wide housekeeping role for TFIID 
edings of the National 
 93, 10620-5 (1996). 
6. Oelgeschlager, T., Chiang, C. M. & Roeder, R. G. Topology and 
reorganization of a human TFIID-promoter complex. Nature 382, 735-8 
7. Auble, D. T. et al. Mot1, a global repressor of RNA polymerase II 
 mechanism. 
, Ha, I., Lane, W. S. & Reinberg, D. Dr1, a 
otein and inhibitor of class II 
gene transcription. Cell 70, 477-89 (1992). 
ed by excising the BglII-PstI fragment from pSV-CMVTAF1 and clone it into 
the BglII (klenow)-BamHI site of pSG5-new. The monoclonal antibodies Myc, HA 
and SL39, preparation of cell extracts, SDS-PAGE, immunoblotting and 
immunoprecipiation have been described38.  
 
Cell culture and transient transfections  
U2-OS cells were maintained in DMEM supplemented with 10% FCS, P19 EC cells 
were maintained as described38.  Transient transfections were performed as 
previously38. 
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CHAPTER 4 
Abstract   
The transcription factor TFIIA is encoded by two genes, TFIIAαβ and 
γ. In higher eukaryotes, the TFIIAαβ is translated as a precursor and undergoes 
roteolytic cleavage; the regulation and biological implications of the cleavage have 
remained elusive. We determined by E egradation that the TFIIAβ subunit 
starts at Asp 278. We found that a C
TFIIA
p
dman d
leavage Recognition Site (CRS), a string of amino 
cids QVDG at position -6 to -3 from Asp 278, is essential for cleavage. Mutations in 
e CRS that prevent cleavage significantly prolong the half-life of TFIIA. 
onsistently, the cleaved TFIIA is a substrate for the ubiquitin pathway and 
roteasome-mediated degradation. We show that mutations in the putative 
hosphorylation sites of TFIIAβ greatly affect degradation of the β-subunit. We 
prop  in 
the cell and consequently the l
 
 
 
 
 
 
 
 
a
th
C
p
p
ose that cleavage and subsequent degradation fine-tunes the amount of TFIIA
evel of transcription.  
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Introduction 
11-17
bunits are referred to as TOA2 in 
udding yeast and TFIIAγ in higher eukaryotes and show a high degree of overall 
omology. Whereas the large subunits, called TOA1 in yeast and TFIIAαβ or TFIIA-
 in human, show extensive homology in both N- and C-terminus, the central part is 
ss conserved and structured18. A remarkable phenomenon in higher eukaryotes is the 
roteolytic cleavage of TFIIAαβ into TFIIAα and TFIIAβ subunits19-21. The site and 
mino acid requirements for cleavage have not been described until now, and it is also 
nclear whether cleavage is a specific and regulated process. Originally, only the 
leavage products of native TFIIAαβ were detected in cell extracts in association with 
FIIAγ. However, we recently identified a novel transcription complex, TAC, in 
mbryonal carcinoma (EC) cells that contains TFIIAαβ along with TFIIAγ in a 
complex with TBP22,23. This observation and data presented in this study suggest that 
A critical step in transcription is the recruitment and assembly of the 
preinitiation complex on the promoter1,2. RNA polymerase II and the basal 
transcription factors are necessary and sufficient to support basal transcription in vitro 
3,4. The basal transcription factor TFIIA has been shown to enhance transcription by 
interacting with TBP and stabilising its binding to DNA, thereby accelerating a rate-
limiting step5. In addition, TFIIA possesses activator activity and can counteract 
negative co-factors like NC2/Dr1 and Dr2/PC36-10. Basal transcription factors were 
originally defined as such because they were thought to be universally required for 
transcription. The identification of cell type-specific and gene-specific basal 
transcription factors such as the TBP paralogs, TLFs or the TFIIA paralog, ALF , 
implies a higher degree of complexity than previously assumed.  
TFIIA is encoded by two genes; the small su
b
h
L
le
p
a
u
c
T
e
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cleavage of TFIIAαβ precursor is a regulated process and that the cleaved (α+β+γ) 
and un
ge process. Edman 
degrad
cleaved (αβ+γ) TFIIA may have distinct cellular functions. 
Key transcriptional regulatory mechanisms include post-translational 
modifications like acetylation, phosphorylation and ubiquitylation. Classically, 
ubiquitylation has been viewed as a protein disposal pathway, but cells also appear to 
use this system as a means of fine-tuning transcriptional regulation that involves non-
proteolytic pathways24. It has recently been demonstrated that ubiquitin-proteasome 
function is required for the transcriptional activity of ERα and VP16 activator25-27. 
Ubiquitylation of transcription factors can therefore affect their activity, accumulation 
and localisation. 
In this study, we determine the N-terminal amino acid of TFIIAβ and elucidate 
the mechanism and biological consequences of the cleava
ation and mutational analysis of the region surrounding the cleavage site 
revealed the Cleavage Recognition Site (CRS), a string of four amino acids adjacent 
to the cleavage site that is essential for cleavage. We provide evidence that cleavage 
triggers degradation of TFIIA via the ubiquitin-proteasome pathway and determines 
its half-life. Our results further suggest that degradation of TFIIAβ is likely regulated. 
In conclusion, cleavage and degradation of TFIIA appear to control the level of this 
basal transcription factor to meet the demands of the cell to rapidly adapt transcription 
processes.  
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Results  
Identification of the N-terminus of TFIIAβ 
To fac
Aγ due to interaction with transduced human TFIIAαβ. Thus, the 
transdu
ilitate rapid purification of TFIIA we employed classical biochemical and 
immuno-affinity purification methods using a retrovirally transduced FM3A mouse 
cell line that stably expresses human TFIIAαβ with Myc-and HA-epitopes at the N- 
and C-termini, respectively. The transduced human TFIIAαβ protein is partially 
cleaved into TFIIAα and TFIIAβ subunits of the expected sizes (Figure 1A). 
Interestingly, over-expression of TFIIAαβ results in elevated levels of endogenous 
TFIIAγ (compare lane 1 with lane 2), likely resulting from stabilization of 
endogenous TFII
ced human TFIIAαβ is able to form a complex with mouse TFIIAγ. Whole 
cell extracts prepared from a pool of transduced FM3A cells were used for 
purification of TFIIA as outlined in Figure 1B. Fractions from the Superose 6 column 
were analysed by SDS-PAGE and silver staining (Figure 1C) and by immunoblotting 
Fig. 1. Expression and purification of TFIIA. (A) 
subunits. Extracts from non-transduced (lane 1) 
PAGE and immunoblotting using antibodies 
product. (B) TFIIA purification scheme using 
whole cell extracts from FM3A cells stably 
expressing hTFIIAαβ. (C) Superose 6 fractions 
were subjected to SDS-PAGE and silver staining. 
Fractions 12 and 13 contain TFIIA subunits (α, β 
and γ), as depicted by arrows. (D) TFIIA-
containing fraction 12 from Superose 6 column 
(lane 1) or extract from non-transduced FM3A 
cells (lane 2) were subjected to 
immunoprecipitation using the 12 CA5 (HA) 
antibody against HA-tagged-hTFIIAβ. The 
immunoprecipitates were eluted with an excess of 
the HA synthetic peptide and analysed by SDS-
PAGE and silver staining. endTFIIA=endogenous 
TFIIA. 
hTFIIAαβ stably expressed in transduced FM3A 
cells is cleaved to yield TFIIAα and TFIIAβ 
and stably transduced cells expressing Myc-HA-
tagged hTFIIAαβ (lane 2) were analysed by SDS-
against TFIIAα, TFIIAβ and TFIIAγ. The band 
marked with an asterisk is a minor TFIIAα 
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(data not shown). Fraction 12 containing the highest concentration of TFIIA was 
 CA5 monoclonal antibody against the 
 
mutational analysis (alanine scan) of the region su
type and mutant TFIIAαβ were co-transfected alo
and analysed by immunoblotting (Figure 2B). Int
acids at positions -6 to -3 with respect to the cleavage site (Q272A, V273A, D274A 
and G275A) either abolished cleavage or yielded
products. Mutation of the amino acid at +1, i.e. th
significant reduction in the levels of the cleavage
well as increased accumulation of TFIIAαβ. In contrast, mutation of the amino acids -
subjected to immunoprecipitation using the 12
HA-epitope on the C-terminus of the β subunit (Figure 1D). The immunoprecipitate 
contained, amongst others, polypeptides with molecular weights of about 40, 20 and 
12 kDa, the expected sizes of the TFIIA subunits. Western blotting indeed identified 
these as the α, β and γ subunits of TFIIA, respectively (data not shown). The 40-kDa 
protein as well as other slower migrating polypeptides (Figure 2D) were excised and 
analysed by mass spectrometry. A tryptic fragment of 11 amino acids conserved 
between mouse and human identified the 40-kDa polypeptide as the TFIIAα subunit. 
The identity of the slower migrating polypeptides indicated that they were most likely 
non-specific contaminants (data not shown). The 20-kDa polypeptide corresponding 
to TFIIAβ was subjected to N-terminal sequence analysis (Edman degradation) that 
revealed Asp278 as the most N-terminal amino acid. The sequence of amino acids is 
presented in Figure 2A. 
Analysis of the cleavage site 
To elucidate the molecular determinants of the cleavage, we performed a 
rrounding the cleavage site. Wild-
ng with TFIIAγ into U2-OS cells 
erestingly, mutation of the amino 
 only trace amounts of cleavage 
e cleavage site (D278A), caused a 
 products TFIIAα and TFIIAβ as 
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2 and -1 (T276A and G277A, respectively) did not significantly affect cleavage. 
Mutations at -8, +3 and +5 (V270A, S280A and E282A) slightly affected cleavage 
and yielded elevated levels of the precursor. S280A affected the efficacy of the 
cleavage as well as yielded a doublet at the position of TFIIAβ. Whether this doublet 
is due to alternative cleavage or a post-translational modification is currently under 
investigation.  
Fig. 2. Mutational analysis of the TFIIAαβ 
indicates conservation of the GTG/DT TFIIAαβ 
cleavage site (marked by arrow) among Human, 
twelve residues following the arrow were from 
cycle 1-12 in the Edman degradation. The amino 
cleavage region. (A) Sequence alignment 
Mouse, Xenopus, Drosophila and S. pombe. The 
acids of the Cleavage Recognition Site (CRS) 
plasmids expressing Myc-tagged hTFIIAαβ (wt 
immunoblotting using antibodies against 
residue A267 that was not included in the 
analysis. (C) U2-OS cell extracts from panel B, 
were subjected to immunoprecipitation using an 
antibody against TFIIAγ. The 
immuniprecipitates were analysed by SDS-
PAGE and immunoblotting as in B. (D) Whole 
cell extracts (WCE) from U2OS cells 
transfected with plasmids expressing hTBP, 
Myc-tagged hTFIIAαβ (wt or the indicated 
adenovirus 2 major late TATA box (lanes 4-13). 
(lane 3).  
that are essential for cleavage are boxed. (B) 
Extracts from U2-OS cells transfected with 
or the Ala mutants of the indicated residues) and 
hTFIIAγ were analysed by SDS-PAGE and 
TFIIAα (upper panel), TFIIAβ and TFIIAγ 
(lower panel). The asterisk marks the position of 
mutants) and hTFIIAγ, as indicated, were used 
for electrophoretic mobility shift assay with a 
synthetic oligonucleotide comprising the 
Recombinant TBP and TFIIA were used giving 
rise to the DA (TBP-TFIIA-DNA) complex 
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 To test whether the different TFIIAαβ mutants and in particular the uncleaved 
mutant forms were assembled into functional complexes, co-immunoprecipitation 
experiments were performed under high-stringency conditions using an antibody 
against the TFIIAγ subunit (Figure 2C). Cleaved and the uncleaved TFIIAαβ were 
recovered with equal efficacy as judged from their relative abundance in the input and 
in the immunoprecipitates. Interestingly, both TFIIAβ polypeptides obtained with 
y co-immunoprecipitated with TFIIAγ, demonstrating 
lex.  
extr  
revealed that the mutated, uncleaved TFIIA facilitat  
the presence of TBP similar to that observed with wild type TFIIA (Figure 2D, lanes 
3, 5 and 8-13). Similarly, the uncleaved mutan  
transcription from a tk-promoter 22 to levels simil -
type protein (data not shown). Sub-cellular localiza t 
the uncleavable TFIIA was distributed similarly to the wild-type protein (data not 
shown). 
Taken together, our data show that uncleav  
participate in TFIIA complex formation and suppo  
vitro and transcriptional activation in vivo. 
 
The cleavage site is highly conserved 
The mutational analysis revealed a Cleavage Recognition Site (CRS), a string 
of four residues in the TFIIAα subunit essential for cleavage. Alignment of the region 
surrounding the cleavage site revealed a high degree of homology with TFIIAαβ from 
other organisms except budding yeast (Figure 2A). First, the Asp at position +1 is 
acts from transfected U2-OS cells
es a so-called DA-mobility shift in
ts of TFIIA raised activation of
ar to that observed with the wild
tion experiments also showed tha
able and cleavable TFIIA equally
rt TBP-TFIIA binding to DNA in
mutant S280A were efficientl
that both peptides are part of a TFIIA comp
Bandshift assays performed with crude 
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conserved in all species for which the sequence of TFIIAαβ is known. Second, the 
CRS is fully conserved in vertebrates and highly similar in D. melanogaster, C. 
elegans and S. pombe. Furthermore, the spacing between the cleavage site and the 
CRS is conserved with the exception of C. elegans and S. pombe. The cleavage site is 
followed by several potential CKI and CKII phosphorylation sites (TSSEED)28. The 
high homology at and preceding the cleavage site is even more striking considering 
that the CRS is embedded in a part of TFIIAαβ that is of low sequence complexity 
and overall poorly conserved. Interestingly, a CRS is absent in S. cerevisiae and 
consist
LF), a TFIIA variant (Figure 3A), we examined whether human ALF is 
cleaved
olypeptide that migrates at the position of 
ll-length, recombinant ALF as well as a second ALF-derived polypeptide migrating 
e N-terminal moiety of ALF (left panels, lane 
2). Thi
ently TFIIA is not cleaved in this organism. Therefore, the high conservation 
of the CRS in addition to its critical role in the cleavage process strongly suggest that 
the CRS determines the position of the cleavage and furthermore predicts that 
cleavage of TFIIA also occurs in C. elegans and S. pombe.  
 
Human ALF is cleaved 
 As the CRS is also highly conserved in the germ cell-specific TFIIA-like 
Factor (A
 as well. Extracts from U2-OS cells transfected with Myc-tagged ALF alone or 
together with TFIIAγ were analysed by immunoblotting using the Myc-antibody 
(Figure 3B). Western blotting identified a p
fu
with the relative mobility expected for th
s is in accordance with a recent report that Xenopus laevis ALF is subject to 
cleavage in Xenopus oocytes29. Co-immunoprecipitation experiments further showed 
that both forms of ALF indeed form a complex with TFIIAγ (Figure 3B, right panels, 
lane 4). ALF could not be detected in the absence of TFIIAγ, suggesting that ALF, 
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like TFIIAαβ, is unstable and formation of a complex between ALF and TFIIAγ is a 
prerequisite for its accumulation. Given the fact that a TFIIAγ paralog has not been 
found in the genome, the recent study in Xenopus29 and our data in mammalian cells 
strongly suggest that TFIIAγ is the natural partner of TFIIAαβ as well as ALF.  
Fig. 3. The TFIIA-like Factor ALF is 
among hTFIIAαβ and human and 
mouse ALF. The CRS is marked in the 
figure. (B) Extracts from U2-OS cells 
transfected with plasmids expressing 
hTFIIAγ together with Myc-tagged 
hTFIIAαβ (lanes 1, 3) or Myc-tagged 
hALF (lanes 2, 4) were subjected to 
immunoprecipitation using an antibody 
against TFIIAγ. The 
immunoprecipitates were analysed by 
SDS-PAGE and immunoblotting using 
the Myc antibody (upper panels) and 
the TFIIAγ specific antibody (lower 
panels).  
cleaved. (A) Sequence alignment 
 
Cleavage of TFIIA affects its stability 
Our results show that the uncleavable forms of TFIIAαβ such as G275A 
accumulated to higher levels than the wild type protein (Figure 2B). Accordingly, 
TFIIAγ accumulated to higher levels when co-transfected with the uncleavable 
TFIIAαβ mutants than with wild-type TFIIAαβ. To investigate whether these 
mutations affected stability of the different forms of TFIIA, we performed pulse-chase 
experiments to assess their half-life in vivo. Figure 4A shows that significant cleavage 
of TFIIAαβ occurred already during the pulse period, i.e. within 1 hour. Yet, cleavage 
takes several hours to complete, suggesting that there is a limiting factor that is 
required for cleavage. Furthermore, the uncleavable mutant appeared to be more 
stable than wild type TFIIA that undergoes cleavage (compare lanes 7-11 with lanes 
2-6). Quantitation analysis revealed that equal amounts of wild type products 
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(TFIIAαβ+α+β) and uncleavable mutant TFIIA G275A were detected immediately 
after the pulse (Figure 4B), showing that both forms are produced at about equal rate. 
However, clear differences in accumulation can be observed after 8 and 24 hours of 
chase, at which point uncleavable TFIIA G275A is roughly four times more abundant 
than wild type protein. These data suggest that cleavage causes destabilisation of 
TFIIA. Experiments performed in the presence of cycloheximide to prevent de novo 
protein synthesis demonstrated similar differences in accumulation of the wild-type 
Fig. U2-OS cells transfected with plasmids expressing 
hT tant G275A (lanes 7-11) were labelled for 1 hour with 
STrans followed by a chase for 1, 2, 4, 8 and 24 hours. Extracts from these cells were subjected to immunoprecipitation using 
the Myc antibody followed by SDS-PAGE and fluorography. (B) Quantitation of labelled proteins from (A) was performed by 
periments. (C) Extracts from U2-OS cells transfected 
IAαβ wild-type or mutant G275A and treated with CHX were 
nst TFIIAα and GFP.  Plasmid expressing GFP was co-
transfecte
tagged hT
immunoblotting using antibodies against TFIIAα. (E) Quantitation of (D) was done by Phosphoimager. The result represents 
 4. Uncleavable TFIIA is more stable than cleavable TFIIA. (A) 
FIIAγ together with Myc-tagged hTFIIAαβ wt (lanes 2-6) or mu
35
Phosphoimager. The results represent the average of three independent ex
with plasmids expressing hTFIIAγ and Myc-tagged hTFI
analysed by SDS-PAGE and immunoblotting using antibodies agai
d as the internal control. (D) Extracts from U2-OS cells transfected with plasmids expressing hTFIIAγ and Myc-
FIIAαβ wild-type or mutants as indicated and hTFIIAγ and treated with CHX, were analysed by SDS-PAGE and 
the average of three independent experiments. 
and mutant forms of TFIIA (Figure 4C and data not shown). To extend our analysis, a 
number of mutants that displayed impaired cleavage were tested in identical settings 
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(Figure 4D and E). Similarly, these results show that CRS mutants are stabilised up
4 fold compared to the wild-type protein.  
Cleaved TFIIA is a substrate for the 26S proteasome 
Having established that cleavage of TFIIA reduces its stability, we teste
whether TFIIA is a substrate for the ubiquitin-proteasome pathway. Extracts from
OS cells co-transfected with TFIIAαβ and TFIIAγ and treated with the proteasome 
inhibitor MG132 were analysed by immunoblotting. Figure 5A shows that the
α and TFIIAβ subunits are stabilised upon treatment with MG132 (com
lane 2 with lane 1), indicating that these subunits are degraded by the 26S proteasom
In striking contrast, the uncleaved form of the protein is unchanged upon MG132 
 to 
 
 d 
 U2-
 
TFIIA pare 
e. 
trea
d  
i
d  
prerequisite for degradation and is in agreement with the half-life studies.  
Given that most substrates for the proteasome are ubiquitylated, we next investigated 
whether cleaved TFIIA is ubiquitylated. Extracts from U2-OS cells co-transfected with 
a HA-tagged form of ubiquitin along with TFIIA were used for immunoprecipitation 
with an antibody against TFIIAβ under high stringency conditions. Western blot 
analysis using the HA antibody revealed a characteristic laddering of ubiquitylated 
proteins only when TFIIA and HA-ubiquitin were co-expressed (Figure 5B, compare 
lanes 5-7 with lane 8). A weak laddering was observed when HA-ubiquitin was 
transfected alone, which may be due to ubiquitylation of endogenous TFIIA (lane 6). 
The smallest ubiquitylated polypeptide migrates at the position of ~29 kDa (asterisk), 
tment, demonstrating that TFIIAαβ is not targeted for proteasome-mediated 
egradation. Stabilisation of endogenous p53 in the presence of MG132 served as an
nternal control 30. Thus, the cleaved TFIIAα and TFIIAβ, but not TFIIAαβ are 
egraded via the proteasome which supports the notion that cleavage of TFIIA is a
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consistent with the predicted size of mono-ubiquitylated TFIIAβ. Importantly,
ubiquitylated TFIIA subunits could not b
 
e detected following immunoprecipitation 
sing antibodies against TFIIAα and TFIIAγ (data not shown). Collectively, the above 
 or even disrupts the TFIIA 
mple
u
data suggest that ubiquitylation of TFIIAβ destabilises
co x.  
 
 
 
 
 
We have demonstrated that inhibiting TFIIA cleavage through mutations in the 
CRS increases the stability of the protein, linking processing of TFIIA to its 
Fig. 5. Cleaved TFIIA is a substrate for proteasome-mediated degradation. (A) Inhibition of proteasome activity results in 
stabilization of hTFIIAα and hTFIIAβ subunits. Extracts from U2-OS cells transfected with plasmids expressing hTFIIAαβ and 
hTFIIAγ and treated (lane 2) or not (lane 1) with MG132 were analysed by SDS-PAGE and immunoblotting using antibodies against 
TFIIAα (upper panel) TFIIAβ (middle panel) and p53 (lower panel). (B) Extracts from U2-OS cells transfected with plasmids 
expressing hTFIIAγ, Myc-tagged hTFIIAαβ, and HA-tagged Ubiquitin, as indicated, were subjected to immunoprecipitation under 
high stringency conditions using an antibody against TFIIAβ. Extracts (lanes 1-4) and immunoprecipitates (lanes 5-8) were analysed 
panel) and HA (lanes 5-8). (C) Extracts from U2-OS cells transfected with plasmids expressing hTFIIAγ and Myc-tagged hTFIIAαβ 
wild-type or mutants as indicated were analysed by SDS-PAGE and immunoblotting using antibodies against TFIIAα, TFIIAβ and 
mutant as indicated and treated with CHX, were analysed by SDS-PAGE and immunoblotting using antibodies against TFIIAα and 
TFIIAβ (E) Quantitation of (D) was done by Phosphoimager. The results represents the average of three independent experiments 
the presence or the absence of α-amanitin or ActD, as indicated, were analysed by SDS-PAGE and immunoblotting using antibodies 
against TFIIAα and GFP (upper panel), TFIIAβ (middle panel) and TFIIAγ (lower panel). Plasmid expressing GFP was co-
by SDS-PAGE and immunblotting using antibodies against TFIIAα (lanes 1-4, upper panel), TFIIAβ and TFIIAγ (lanes 1-4, lower 
TFIIAγ.  (D) Extracts from U2-OS cells transfected with plasmids expressing hTFIIAγ  and Myc-tagged hTFIIAαβ wild-type or 
(F) Extracts from U2-OS cells transfected with plasmids expressing hTFIIAγ and Myc-tagged hTFIIAαβ  and treated with CHX in 
transfected as the internal control. 
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degradation. Furthermore, we have shown that treating cells with proteasome inhibitor 
stabilises the cleaved forms of TFIIA but not the uncleaved form, suggesting that 
TFIIAα and TFIIAβ are substrates for proteasomal degradation. Interestingly, cleavage 
of TFIIA creates an N-terminal aspartate, a secondary destabilising residue according 
to the N-end rule31. To study the significance of the N-terminus of TFIIAβ for its 
stability, we generated two mutants; D278M, yielding a stabilising N-terminal residue, 
and D278R, yielding a primary destabilising N-terminus. Extracts from U2-OS cells 
transfected with TFIIAγ and wild-type or mutant TFIIAαβ (D278A, D278M and 
D278R, respectively) were analysed by western blotting using antibodies against 
different TFIIA subunits (Figure 5C). In agreement with data presented in Figure 2, all 
D278 mutants showed reduced cleavage efficacy, indicating that residue D278 is 
important but not essential for cleavage, in contrast to residues within the CRS.  
Interestingly, while the steady-state levels of TFIIAγ remained the same, 
significant differences were observed with respect to TFIIAβ levels. TFIIAβ 
accumulated to a higher level when Asp was mutated to Met compared to Arg, 
supporting the hypothesis that TFIIAβ is a substrate for the N-end rule (Figure 5C, 
compare lane 4 with 5). D278A behaved similar to D278R, consistent with alanine 
being an unstable N-end residue. The effect was observed to a lesser extent for 
type or mutant TFIIAαβ (D278M and D278R) in the presence of cycloheximide. 
TFIIAα, suggesting that destabilisation of TFIIAβ also affects the stability of other 
subunits. Quantitation of the endogenous TFIIA subunits revealed that TFIIAβ is 
under-represented as compared to TFIIAα in extracts from U2-OS cells (data not 
shown), in agreement with the above observations. 
To extend and corroborate these observations, we compared the turn-over of 
TFIIAαβ, TFIIAα and TFIIAβ using extracts from U2-OS cells transfected with wild-
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Figure 5D and 5E show that the stability of TFIIA is dependent on the identity of 
residue 278 and that both D278M and D278R mutants of TFIIAαβ exhibit reduced 
cleavage as compared to wild-type protein. Interestingly, mutant D278M stabilises the 
TFIIAβ subunit whereas D278R increases its degradation (Figure 5D and E). The 
above results support our notion that cleavage of TFIIAαβ is linked to turn-over of the 
protein and that TFIIAβ is a substrate for N-end rule degradation.  
Our observation that TFIIAβ is likely degraded via the proteasome combined 
with recent publications showing that transcription is required for the proteasome-
mediated degradation of liganded hERα and SREBP27,32 led us to assess whether 
degradation of TFIIA subunits is linked to transcription. Therefore, TFIIA was 
expressed in U2-OS cells and the effect of transcription inhibitors was tested in the 
presence of cycloheximide. Figure 5F shows that treatment with α-amanitin or 
actinom
orylation sites directly C-terminal 
of the 
ycin D (ActD) neither affects cleavage nor degradation of TFIIA subunits. 
Similar results were also obtained with pulse-chase experiments in the presence of 
transcription inhibitors (data not shown). Taken together, our data indicate that 
degradation of TFIIAβ via the proteasome, probably via the N-end rule, occurs 
independently of its transcriptional activity. 
  
TFIIAβ stability is regulated by residues C-terminal of the cleavage site 
 Our results demonstrate that the cleaved TFIIA is degraded by the proteasome 
and indicate that TFIIAβ is ubiquitylated. As previously mentioned, the TFIIAβ 
subunit contains three conserved, potential phosph
cleavage site (TSS). The single mutations T279A and S280A displayed no 
apparent effect on cleavage or stability, whereas S281A reduced the steady-state 
levels of TFIIAαβ (Figure 2 and 6A, lanes 2-4) suggesting that S281A is unstable or 
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cleaved at a higher rate than wild type TFIIAαβ. To remove all phosphorylation sites 
simultanously, we mutated T279/S280/S281 to alanines (TSS-A). This had a dramatic 
effect on the stability of TFIIAα and particularly the TFIIAβ, which was only 
detectable after long exposure (Figure 6A, compare lanes 1 and 5).  
 Similarly, mutating the recognition sites of casein kinase I and II by the triple 
mutation E282A/E283A/D284A dramatically destabilized the β-subunit (data not 
shown)
 and recognition by the antibody of the respective TFIIAαβ mutants is 
al results 
. The β-specific antibody is raised against the most C-terminal 76 amino acids 
of the precursor
Fig. 6. Residues adjacent to the cleavage 
(A) Extracts from U2-OS cells transfected 
with plasmids expressing hTFIIAγ and 
mutants as indicated and labelled with 
site are important for stability of TFIIAβ 
Myc-tagged hTFIIAαβ wild-type or 
purification and immunoprecipitation with 
using antibodies against TFIIAα, TFIIAβ 
plasmids expressing hTFIIAγ and 
and immunoblotting using antibodies 
32PO4 were subjected to Ni-NTA 
the Myc antibody followed by analysis 
with SDS-PAGE and immunoblotting 
and TFIIAγ or fluorography. (B) Extracts 
from U2-OS cells transfected with 
hTFIIAαβ wild-type or mutants as 
indicated were analysed by SDS-PAGE 
against TFIIAα, TFIIAβ and TFIIAγ. 
 
unaffected, arguing against reduced epitope recognition. In addition, identic
were obtained using antibodies against the C-terminal HA-tag of the β-subunit.  
To assess directly whether residues 279-281 are phosphorylated, we 
performed in vivo labelling experiments using TFIIA wild-type, the mutants T279A, 
S280A and S281A, and the triple mutant TSS-A. Figure 6A shows that TFIIAαβ and 
TFIIAβ but not TFIIAα and TFIIAγ, are phosphorylated (lane 6). None of the 
mutations significantly affected the overall 32P incorporation into TFIIA and the 
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phosphorylation level roughly corresponded to the protein level in all cases (Figure 
6B, compare lane 1 to 6, 2 to 7,3 to 8, 4 to 9 and 5 to 10). Mimicking constitutive 
phosphorylation by mutating T279/S280/S281 to Asp or Glu yielded ambiguous 
results. Whereas T279D and S280D destabilized the β-subunit, T279E, S280E, S281E 
TFIIA.  
 
 e that TFIIA undergoes co- or post-
e sit ns 
of the cleavage have been described. In the prese he 
cleavage site of TFIIAαβ and shed light on the e 
identified the CRS, a string of four residues N-term s 
essential for the cleavage process and showed that the  at the 
cleavage site is less critical.  The CRS partially overlaps with a region in TFIIAαβ 
S are 
surface
and S281D behaved similar to wild type (Figure 6B).  
 In conclusion, we have found that the residues immediately C-terminal to the 
newly created N-terminus are critical for the stability of TFIIAβ and consequently to 
that has the propensity to form a β-sheet and is directly followed by a highly acidic, 
probably unstructured part. Given the high conservation of the charged region 
following the conserved CRS, it is likely that the cleavage site and the CR
Discussion 
It has been known for quite some tim
translational cleavage19-21 but neither the cleavag e nor the biological implicatio
nt study, we characterised t
function of the cleavage. W
inal of the cleavage site that i
 identity of the amino acid
-exposed.  
The amino acid sequence of the cleavage site and CRS do not match the 
recognition site of a known protease. The only protease that is known to cleave N-
terminal to an Asp is the endopeptidase N-Asp from Pseudomonas fragi, which does 
not appear to have a homologue in eukaryotes. Recent studies addressing the 
 101
CHAPTER 4 
processing of MLL, a human homologue of the Drosophila trithorax protein, revealed 
a cleavage recognition site -QV/LDG- which is virtually identical to the CRS in 
TFIIAαβ33,34. Furthermore, in MLL the CRS also precedes a highly acidic stretch 
containing multiple potential phosphorylation sites. MLL is cleaved in the CRS, 
between D and G, while we identified the cleavage site of TFIIA more C-terminal of 
dase activity. Identification and characterisation of the CRS-specific 
FIIAαβ protease will shed more light on the regulatory role of the cleavage and the 
 between TFIIA and MLL processing.   
ng to accumulation of the protein which is consistent with the 
observe
the CRS. Currently, we cannot exclude the possibility that cleavage of TFIIA occurs 
within the CRS and that the N-terminal D278 is generated by a secondary cleavage or 
exopepti
T
possible link
In our experiments, the uncleaved and cleaved forms of TFIIA behave 
similarly with respect to TBP-DNA binding and transcriptional activity. While these 
assays are generally used to assess the ‘classical’ characteristics of TFIIA like 
stabilising TBP-DNA interactions, their in vivo value is rather limited, as they do not 
provide insight into potential promoter-specific differences. Although it seems likely 
that cleaved and uncleaved TFIIA may have distinct roles as could be inferred from 
the presence of the uncleaved TFIIA in the TAC complex, appropriate assays are 
currently under investigation. However, the present study provides evidence that 
cleavage has an important consequence for the half-life of TFIIA. Inhibition of 
cleavage as obtained with the mutation in the CRS impair or prevent protein 
degradation, leadi
d increased half-life of the uncleaved TFIIA. 
Our results demonstrate that the cleaved, but not the uncleaved TFIIA 
complex is a substrate of the 26S proteasome. Several pieces of evidence suggest that 
ubiquitylation occurs on TFIIAβ followed by its degradation, and subsequently the 
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TFIIAα and TFIIAγ subunits are degraded. First, the stabilising effect of the 
proteasome inhibitor MG132 is seen with the α- and β-subunits but not with the 
TFIIAαβ precursor. Second, the smallest ubiquitylated polypeptide is approximately 
29 kDa, consistent with mono-ubiquitylated TFIIAβ. Third, under high-stringency 
conditions the poly-ubiquitylated forms of TFIIA can only be immunoprecipitated 
with antibodies raised against TFIIAβ but not TFIIAα or TFIIAγ. Last, the instability 
of the β-subunit is markedly enhanced by mutating sites adjacent to the cleavage site, 
indicating an important role for these residues in TFIIA degradation and suggesting 
that degradation of different subunits can occur partly independent on each other. The 
precise role of the putative phosphorylation sites can only be speculated upon at 
present
for c-fos and NF-κB .  
Cleavage of TFIIA creates an N-terminal aspartate, which is a secondary 
destabilizing residue according to the N-end rule pathway . This N-terminal 
aspartate, though highly conserved in TFIIA and ALF of all higher eukaryotes, is 
important but not essential for cleavage. It is therefore likely that the aspartate is 
conserved mostly to render the cleavage product instable. Recent studies have shown 
that caspase-mediated cleavage of DIAP1 (Drosophila IAP1) converts the more stable 
full-length protein into a highly unstable Asn-bearing N-degron and that its 
subsequent degradation by the N-end rule pathway is essential for regulation of 
apoptosis . It is therefore conceivable that TFIIAαβ represents a stable pro-N-
degron and that its cleavage results in production of the unstable Asp-bearing N-
. It is likely that phosphorylation of residues T279-S281 protects the β-subunit 
against proteasomal degradation, and that dephosphorylation accelerates degradation 
of TFIIAβ as well as the other subunits of TFIIA, similar to what has been reported 
35,36
31
37,38
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degron (TFIIAβ). Whether TFIIA indeed represents another physiological N-end rule 
metazoan substrate remains to be investigated. 
We hypothesize that the biological significance and implications of cleavage is 
to generate a destabilizing N-terminus that triggers destruction of the protein to fine-
tune the level of this basal transcription factor and consequently the transcriptional 
activity of the cell. The level of expression of the TFIIA protease and its activity are 
likely to have consequences for transcriptional initiation and re-initiation. Regulation 
of cleavage of TFIIA and subsequent degradation of the protein may provide 
directionality to the transcription process and prevent recycling of the basal factor. 
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Materials and Methods 
Plasmids, mutagenesis and antibodies 
Expression plasmids encoding hTBP (pSG5-hTBP), Myc-tagged hTFIIAαβ 
(pSG5-Myc-hTFIIAαβ) and hTFIIAγ (pSG5-hTFIIAγ) have been described earlier22. 
Expression plasmid encoding Myc-HA-tagged hTFIIAαβ (pSG5-Myc-HA-
hTFIIAαβ) was constructed by insertion of a double-stranded oligonucleotide 
encoding for the HA epitope at the 3’-end of hTFIIAαβ in pSG5-Myc-hTFIIAαβ. 
pSRα-tk-neo-Myc-HA-hTFIIAαβ was constructed by subcloning the appropriate 
fragment from pSG5-Myc-HA-hTFIIAαβ into the EcoRI site of pSRα-tk-neo. 
Plasmid expressing Myc-tagged hALF (pSG5-Myc-ALF) was constructed by 
subcloning the appropriate fragment from pRSET-ALF (provided by J. DeJong) into 
pSG5-Myc plasmid22. Plasmid pSG5-Myc-hTFIIAαβ was used for mutagenesis 
according to the manufacturer’s instructions (Quick Site-directed Mutagenesis, 
Stratagene). Plasmid expressing enhanced green fluorescence protein (pEGFP-N1) 
was from Clontech.  
The monoclonal antibodies Myc, HA and SL39 have been previously 
described22. Polyclonal antibodies against hTFIIA were as follows: αΝ-specific 
(against the N-terminus, amino acids1-63), β-specific (against amino acids 301-376) 
and γ-specific against the TFIIΑγ subunit. Polyclonal antibody against GFP was 
purchased from Clontech.  
 
Cell culture, retroviral transduction, transient transfections, treatment with 
cycloheximide (CHX), α-amanitin, actinomycin D (ActD) and the proteasome 
inhibitor MG132, pulse-chase labelling and in vivo phosphate labelling  
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U2OS, HeLa, COS7 and Bosc23 cells were maintained in DMEM 
ells were maintented as described39. FM3A 
cells w
ine-free DMEM supplemented with 10% dialyzed FBS (against 
0.15 M
ented with 0.5 mCi/ml 32P PO4 (ICN) for 
2+
chromatography, protein extracts, SDS-PAGE, immunoblotting, treatment with 
supplemented with 10% FCS. P19 EC c
ere maintained in RPMI medium supplemented with 5% FCS. FM3A cells 
stably expressing hTFIIAαβ were generated by retroviral transduction. Supernatant 
from Bosc23 packaging cells transfected with plasmid pSRα-tk-neo-TFIIAαβ was 
used to transduce FM3A cells at a density of 100,000 cells/ml, followed by selection 
with G418 (800 µg/ml)40,41.  
Transient transfections were performed as previously described22. Transfected 
cells were washed with PBS, incubated with fresh medium for 24 hours and then 
treated or not with CHX (20 µg/ml) alone or together with α-amanitin (2.5 µg/ml) or 
ActD (50 ng/ml), for the indicated periods of time. For treatment with the proteasome 
inhibitor MG132, transfected cells were incubated with 20 µM MG132 for 5 hours at 
37 oC. 
For pulse-chase labelling, 48 hours after transfection, cells were incubated in 
methionine- and cyste
 NaCl, cut-off 10 kDa), for 15 minutes at 37 oC. After starvation, cells were 
labelled in DMEM supplemented with 10 % FBS and 20 µCi/ml Tran35S Label (ICN) 
for 1 hour, followed by different chase periods in fresh medium. 
For in vivo phosphate labelling, 36 hours after transfection, cells were 
incubated in phosphate-free DMEM supplem
4 hours.  
 
Ni -agarose affinity chromatography, ion exchange and gel filtration 
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bacter
by immunoblotting. Preparation of cell extracts, SDS-
PAGE 
raphy were as previously described22.  
 
42
18 (2.1x220 
mm; 5 m
g peptide mixtures analyzed by matrix-assisted laser-desorption / 
tion reflectron time-of-flight (MALDI-reTOF) mass spectrometry (MS) (Reflex 
43
ABI/MDS SCIEX, Thornhill, Canada) modified with an ultra-fine ionization source44.  
ial alkaline phosphatase (BAP), immunoprecipitation, fluorography and 
electrophoretic mobility shift assay (EMSA)  
Purification of TFIIA from FM3A extracts by Ni2+-NTA-agarose affinity 
chromatography and MonoQ column were carried out as described19. Fractions 
containing TFIIA were loaded on a Superose 6 column in 20 mM Tris (pH 7.3), 100 
mM KCl, 20 % glycerol, 0.2 mM EDTA, 5 mM DTT and 0.5 mM PMSF. Fractions 
were collected and assayed 
and immunoblotting have been described39. For quantitative immunoblotting, 
proteins were detected by ECL plus (Amersham) and analysed by PhosphorImager 
(Molecular Dynamics). For treatment with bacterial alkaline phosphatate (BAP), cell 
extracts were incubated with 0.05 unit of BAP/µl of extract, in the presence or the 
absence of 0.1 M NaH2PO4, for 1 hr at 30 oC. EMSA, immunoprecipitation and 
fluorog
Chemical sequencing and Edman degradation analysis 
Chemical sequencing was done using a Procise 494 instrument from Applied 
Biosystems (AB) as described .  Step-wise liberated PTH-amino acids were 
identified using an "on-line" HPLC system (AB) equipped with a PTH C
icron particle size) column (AB).  
Gel-resolved proteins were digested with trypsin, partially fractionated, and 
the resultin
ioniza
III; BRUKER Daltonics, Bremen, Germany), as described ; and also using an 
electrospray ionization (ESI) triple quadrupole MS/MS instrument (API300; 
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Selected precursor or fragment ion masses from the MALDI-TOF MS or NanoES-
MS/MS spectra were taken to search the human segment of a protein non-redundant 
databas
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Abstract 
In higher eukaryotes, the large subunit of the general transcription factor 
FIIA is encoded by a single gene TFIIAαβ and post-translationally cleaved into an 
- and β-subunit. The molecular mechanisms and biological significance of this 
proteolytic process have remained obscure. Here, we show that TFIIA is a substrate of 
Taspase1 as reported for the trithorax group protein, MLL. We demonstrate that 
recombinant Taspase1 cleaves TFIIA o. Transfected Taspase1 enhances 
cleavage of TFIIA and RNAi knock inishes 
cleavage of TFIIA in vivo. Taspase1 is localized in the nucleus and associated with 
chromatin suggesting that cleavage by Taspase1 might occur on chromatin. We 
propose that cleavage by Taspase1 regulates the levels of TFIIA, MLL and other 
substrat
 
 
 
 
T
α
 in vitr
-down of endogenous Taspase1 dim
es in the cell and plays a critical role in transcription and development. 
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Introduction 
gnition 
ite (CRS) that is essential for TFIIA cleavage has been identified as -QVDG- (aa 
72-275), and the N-terminus of the β subunit was determined to be at D278 located 
ree amino acids downstream of the CRS (Fig. 1B)10. The CRS shares remarkable 
imilarity in different evolutionarily distinct species and is embedded in an otherwise 
non-conserved and probably unstructured region11-13. The germ cell-specific TFIIA-
like factor (ALF), a TFIIA variant that contains the CRS, was also shown to be 
cleaved10,14. The biological significance of cleavage has however remained elusive. 
Both uncleaved αβ and cleaved α and β subunits can be found in association with the 
TFIIAγ subunit in vivo15,16, and both forms interact with TBP on DNA and support 
transcription to a similar extent in vitro and in reporter assays10,17. TFIIA is mainly 
found in the cleaved form (α+β+γ) in differentiated cells. In embryonal carcinoma 
P19 cells, a substantial amount of the uncleaved TFIIA (αβ+γ) is detected and stably 
interacts with TBP in the TAC complex to mediate transcription15,16. Therefore, 
In eukaryotes, initiation of RNA polymerase II (pol II) transcription requires 
the assembly of a preinitiation complex (PIC). Specific binding of TBP to promoters 
is a key step in formation of PIC, which is followed by recruitment of general 
transcription factors and pol II. The basal transcription factor TFIIA interacts with 
TBP and stabilizes its binding to DNA1,2.  TFIIA is also shown to interact with several 
activators3,4, and is required for transcriptional activation of certain genes5-8.  
In higher eukaryotes, purified TFIIA is composed of three subunits, α, β and γ. 
TFIIA α and β are encoded by one single gene, and cleaved post-translationally to α 
and β subunits. The γ subunit is conserved among different species, whereas sequence 
similarity in TFIIAαβ is limited mostly to the N-terminal region of the α subunit and 
the C-terminus covering most of the β subunit9. Recently, the cleavage reco
s
2
th
s
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uncleaved and cleaved forms of TFIIA may have distinct gene regulatory functions in 
differen
t match 
known
20
21
Here, we show that TFIIA is a genuine substrate of Taspase1. Taspase1 
cleaves TFIIA efficiently in vitro and in vivo, and RNAi knock-down of Taspase1 
reduces cleavage of TFIIA. TFIIA interacts with Taspase1, and Taspase1 is localized 
in the nucleus and associated with chromatin. These results suggest that cleavage 
occurs on chromatin and may be a regulating step in various transcription processes 
mediated by TFIIA, MLL and other substrates. Moreover, identification of Taspase1 
tiation. The observation that cleavage is the prerequisite for proteasome-
mediated degradation of TFIIA10 indicates that cleavage regulates protein levels of 
TFIIA, and may play a role in transcription. Elucidation of the biological function of 
TFIIA cleavage is hampered because the protease(s) that specifically cleaves TFIIA 
has not been identified. 
The recently identified cleavage site in TFIIAαβ, G277/D27810, did no
 consensus sequences of proteases. We did notice however that the CRS -
QVDG- of TFIIA is virtually identical to the cleavage sites of MLL, Mixed-Lineage 
Leukemia protein, -QVD/G- (aa 2664-2667) and -QLD/G- (aa 2716-2719) (Fig. 
1B)18,19. MLL is a 500 kDa nuclear protein of the trithorax (Trx) group proteins and 
required for maintenance of proper HOX gene expression. Chromosomal 
translocation results in different MLL fusion proteins that are involved in various 
leukemias . MLL is proteolytically cleaved at two adjacent cleavage sites by a single 
protease, Taspase1, an endopeptidase with an asparaginase_2 homology domain . 
Moreover, there is an acidic stretch downstream of the cleavage site in both MLL and 
TFIIA. These high similarities strongly indicate a molecular and/or functional link 
between TFIIA and MLL processing and prompted us to assess whether TFIIA is a 
substrate of Taspase1. 
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as the protease for TFIIA provides a new tool to further our understanding of the role 
of TFIIA cleavage and function of TFIIA. 
 
Specific protease activity for TFIIA cleavage in HeLa cell nuclear extracts 
To identify the protease for TFIIA, we set up an in vitro cleavage assay using 
purified recombinant T
Results 
FIIA comprised of uncleaved αβ and γ subunits as the 
substra
ge activity for TFIIA in HeLa nuclear extracts is specific. 
te to test for a cleavage activity for TFIIA in HeLa cell extracts. HeLa nuclear 
extracts (Fig. 1A, lanes 1, 2) showed reasonable levels of cleavage activity for 
recombinant wild-type TFIIA, yielding bands with apparent correct sizes for the 
cleaved α and β subunits. Fractionation of nuclear extracts on a P11 column showed 
that the cleavage activity was eluted at 500 mM KCl (PC-C fraction) (Fig. 1A, lanes 
7, 8). The PC-C fraction was further fractionated on a Mono S column, and the 
cleavage activity was recovered at approximately 300 mM KCl in fractions 17, 18 and 
19 (Fig. 1A, lanes 11-13). To assess whether the observed cleavage activity is specific 
and displays the same amino acid sequence requirements as in vivo, we tested in our 
in vitro assay a TFIIA cleavage site mutant G275A that was shown uncleavable in 
vivo10. As shown in Fig. 1A, the protease activity in the Mono S peak fraction 18 was 
able to cleave the wild-type TFIIA but not the G275A mutant (lanes 14 and 15), 
showing that the cleava
Having identified the cleavage recognition site (CRS) for TFIIA10, we noticed 
that the CRS in TFIIA, -QVDG- (aa 272-275), is identical or similar to the cleavage 
sites in MLL, -QVDG- (aa 2664-2667) and -QLDG- (aa 2716-2719) that are both 
cleaved at D/G by Taspase1 (Fig. 1B). This similarity indicated that TFIIA and MLL 
might be cleaved by the same protease. To test whether HeLa nuclear fractions 
enriched for TFIIA cleavage activity contain Taspase1, western blotting analysis was 
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Fig. 1 Taspase1 activity in HeLa nuclear extract. A) A Protease 
substrate as indicated, and western blotting analysis was used to 
 
 
column (lanes 11-13). The specificity of the protease activity was 
Nonspecfic bands are indicated with *. B) Alignment of the CRS 
(d). The conserved CRS is boxed. Cleavage of TFIIA and MLL by 
 
from mammalian cells. The acidic stretch (residues in blue and 
 
 
fractions containing the protease activity. 
assay was performed to detect TFIIA cleavage activity in HeLa 
nuclear extract. Highly purified recombinant TFIIA was used as the 
detect the cleavage products. The protease activity was further
fractionated on a P11 column (lanes 3-10), followed by a Mono S
tested by incubation of purified wild-type TFIIA or the cleavage site 
mutant G275A with the Mono S fraction 18 (lanes 14, 15). 
and the cleavage site of TFIIA and MLL from different organisms, 
human (h), mouse (m), Xenopus (x), pufferfish (p) and Drosophila 
Taspase1 is at D/G, indicated with a red arrow. D278 marked with ◊ 
is the identified N-terminal end of the β subunit of TFIIA purified
purple) is relatively conserved in TFIIA and MLL. C) Endogenous
Taspase1 was detected by a Taspase1 specific antibody in all
performed using an anti-Taspase1 antibody .  Figure 1C shows that auto-cleaved 
Taspase1 is present in fractions with cleavage activity for TFIIA including the nuclear 
peaking in fraction 18 that has the highest cleavage activity (lanes 7-9), but not in 
fractions without cleavage activity. The full-length Taspase1 could not be observed in 
whole cell extracts  or nuclear extracts (lane 1) but was detectable in PC-C fraction 
and was further enriched in Mono S fractions 17-19. These data strongly suggest that 
  
Cleavage of TFIIA by Taspase1 in vitro  
To directly assess whether TFIIA is a substrate of Taspase1, we first tested 
cleavage in vitro using recombinant TFIIA and Taspase1. Recombinant wild-type 
of Taspase1, T234A, did not cleave wild-type TFIIA (Fig. 2A, lanes 6-10). Although 
21
extracts (lane 1), the PC-C fraction (lane 4) and the Mono S fractions 17, 18 and 19 
21
Taspase1 is the protease for TFIIA cleavage. 
Taspase1 cleaved TFIIA efficiently (Fig. 2A, lanes 1-5), while the active site mutant 
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the in vitro assays showed that Taspase1 cleaves TFIIA, the determined cleavage site 
of MLL is different from that of TFIIA purified from cell extracts and analyzed by 
Edman degradation. Edman sequencing showed that cleavage in MLL occurs at D/G 
within the conserved CRS, -QVDG- or -QLDG-18, whereas in TFIIA, the most N-
terminal amino acid of the β subunit was determined to be D278, three amino acids 
downstream of the CRS (Fig. 1B) 10. To r
TFIIAβ generated in vitro by recombinan
left panel) was subjected to Edman degra
sequence GTGDTSSE, showing that cl
D274/G275 (Fig. 2A). This cleavage site 
for TFIIA cleavage, and it is consistent w
10. A 
panel of mutants covering the CRS which was tested previously in vivo and wild-type 
TFIIA were expressed in E. coli and purified with Ni-NTA resin, and subsequently, 
the Ni-NTA eluates were analyzed in the in vitro assay with recombinant Taspase1. In 
this assay, wild-type TFIIA (Fig. 2B, lanes 1, 2) and mutants outside the CRS (data 
not shown) were readily cleaved by Taspase1, whereas cleavage of the CRS mutants 
was either completely blocked (D274A and G275A) or occurred weakly (Q272A and 
V273A) (Fig. 2B, lanes 7-10 and 3-6, respectively). Thus, the in vitro data match the 
in vivo cleavage profile (Fig. 3B,10), showing that cleavage by Taspase1 requires the 
CRS, and that Taspase1 is the primary protease for TFIIA and it cleaves TFIIA at 
D274/G275. 
 
Having shown that TFIIA is cleaved by Taspase1 in vitro and the cleavage site 
is identical to that of MLL, we tested whether cleavage of TFIIA by Taspase1 has the 
same amino acid requirement as cleavage of TFIIA in vivo as shown previously
esolve this ambiguity, the N-terminus of the 
t Taspase1 (Fig. 2A, the marked bands in the 
dation. The analysis yielded an amino acid 
eavage of TFIIA by Taspase1 occurred at 
is within the conserved CRS that is essential 
ith cleavage sites of MLL by Taspase121.  
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Cleavage of TFIIA by Taspase1 in vivo 
To corroborate and extend our in vitro observations, we tested whether TFIIA 
in vivo
type Taspase1 followed by western blot analysis with Taspase1 antibody against the 
N-terminal region of Taspase1 21 revealed two polypeptides of approximately 50 kDa 
and 28 kDa in size (Fig. 3A, lanes 3, 5) corresponding to the full-length Taspase1 
(Taspase1-FL) and the auto-cleaved N-terminus (Taspase1-N28)18. Co-expression of 
FIIA α and β subunits upon complete cleavage of TFIIAαβ (compare 
nes 5 and 6), suggesting that in vivo the levels of cleaved TFIIA are measured and 
Fig. 2 Cleavage of TFIIA by Taspase1 
in vitro. A) Coomassie staining was 
performed to detect cleavage of 
recombinant TFIIA complex by 
recombinant Taspase1. wtTFIIA was 
incubated with different amounts of 
wtTaspase1 (lanes1-5) or mtTaspase1 
(  (lanes 6-10) as indicated. The 
β-subunit of TFIIA marked with ◄ was 
cut out from the gel and subjected to 
Edman analysis. Edman analysis 
showed that G275 is the N-terminal end 
of the β subunit. B) Western blot 
analysis was performed to test cleavage 
of TFIIA mutants covering the CRS. 
These mutants were expressed in 
complex with the γ subunit in E. coli, 
and one-step Ni-NTA purification was 
applied to obtain semi-purified proteins. 
Nonspecific bands are indicated with *. 
 
T234A)
is cleaved by Taspase1  in transient transfection assays. Expression of wild-
TFIIA and Taspase1 led to complete cleavage of TFIIAαβ (lanes 5), while expression 
of mutant Taspase1 T234A that cannot undergo auto-cleavage did not change the ratio 
of uncleaved and cleaved TFIIA (compare lanes 6 and 2), showing that TFIIA is 
cleaved specifically by Taspase1 in vivo. Interestingly, we did not observe a clear 
increase of T
la
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maintained in cells. To assess whether the CRS is essential for Taspase1 cleavage in 
vivo, we again utilized the alanine scanning m Without 
overexpression of Taspase1, mutations in the lished 
cleavage of TFIIA (Q272A, D274A, G275A) (Fi 6, 7) or 
yielded only small amount of the cleaved products (V273A) (lane 5), as observed 
previously 10. Co-expression of Taspase1 with w outside 
the CRS resulted in significant reduction of the un , lower 
panel, lanes 2, 3 and 8-11). Mutants Q272A and V273A showed elevated cleavage in 
the presence of overexpressed Taspase1, but the cleaved products remained at low 
levels (lanes 4, 5). Importantly, mutants at the cleavage site D274A and G275A 
cannot be cleaved even upon overexpression of Taspase1 (lanes 6, 7), demonstrating 
utants covering the CRS. 
CRS either completely abo
g. 3B, upper panel, lanes 4, 
ild-type TFIIA and mutants 
cleaved αβ subunits (Fig. 3B
Fig. 3 Cleavage of TFIIA by Taspase1 in vivo. A) 
wild-type (wt) TFIIA was transfected either alone 
or together with either wild-t or mutant 
(mt) Taspase1 (T234A) in U2OS cells, and 
cleavage was analyzed by western blotting. B) 
TFIIA mutants covering the CRS were tested either 
alone or together with Taspase1 for their cleavage 
in U2OS. Green Fluorescent Protein (GFP) was co-
transfected as the internal control. Nonspecific 
bands detected by Taspase1 antibody are indicated 
with *. C) Endogenous Taspase1 was knocked-
down by RNAi duplex oligos. Control oligos (C) 
and Taspase1 oligos (T) were used in this 
experiment. To test the effect on transiently 
transfected TFIIA, oligos were transfected for 48 
TFIIA constructs. To test the effect on endogenous 
TFIIA, U2OS cells were treated with oligos for 3 
detected by TFIIAα-specific antibody are marked 
with *. 
ype (wt) 
 
hours and removed, followed by transfection of 
and 4 days as indicated. Nonspecific bands 
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that the amino acid requirement for TFIIA cleavage in vivo is identical to that of 
Taspase1 and supporting the notion that Taspase1 is the primary protease for TFIIA. 
The role of endogenous Taspase1 in TFIIA cleavage was further tested using 
an RNAi approach. In an experiment with transfected TFIIA, Taspase1 RNAi knock-
down led to a clear accumulation of the uncleaved TFIIAαβ subunit and a small 
decrease of the cleaved products (Fig. 3C, compare lanes 2 and 4). To investigate the 
effect on endogenous TFIIA, a prolonged treatment of Taspase1 RNAi oligos was 
applied, and this treatment gave rise to a clear decrease of the endogenous Taspase1 
level, and concomitantly, an accumulation of the uncleaved form of endogenous 
TFIIAαβ and a slight decrease of the cleaved α and β subunits  (compare lanes 5 and 
6, lanes 7 and 8). In summary, our in vivo results show that TFIIA is a genuine 
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substrate for Taspase1. 
 
Regulation of Taspase1 cleavage in different cell lines 
We noticed previously that TFIIA is cleaved to different extents in different 
cell lines 15. After Ni-NTA purification of cell extracts, a considerable amount of 
Fig. 4 Regulation of Taspase1 cleavage 
in different cell lines. A) Endogenous 
TFIIA from different cell lines was 
purified with Ni-NTA resin and 
detected using a TFIIAα-specific 
antibody. Endogenous Tapase1 from 
corresponding cell lines was also 
visualized by western blotting and α-
tubulin served as the loading control. B) 
The ratios of TFIIAαβ to α and 
Taspase1 to α-tubulin were quantitated. 
TFIIA IS CLEAVED BY TASPASE1 
uncleaved TFIIA was observed in embryonal carcinoma P19 and HeLa cells extracts, 
while in COS7 and U2OS extracts, the cleaved TFIIA appeared to be the major form 
(Fig. 4
expression levels of Taspase1, suggesting that regulation of 
FIIA cleavage maybe exerted by the Taspase1 activity or post-translational 
A). Quantitating the ratios of uncleaved αβ subunit to the cleaved α subunit 
revealed that P19 cells contained the highest amount of uncleaved TFIIA (Fig. 4B).  
Next, we assessed whether the difference in TFIIA cleavage is due to different 
expression levels of Taspase1 in the various cell types. Therefore, endogenous 
Taspase1 from different cell lines was monitored by western blotting (Fig. 4A) and 
quantitated using α-tubulin as the reference (Fig. 4B). Quantitation showed that the 
Taspase1 level is higher in P19 cells than in U2OS cells, which does not correlate 
with the presence of higher uncleaved TFIIA in P19 cells as compared to U2OS cells. 
These data indicate that the observed difference in efficiency of TFIIA cleavage is not 
controlled by different 
T
modification of the TFIIA cleavage site. 
Fig. 5 as performed to 
detect inter ected either alone or 
together 10 of total) and 
precipitate ( agged Taspase1 
used to stain the 
sfected with wt 
Ta extracts and the 
chroma
Nuclear localization and chromatin association of overexpressed Taspase1. A) Immunoprecipitation w
action of TFIIA and Taspase1. pSG5-TFIIA with a myc epitope at the N-terminus was transf
 with Taspase1. IP was performed with anti-myc antibody. Input (1/5 of total), supernatant (sup, 1/
IP) were analyzed by western blotting. B) U2OS cells were transfected with TFIIA or protein C-t
and subjected to immunostaining using TFIIAα-specific antibody and protein C epitope antibody. DAPI was 
nuclei. C) Chromatin association of Taspase1 was tested using transiently transfected proteins. U2OS cells tran
spase1 and mutant T234A were crosslinked with formaldehyde, followed by CsCl purification. The nuclear 
tin-bound fractions were de-crosslinked and analyzed by western blotting. 
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Nuclear localization and chromatin association of Taspase1 
Having shown that TFIIA is a substrate of Taspase1, we tested whether 
Taspase1 and its substrate TFIIA can form a stable complex using transient 
transfe
nvolved in transcription and it interacts with 
Taspase1, we raised the question whether TFIIA and Taspase1 are localized to the 
ction assays. Following immunoprecipitation of TFIIA, the cleaved form of 
Taspase1 was readily detectable in the precipitated fraction (Fig. 5A, lanes 9-12) even 
under stringent RIPA conditions. Since the uncleaved Taspase1 was masked by the 
IgG heavy chain migrating at a similar position in the precipitated fraction, the 
supernatant was tested. The amount of Taspase1 co-expressed with TFIIA was 
reduced significantly in the supernatant for both the uncleaved and cleaved forms 
(lane 8) compared to that of Taspase1 alone (lane 7), showing that both forms of 
Taspase1 interact with TFIIA. The observed interactions reinforce the notion that 
TFIIA is a substrate for Taspase1. 
Since TFIIA is a nuclear protein i
same subcellular compartment. The presence of Taspase1 activity in HeLa nuclear 
extracts also appeared to be at odds with our previous observations in which Taspase1 
was detected mainly in the light membrane fraction of HEK 293T cells 21. To assess 
the subcellular localization of Taspase1 and TFIIA, we carried out immunostaining in 
U2OS cells. Interestingly, overexpressed Taspase1 was detected predominantly in the 
nucleus (Fig. 5B). The nuclear localization is consistent with the presence of a nuclear 
localization signal predicted in Taspase1 at residues 200-220, 
KRKLELAERVDTDFMQLKKRR (NLSdb, CUBIC). Overexpressed TFIIA was 
present mainly in the nucleus and weakly in the cytoplasm (Fig. 5B). 
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The nuclear localization of Taspase1 combined with the fact that TFIIA and 
r Taspase1 associates 
with ch
ssion of the tagged Taspase1 relative to that of the 
endoge
de cross-linking 
of HT cells for 10 or 30 minutes was sufficient to detect association of Taspase1 with 
MLL are regulators of transcription prompted us to test whethe
romatin. Formaldehyde cross-linked chromatin was isolated from U2OS cells 
transfected with Taspase1, and purified on CsCl density gradients and analyzed for its 
associating proteins. Western blot analysis showed that both precursor and auto-
cleaved forms of Taspase1 were associated with chromatin (Fig. 5C). Similarly, the 
overexpressed Taspase1 mutant T234A was also associated with chromatin.  
To confirm whether Taspase1 expressed at physiological level is associated 
with chromatin, we established a Taspase1 stable HeLa cell line (HT) which 
expressed a protein A-TEV (Tobacco Etch Virus protease) cleavage sites-myc-tagged 
Taspase1 (A-myc-Taspase1) at near physiological levels. To quantitate the expression 
level of the tagged Taspase1, we used recombinant Taspase1 as the reference (Fig. 
6A, lanes 4-6), and compared expre
nous Taspase1 (lanes 1-3) using western blotting analysis. After removal of the 
protein A domain of the tagged Taspase1 by TEV protease, the level of the myc-
tagged Taspase1 appeared to be about 2 to 3-fold higher than that of the endogenous 
Taspase1 (Fig. 6A, compare lanes 3 and 1), showing that it is expressed at a 
physiological level in HT cells, and the higher signal detected from A-myc-Taspase1 
is due to cross-reaction of its protein A domain to any IgG. In this cell line, the 
endogenous TFIIA could be cleaved to a further extent as compared to in the wild-
type HeLa cells (Fig. 6A, lanes 7, 8), showing that the tagged Taspase1 is functional. 
Having established that the expression level of the A-myc-tagged Taspase1 is 
comparable to that of the endogenous protease, we tested whether the tagged 
Taspase1 is associated with chromatin. Shown in Fig. 6B, formaldehy
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chroma
scription 
regulat
, 
tin (Fig. 6B, upper panel, lanes 7, 8). Cross-linking of Taspase1 was at least as 
efficient as compared to that of the TATA-box binding protein (TBP), whereas -
tubulin was barely detectable in the chromatin fraction (Fig. 6B, lower panel, lanes 5-
8). Furthermore, the endogenous Taspase1 was also detected in the CsCl density 
purified fraction (Fig. 6B, middle panel, lane 5-8). Collectively, these data show that 
Taspase1 is able to associate with chromatin, suggesting that cleavage of TFIIA (and 
maybe MLL) by Taspase1 may occur on chromatin and be a part of the tran
ory process.  
Fig. 6 Chromatin association of Taspase1 
Taspase1 cell line, HT, was established in HeLa 
cells that expressed a protein A domain-2xTEV 
terminal part (A-myc-N28) was visualized by 
western blotting using the Taspase1 specific 
Taspase1 in this cell line, equal amount of cell 
extracts from wild-type HeLa cells (wt) and HT 
similarly, cell extracts from HT was also analyzed 
following TEV protease treatment to physically 
Taspase1 (myc-N28) and prevent overestimation of 
the expression level of Taspase1 caused by the 
Taspase1 was detected in the same western blot 
and used as the reference (lanes 4-6). Cleavage of 
lanes 7, 8. B) Chromatin association of A-myc-
tagged Taspase1 was tested by CsCl purification. 
were cross-linked (CL) with formaldehyde for 
either 10 (+) or 30 (++) minutes, and nuclear 
analyzed by western blotting. Endogenous TBP 
was used as the positive control, and α-tubulin in 
negative control for chromatin association. 
expressed at physiological level. A) A stable 
cleavage sites-myc-tagged Taspases1, and its N-
antibody. To estimate the expression level of 
were analyzed by western blotting (lanes 1, 2), and 
separate the protein A domain from the myc-tagged 
tagged protein A domain (lane 3). Recombinant 
the endogenous TFIIA in HT was also shown in 
Wild-type HeLa (wt) and stable HT cells (HT) 
extracts were subjected to CsCl purification and 
the nuclear extract preparation served as the 
Discussion 
In this study, we have provided several lines of evidence that Taspase1 is the 
protease for TFIIA. Firstly, Taspase1 cleaves TFIIA efficiently in vitro and in vivo
whereas the TFIIA cleavage site mutants D274A and G275A cannot be cleaved by 
Taspase1. Secondly, knock-down of endogenous Taspase1 reduces cleavage of 
overexpressed and endogenous TFIIA. Thirdly, TFIIA and Taspase1 interact upon co-
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transfection and immunoprecipitation. Finally, Taspase1 is localized in the nucleus 
and is associated with chromatin.  
We showed that Taspase1 cleaves TFIIA at D274/G275 that is within the 
highly conserved CRS and identical to MLL21.  Both our in vitro and in vivo 
experiments showed that cleavage of TFIIA by Taspase1 has the same amino acid 
requirement in the CRS as TFIIA cleavage by the endogenous protease10, strongly 
arguing that Taspase1 is the primary protease for TFIIA. The conclusion that G275 
rather than D278 is the primary N-terminal residue for the β subunit is also supported 
by the observation that mutations of D274 and y 
whereas mutation of D278 reduced but did not -
terminal residue D278 in the TFIIAβ subunit reported previously is probably 
generated by a secondary protease with either ty 
that removes three more amino acids to gen e 
hypothesize that TFIIA undergoes two consecut , 
a primary cleavage by Taspase1 and a seconda se. 
Cleavage by this second protease is dependent 1 
and ultimately yields the N-terminal D278 that prone to degradation as proposed 
previously. Alternatively, the N-terminus at tic 
degradation during protein purification. Whether cleavag  
ate its transcriptional activity is an 
interesting question. 
 G275 abolished cleavage completel
 abolish cleavage (Fig. 3B)10.  The N
 an endo- or an exopeptidase activi
erate D278 as the N-terminus. W
ive cleavage events for TFIIA in vivo
ry cleavage by an unknown protea
on the primary cleavage by Taspase
D278 might be due to proteoly
e of MLL is linked to
degradation as observed for TFIIA to regul
In our transient transfection experiments, we did not observe a clear increase 
in the levels of the cleaved α and β subunits upon complete cleavage of 
TFIIAαβ. Moreover, in the RNAi experiments, we only observed a slight decrease of 
the levels of the cleaved subunits while a clear increase of uncleaved TFIIAαβ was 
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detected (Fig. 3). These in vivo observations suggest that the levels of the cleaved 
TFIIA is measured and maintained at in cells. One possibility is that the excessive 
amoun
ntain the QV/LDG sequence, and about 1/10 of these proteins 
contain
t of the cleaved subunits is degraded through the proteosome-dependent 
pathway. However, upon proteosome inhibitor treatments in which proteosome-
dependent degradation was blocked, we still could not observe an increase of the 
cleaved α and β subunits when the uncleaved αβ form was completely cleaved by 
overexpressed Taspase1 (data not shown), suggesting that apart from the proteosome-
dependent pathway, there may be other mechanisms involved in maintaining the 
cleaved protein levels.  
The CRS of TFIIA is evolutionarily conserved between different species (Fig. 
2B), with the exception of the large subunit of yeast TFIIA, TOA1, that does not 
contain a CRS and is not cleaved22. In addition to the CRS, a downstream acidic 
stretch is also conserved in TFIIA in different species as well as in Trx-group proteins 
(Fig. 2B). Apart from the CRS and acidic stretch, there is little homology in 
surrounding regions in different TFIIA proteins, and no overall homology between 
TFIIA and MLL. These findings suggest that the CRS together with acidic stretch is 
necessary and probably sufficient for cleavage by Taspase1. The acidic stretch may 
play a role in cleavage recognition or facilitate docking or positioning of the active 
site of Taspase1 on the CRS. TFIIA is the second identified substrate for Taspase1 so 
far. Searching for the CRS sequence QV/LDG in the Swissprot database revealed about 
150 proteins that co
 acidic stretches (data not shown). It will be of interest to test whether they are 
also substrates of Taspase1.  
Proteolysis often leads to cleaved products that have functions distinct from 
those of the uncleaved precursor, such as the membrane-bound transcription factor 
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SREBP that is activated by protease cleavage23. In case of TFIIA, we have previously 
shown that the uncleaved TFIIA interacts with TBP to form a distinct TAC complex 
in embryonal carcinoma P19 cells15,16. Moreover, the ratio of uncleaved (αβ+γ) to 
cleaved (α+β+γ) TFIIA is higher in P19 EC cells than in other differentiated cells 
analyzed thus far, and this difference does not appear to be due to different expression 
levels of Taspase1 (Fig. 4), suggesting that cleavage of TFIIA is regulated by 
Taspase1 activity or modifications on the cleavage site of TFIIA in different cell types 
or developmental stages. Therefore, cleavage of TFIIA is not likely to simply function 
as a step to activate the uncleaved precursor. Our data suggest that, in addition to 
involve
 are transcriptionally active remains to be elucidated.  
ment in degradation, cleavage may also generate cleaved TFIIA products that 
have different roles and/or associate with different subsets of proteins during 
differentiation and development. We hypothesize that uncleaved TFIIA associated 
with TBP plays a transcriptional role in embryonal stage, and after differentiation, 
cleaved TFIIA associated in different complexes takes over the major role in 
transcription. In both stages, the level of TFIIA is regulated by cleavage and 
proteosome-dependent degradation. Reported studies on MLL also suggest that the 
role of MLL cleavage is not a simple activation of the precursor. It was shown that 
various Hox genes were differentially affected upon Taspase1 RNAi treatment21, 
suggesting that uncleaved and cleaved MLL have different specificities in controlling 
Hox gene expression. It was also reported that cleavage generated two subunits with 
opposite transcriptional activities19, reinforcing that the uncleaved and cleaved forms 
might have distinct roles in transcription. Whether the uncleaved or the cleaved, or 
both forms of TFIIA and MLL
Previously Taspase1 was purified from the light membrane fraction of the cell 
extracts of 293 cells21. In our extracts prepared from U2OS cells, a considerable 
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amount of Taspase1 could also be detected in crude cytoplasmic fractions (data not 
shown). Immunostaining experiments showed however that overexpressed Taspase1 
was predominantly localized in the nucleus. In accordance with this observation, 
Taspase1 has a predicted nuclear localization signal indicating that Taspase1 can be 
transported into the nucleus and may have a function in the nucleus. One intriguing 
explanation for the observed discrepancy is that subcellular localization of Taspase1 is 
a regulated process or cell-type specific. Importantly, in U2OS and HeLa cells, 
Taspase1 is in the nucleus and associated with chromatin, which suggests that 
cleavage of TFIIA, MLL and other substrates by Taspase1 might occur on chromatin. 
The fact that two substrates of Taspase1 identified so far, TFIIA and MLL, are 
transcription factors, supports our hypothesis that cleavage might be transcriptionally 
linked. Cleavage and subsequent degradation might control and regulate the levels of 
transcription factors that are substrates of Taspase1, and play a role in transcription 
regulation. By controlling cleavage and transcriptional activities of TFIIA, MLL and 
other substrates, Taspase1 is likely to be an important player in development. To 
understand the role of Taspase1 in transcription and development, the link between 
control of cleavage by Taspase1 and regulation of specific target genes of TFIIA and 
Trx-group proteins needs to be investigated in more detail. 
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Material and Methods  
Plasmids and antibodies 
Mammalian expression vectors, myc-tagged TFIIAαβ (pSG5-myc-TFIIAαβ), 
its CRS mutants (alanine mutants from L271-T279), HA-tagged TFIIAγ (pSG5-HA-
TFIIAγ), green fluorescent protein construct (pEGFP-N1)10, pcDNA-Taspase1 and its 
mutant T234A21 were described previously. TFIIAαβ and γ genes were subcloned 
from their mammalian expression vectors into a single polycistronic vector pST39 24 
between the SacI and KpnI sites and XbaI and BamHI sites, respectively, to generate 
pST-IIAγαβ for expression in E. coli. The CRS mutants (Q272A, V273A, D274A and 
G275A) in pST vector were generated by excision of the MscI and NotI fragments 
containing the mutated sequences from the mammalian vectors, and replacement of 
the wild-type sequence in pST-IIAγαβ.  Oligonucleotides, pRAV-myc1f (5’-
25
AATTTAATGGAGCAGAAGCTTATCAGCGAGGAGGACCTGGGCGGGG-3’) 
and pRAV-myc1r (5’-AATTCCCCGCCCAGGTCCTCCTCGCTGATAAGCTTCTG 
CTCCATTA-3’), containing the myc epitope coding sequence and were annealed and 
cloned into pRAV-FLAG at the EcoRI site  to generate pRAV-myc. Subsequently, 
the EcoRI and BamH1 fragment from pRAV-myc containing one Protein A domain, 
two TEV cleavage sites and a myc epitope was cloned into PZ-1-N (Cellzome) to 
generate PZXN. PZXN-Taspase1 construct for viral infection was generated by 
inserting Taspase1 gene into PZXN at the EcoRI site. Protein C antibody was 
purchased from Roche Molecular Biochemicals. Monoclonal myc antibody, 
polyclonal GFP antibody, polyclonal TFIIAα-specific, β-specific and γ-specific15 and 
Taspase121antibodies were previously described. 
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Cell culture, transient transfection, RNAi, protein extraction, 
munostaining  
21
5
ion rounds of 24 hours each. Cells 
ere then recovered for 24 hours, and a polyclonal pool of cells was selected with 
immunoprecipitation, Im
Maintenance and transfection of U2OS cells and extract preparation were 
performed as previously described10.  Immunoprecipitation was performed with the 
anti-myc monoclonal antibody under RIPA wash conditions15. RNAi knock-down of 
Taspase1 was carried out using duplex RNAi oligos as described previously . After 
48-hour RNAi treatment of U2OS cells, RNAi oligos were removed and cells were 
transfected with TFIIA plasmids. To detect the effect of Taspase1 RNAi knock-down 
on endogenous TFIIA, U2OS cells were treated with RNAi oligos for 3 and 4 days. 
For immunostaining experiments, U2OS cells were seeded and transfected on cover 
slips. Forty hours after transfection, cells were fixed in 4% paraformaldehyde for 10 
minutes, and then permeabilized in 0.2% TritonX-100. Following blocking in 0.5% 
BSA, cells were incubated in the anti-TFIIAα-specific antibody to detect TFIIA or an 
anti-protein C epitope antibody to detect the protein C-tagged Taspase1. 
Subsequently, cells were incubated in corresponding secondary antibodies conjugated 
with either FITC or Texas Red dyes, and visualized under fluorescence microscope. 
 
Establishment of a protein A-myc-Taspase1 stable cell line in HeLa cells  
Phoenix amphotropic packaging cell line was transfected with the retroviral 
plasmid PZXN-Taspase1 using calcium phosphate method. Forty-eight hours after 
transfection, virus containing supernatant was filtered through a 0.22-µm filter, and 
10  HeLa cells were transduced with 3ml filtered virus containing supernatant in the 
presence of 8µg/ml of polybrene for two infect
w
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1µg/ml of puromycin. Subsequently, individual clones were picked up and screened 
for physiological expression. 
 
e
e, HeLa nuclear extracts were prepared in high salt buffer containing Hepes 
PMSF 0.1 mM, 1x com
sequencing analysis, recombinant TFIIA was digested with recombinant Taspase1 
Protein expression and purification, Edman sequencing  
The polycistronic expression plasmid pST-IIAγαβ (and its CRS mutants) 
carrying both TFIIAαβ (and its mutants) and TFIIAγ genes was transform d into 
BL21(DE3)plysS cells, and induced with 0.2 mM IPTG. Overexpressed wild-type 
TFIIAαβ and TFIIAγ proteins were purified as a complex through Ni-NTA, Mono Q, 
Mono S columns to nearly homogeneity. The purified TFIIA complex was 
functionally assayed in EMSA after each purification step. TFIIAγαβ CRS mutants 
expressed from pST constructs were semi-purified with Ni-NTA resin and eluted with 
250 mM imidazole before subjected to the in vitro protease assays. Endogenous 
TFIIA  from P19, COS7, HeLa and U2OS cell extracts were semi-purified with Ni-
NTA resin, eluted with 250mM imidazole and analyzed by western blotting. 
Quantitation of TFIIA subunits was performed by Phophorimager (Molecular 
Dynamics) using ECL plus (Amersham). To purify the protease activity for TFIIA 
cleavag
pH 7.8, KCl 50 mM, NaCl 300 mM, EDTA 0.1 mM, DTT 1 mM, glycerol 10%, 
plete protease inhibitors (Roche Molecular Biochemicals), and 
fractionated on a P11 column, followed by step elutions with 100, 300, 500 and 1000 
mM KCl. The PC-C fraction (500 mM fraction) containing the protease activity was 
further fractionated on a Mono S column. For the Mono S column, a gradient from 
10-1000 mM KCl was applied, and the activity eluted at 300 mM KCl. Protease 
activity was monitored with the in vitro protease assay. To perform Edman N-terminal 
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followed by SDS-PAGE stained with Coomassie. The band corresponding to the β 
subunit was excised and subjected to Edman N-terminal sequencing analysis as 
escribed before18 
In vitro
15
d
 
 protease assay.  
The purified recombinant TFIIA complex and semi-purified TFIIA (and its 
mutants) were incubated at 37°C with the recombinant Tapase1 for 1 hour or with 
HeLa nuclear fractions for 12 hours. The reaction buffer contained 20 mM Tris, pH 
8.0, 100 mM KCl, 0.2 mM EDTA, 2 mM DTT, 10% glycerol. The reaction mix was 
subsequently analyzed by western blotting, and probed for TFIIAαβ, α, β and γ 
subunits using respective antibodies. A-myc-Taspase1 in HeLa cells extracts was 
incubated with Tobacco Etch Virus protease (TEV) at 37°C for 1 hour to cleave the 
protein A domain. TEV protease was purchased from Invitrogen. 
 
Chromatin cross-linking and preparation, CsCl purification 
U2OS cells transfected with pcDNA-Taspase1 and T234A mutant were cross-
linked in 11% formaldehyde for 30 minutes after 40-hour transfection. Wild-type 
HeLa cells and the Taspase1 stable HeLa cell line, HT, were cross-linked in 
formaldehyde for either 10 or 30 minutes.  Chromatin preparation and CsCl 
purification of chromatin-bound fractions were performed as previously described  
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CHAPTER 6 
Abstract 
The N-end rule states that the stability of a protein is dependent on its N-
terminus, and the various amino acids can consequently be categorized as 
primary/secondary destabilizing or stabilizing residues. ATE1 recognises N-terminal 
D and E and converts them to substrates for proteasomal degradation. The 
proteolytical cleavage of the general transcription factor TFIIA has been shown to 
promote its proteasomal degradation,  cleavage-generated N-terminus of 
TFIIAβ, D278, is a secondary destabilizing residue according to the N-end rule. We 
found that TFIIA was stabilized in an ATE1 knock-out cell line compared to a wild-
type cell line. Co-expression of ATE1 and TFIIA lead to a faster degradation of 
TFIIA wild-type, but did not affect the ability of the uncleavable mutant TFIIA 
G275A. Collectively, our data suggest that TFIIA is a substrate for the N-end rule 
thro hat 
TFIIA may be the first physiological substrate for proteasomal degradation through an 
N-
 
 
 
 
 
 
 
 
 
 
 
and the
st
ugh cleavage and ATE1-mediated proteasomal degradation, and indicate t
terminal Asp. 
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Introduction  
proteolytical processes have been implicated in destruction of 
anscription factors, for example the contribution of calpain-mediated proteolysis to 
egradation of p535 and the selective lysosomal proteolysis of IκB6. The most 
ommonly used pathway for protein disposal, however, is poly-ubiquitin-mediated 
roteasomal degradation7. The proteasomal degradation system involves conjugation 
f Ub to the substrate through the sequential action of the ubiquitin-activating enzyme 
1, the ubiquitin-conjugating enzyme E2 and the ubiquitin ligase E38,9. Several 
ubstrates have been reported to contain an element, a so-called degron, signaling 
biquitylation. Most degrons are poorly defined, but amongst the known ones are 
yclin destruction boxes10, regions rich in proline, glutatamate, serine and threonine 
EST sequences)11 and N-end rule degrons12. In addition to the destabilizing N-
 The activity of most transcription factors is tightly regulated because cells 
need to swiftly respond to environmental changes by altering its gene expression 
profile. Several mechanisms contribute to supply cells with the necessary plasticity 
for progression through the cell cycle, commitment to a particular differentiated state 
or response to stress. Protein activity can be regulated through post-translational 
modification, exemplified by the interaction between cAMP-responsive element 
binding protein (CREB) and CREB-binding protein (CBP)1 and subcellular re-
localisation which is important in the Smad signaling pathway2. Protein activity can 
also be controlled through proteasomal degradation of which important examples are 
the consecutive degradation of cyclins enabling progression through the cell cycle and 
the degradation of SCC1 facilitating chromatin segregation3,4. This form of regulation 
may be crucial to ensure irreversibility in processes where uni-directionality is 
critical.  
 Various 
tr
d
c
p
o
E
s
u
c
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terminal residue, the degradation signal in an N-end rule substrate consists of a lysine 
that serves as a determinant for (poly)ubiquitylation. The N-end rule has a hierarchal 
organization, where Asp is a secondary destabilizing residue that must undergo 
arginylation by arginine-tRNA transferase (ATE1) (see figure 1) to be recognized by 
the ubiquitin ligase13-15. It has been shown that the presence of ATE1 is required for 
cardiogenesis and angiogenic remodeling during mouse embryogenesis, but the 
mechanistic background for this is unknown. 
 
 
 
 The physiological significance of the N-end rule is unclear because few 
substrates
Figure 1 The N-end rule pathway for the type 1 substrates Asp and Glu. N-terminal residues are 
denoted by single letter abbreviations for amino acids. The ovals represent the rest of a protein 
include UBR1 (E3α) and UBR2
substrate. Primary destabilising residues are recognised by functionally overlapping E3s that 
15. 
 have been found in nature16. The first bona fide substrate to be identified 
was the cohesion subunit SCC1 that undergoes cleavage and subsequent degradation 
through its exposed N-terminal Arg, and whose degradation is essential for chromatin 
stability3. Furthermore, the γ2 subunit of the G protein heterotrimer is targeted for 
degradation through cleavage and exposure of Arg17, and a recently identified N-end 
substrate, DIAP1, undergoes caspase-mediated cleavage and exposure of Asn, 
followed by degradation through deamidation and arginylation by ATE118.  
 The human general transcription factor TFIIA consists of the three subunits 
α, β and γ,  of which TFIIAαβ is expressed from one gene and post-translationally 
cleaved19,20. Recently, the protease responsible for TFIIA cleavage was identified 
(Zhou et al. manuscript in preparation), and found to be Taspase1, a protease known 
to cleave MLL. The function of cleavage has remained elusive because uncleaved and 
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cleaved forms of TFIIAαβ are equally able to interact with TFIIAγ, bind DNA, 
support trans-activation and activate transcription in vivo21. It appears, though, that 
cleavage affects the half-life of TFIIA and is a pre-requisite for proteasome-mediated 
degradation.  
 Because of the link between cleavage of TFIIA and its degradation, in addition 
to the cleavage-mediated exposure of an N-terminal Asp, we wished to assess the role 
of ATE1 in the regulation of TFIIA stability. We found that over-expressing ATE1 
and TFIIA results in faster degradation of TFIIA in U2-OS cells, compared to when 
ATE1 is omitted. Importantly, ATE1 over-expression does not appear to affect the 
stability of the uncleavable TFIIA mutant G275A. Further, we find that in an ATE1 
nock- ld-
pe M ndicate that TFIIA is the first identified protein to 
Results and Discussion 
ATE1 over-expression leads to increased degradation of TFIIAα, -β and -γ 
 We have previously shown that TFIIA is degraded via the proteasome and that 
cleavage is a pre-requisite for this degradation21. Since Edman sequencing of the 
purified TFIIAβ in FM3A cells identified the N-terminus as Asp, which is a 
secondary destabilizing residue according to the N-end rule, we wished to study the 
role of the N-end rule pathway in TFIIA degradation. We therefore set out to test the 
effect of ATE1 on TFIIA levels by co-transfecting the proteins in U2-OS cells. 
Analysis by western blotting revealed that over-expressing ATE1 lead to a reduction 
in the steady-state levels of TFIIAα, TFIIAβ and TFIIAγ (Figure 2A, compare lane 2 
αβ
k out cell line, endogenous TFIIA subunits are stabilized compared to a wi
EF cell line. Our findings ity
undergo degradation through arginylation of an N-terminal Asp.  
 
and 3), whereas the levels of TFIIA  remained unchanged (Figure 2A and B). This 
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is consistent with ATE1 having a role in TFIIA stability following cleavage.  Green 
fluorescent protein (GFP), which was used as a control, was unaffected by ATE1, 
demonstrating that there was no global effect on transfection efficacy or protein 
expression.  Levels of TFIIAα, β and γ subunits inversely correlated with the ATE1 
e of ATE1 for TFIIA, we compared 
 have 
i
levels and TFIIA stability was reduced upon increasing amounts of transfected ATE1 
(Fig. 2B, compare lanes 5-8). At high levels of ATE1, also the level of TFIIAαβ was 
modestly affected, albeit clearly less than the cleaved subunits of TFIIA.  
 
 
TFIIA stability (A) Extracts 
from U2-OS cells transfected 
analysed by western blotting. 
GFP was added as a control. 
transfected with TFIIA and 
increasing concentrations of 
western blotting.  
Figure 2 Effect of ATE1 on 
with TFIIIA and ATE1 were 
(B) Extracts from U2-OS cells 
ATE1 were analysed by 
 To investigate the physiological relevanc
TFIIA levels in MEF ATE1+/+ and MEF ATE1-/- cells. The MEF ATE-/- cells
previously been demonstrated to lack the N-end degradation pathway for proteins 
with secondary destabilizing N-termini, establ shing the role of ATE1 for the 
degradation of these substrates15. We found that the levels of the endogenous, cleaved 
TFIIA subunits and particularly TFIIAβ were stabilized in the MEF ATE1-/- cells 
(Figure 3A, compare lanes 1 and 2), while the level of TFIIAαβ was largely 
unchanged.  α-tubulin as a control confirmed that equal amounts of extracts were 
used.  These results suggest that ATE1 affects the stability of endogenous TFIIA and 
further support the model that TFIIA is a substrate for the N-end rule. To further 
establish that the ATE1-induced reduction in TFIIA stability was a result of increased 
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(Figure 3B, compare lanes 1 and 5). At later time points, all TFIIA subunits were 
dramatically reduced upon ATE1 expression, and after 24 hours the protein was 
hardly detectable. Interestingly, the TFIIAαβ appeared to have a faster turn-over in 
the presence of ATE1 (Figure 3B, compare lanes 2, 3  8) in this 
setting, which could reflect increased cleavage as a response to accelerated depletion 
of the processed subunits.   
 Previously, we have found that inhibition of cleavage through a mutation in 
the CRS prolongs the half-life of TFIIA . The increased stability of an uncleavable 
turn-over of the protein, the stability of transfected TFIIA was studied in the presence 
of cycloheximide to prevent de novo protein synthesis. The degradation rates of the 
various TFIIA subunits were compared in MEF ATE1-/- cells without and with re-
storage of ATE1 expression. At time=0 the levels of TFIIAαβ were similar, whether 
or not ATE1 was expressed (figure 3B compare lanes 1 and 5). In contrast to that, 
levels of TFIIAα, β and γ were considerably reduced when ATE1 was expressed 
 and 4 to lanes 6, 7 and
Figure 3 Effects of ATE1 on 
TFIIA in MEF ATE1-/- and MEF 
ATE1+/+ cells (A) Extracts from 
lls and MEF 
re analysed by 
G275A mutant (lanes 1-3) and 
western blotting. 
MEF ATE1-/- ce
ATE1+/+ cells we
western blotting. (B) Extracts 
from MEF ATE1-/- cells 
transfected with TFIIA (lanes 1-4) 
and TFIIA + ATE1 (lanes 5-8) 
and treated with cycloheximide 
were analysed by western blotting. 
(C) Extracts from MEF ATE1-/- 
cells transfected with the TFIIA 
ATE1 (lanes 4-6) and treated with 
cycloheximide were analysed by 
1    2    3    4       5     6     7     8
1   2    3          4    5    6 
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TFIIA mutant could be explained if the increase in TFIIA degradation upon ATE1 
expression is due to arginylation of the exposed Asp on TFIIAβ.  If this is true, ATE1 
over-expression should not affect the level of uncleavable TFIIA. To this end, we 
employed the mutant TFIIAαβ G275A and compared it to TFIIA wild-type.  In 
CHAPTER 6 
contrast to wild-type TFIIA, ATE1 expression has no effect on the stability of 
TFIIAαβ G275A (figure 3C, compare lanes 1, 2, 3 to lanes 4, 5, 6). 
 Taken together, our data show that ATE1 expression leads to degradation of 
TFIIAα, -β and -γ. Importantly, ATE1 has no effect on stability of the uncleavable 
mutant TFIIAαβ G275A, supporting the hypothesis that cleavage of TFIIA generates 
a substrate for N-end coupled degradation of TFIIA through its exposed Asp. 
Surprisingly, the results showed that the cleavage efficacy or degradation rate of 
TFIIAαβ is increased upon ATE1 expression, suggesting a feedback loop that serves 
to generate more cleaved TFIIA as a result of increased degradation of the protein.  
 To investigate whether the ATE1-induced increase in protein degradation 
depended on the amino acid identity of the N-end of TFIIA, we compared the stability 
of TFIIA mutants with different N-termini. According to the N-end rule, replacing 
Asp with Met should stabilize TFIIA, whereas Arg should have a destabilizing effect. 
To investigate the half-life of the respective TFIIA mu
performed in the presence of cycloheximide to prevent de no  
tants, experiments were 
vo protein synthesis, and
B
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Figure 4 Effect on TFIIA stability by mutating D278 (A) 
analysed by western blotting. (B) The results from (A) were 
treated with cycloheximide were analysed by western 
TFIIA+ATE1 (figure 4A and B from ) 
C 
Extracts from U2-OS cells transfected with TFIIA or 
mutants as depicted and treated with cycloheximide were 
quantified and represented graphically. (C) Extracts from 
U2-OS cells transfected with TFIIA or TFIIA+ATE1 and 
blotting and the results were quantified and represented as 
concentration of TFIIA-ATE1/concentration of 
21
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the stability of the respective TFIIA subunits was monitored over time. Figure 4A 
demonstrates that a severe complication in the interpretation of these results is the 
effect on cleavage efficacy upon mutating the residue D278. The mutants are cleaved 
ve 
stability of TFIIA is dependent on the identity of residue 278. The mutant D278M is 
stabilized and D278R is destabilized compared to TFIIA wild-type, whereas neither 
D278M nor D278R are affected upon ATE1 expression, suggesting a role for D278 in 
substrate recognition. Our data suggest that ATE1 may play a role in TFIIA 
degradation and that TFIIA is a substrate for the N-end rule.  
 
The CRS is conserved in ALF 
 We have identified the cleavage re co  
stretch of four residues essential for cleavag
less efficiently than wild-type and because of the continuous generation of cleaved 
TFIIAα and β over time, it is not possible to accurately determine the half-life of the 
cleaved subunits (Fig. 4, compare lanes 1-4 with 5-8 and 9-12). Because of these 
problems, the data were interpreted by comparing the half-life of each single mutant 
by adding the total level of TFIIAαβ+TFIIAα+TFIIAβ. The level of wild-type TFIIA 
is reduced to 20% after 8 hour, whereas D278M remains roughly unchanged and 
D278R is halved (Fig. 4A, B). To investigate the effect of ATE1 on the respecti
mutants, ATE1 was co-expressed with TFIIA and the stability was quantified as 
described above. After 8 hours, over-expressing ATE1 lead to 4-5 fold increase in 
protein turn-over of wild-type TFIIA (Figure 4C). In contrast, restoring ATE1 
expression did not significantly affect the levels of TFIIA D278M or TFIIA D278R 
(Figure 4B, C). 
 Taken together, these results suggest that the ATE1-mediated effect on 
gnition site (CRS) of TFIIA, which is a
e21. The CRS is conserved in the proto-
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Figure 5. The CRS is essential for efficient 
transfected with ALF and mutants as depicted were 
analysed by western blotting. 
cleavage of ALF. Extracts from U2-OS cells 
oncogene MLL and in the TFIIA homologue ALF. This strongly suggests that the 
CRS is essential also for cleavage of the ALF, and furthermore, that the CRS and the 
responsible protease may serve a more global role regulating other proteins with a 
conserved CRS.  
 To test the role of the CRS for efficient cleavage of ALF, single residues 
within the CRS were mutated to alanine, and the mutants were analysed. Our results 
showed that any single mutation within the CRS virtually abolished cleavage (Figure 
5), consistent with the results from TFIIA . Importantly, the effect is dramatic when 
D354, analogous to TFIIA D278, was mutated to Ala, supporting the notion that this 
residue is crucial
21
 for cleavage of ALF.   
22
rs)21. Our results suggest 
at cleavage of TFIIA, rather than causing a rapid protein removal, places a ‘timer’ 
r destruction. It has been argued by Reinberg et al. 
19,23
 
Conclusions 
 The intracellular levels of many short-lived transcription factors are largely 
determined by the rate of proteasomal degradation rather than de novo synthesis, as 
illustrated by p53, whose activity is mainly regulated through protein stability . 
TFIIA was found to have an intermediate half-life (a few hou
th
on it and marks it irreversibly fo
that the two forms of TFIIA (uncleaved and cleaved) may fulfill the same function, 
but that one may be more efficient than the other . It is conceivable that the two 
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forms have similar or largely overlapping functions in the cell, the main difference 
being that the cleaved form  for destruction. This would permit the protease 
a  the protein without significantly altering the 
function of it, and the cell could even regulate cleavage of TFIIA to keep a ‘pool’ of 
stable TFIIA (i.e. the TAC form of TFIIA). Our hypothesis does not exclude, 
an endo- or an exopeptidase activity. The fact that only D278 was 
that this manner of regulating protein 
vels/activities has a more global function and could involve other proteins as well. 
ateri
and pCATE  have all been described. Plasmid pSG5-Myc-hALF was used for 
 is primed
ctivity to regulate the stability of
however, that the two forms of TFIIA have promoter-specific functions.  
 The discrepancy between the N-termini of TFIIAβ cleaved in vitro (Zhou et 
al., manuscript in preparation) and in vivo21 may be a result of a secondary cleavage 
event with either 
identified in the Edman analysis of the FM3A-derived material suggests that the 
second event is rapid after primary cleavage. However, the relatively long in vivo 
half-life of cleaved TFIIA may indicate that the N-terminal Asp is initially 
inaccessible for ATE1 until an unknown step exposes it.  
 The high conservation of the CRS and the adjacent Asp in other proteins, 
including ALF and MLL, indicate 
le
 
M als and methods 
Cell lines, plasmids, antibodies, protein extracts, SDS-PAGE, immunoblotting, 
mutagenesis 
 U2-OS cells21 and MEF ATE-/- AND+/+ cells15 were cultivated as described 
earlier.   Transfections, protein extracts, SDS-PAGE and western blotting were 
performed as described earlier24. PSG5-TFIIAαβ, pSG5-TFIIAγ, pSG5-myc-ALF21 
15
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mutagenesis according to the manufacturer’s instructions (Quick Site-directed 
Mutagenesis, Stratagene)..  
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CHAPTER 7 
 Why is TFIIAαβ cleaved? This question was the main motivation for 
initiating the work described in this thesis. Despite it being a fundamental aspect of 
TFIIA -TFIIA likely undergoes cleavage in all higher eukaryotes– this is a subject that 
hitherto has remained largely ignored and ost or all cellular 
TFIIA was found to be cleaved, suggestive of a lack of a physiological role of 
uncleaved TFIIA and regulation of cleava and these findings were not considered 
interesting enough to invest time and effort. Renewed interest into the topic was 
evoked by the identification of the cell-specific protein complex TAC, consisting of 
the uncleaved form of TFIIA together w . Its presence in a subset of cell lines 
indicated that cleavage of TFIIA is regu e regulation may be linked to 
the differentiation state of the cell. These ndings strongly called for further studies 
addressing the characteristics of the cleava cess. We specifically asked ourselves 
the fundamental questions: What is the cleavage site of TFIIA and what are the 
requiremen eavage of 
TFIIA? What other factors regulate the tim  How 
does cleavage of TFIIA relate to general tr nscription? And ultimately, why is TFIIA 
cleaved and what are the functional differences between the two forms of TFIIA? 
The complexity of the gene-specific regulation in Eukarya that was unveiled 
by the discovery of multiple forms (I, II and III) of polymerase in addition to separate 
sets of general transcription factors, now represents only the very beginning of a yet 
on-going uncovering of the remarkable machinery that regulates eukaryotic gene 
transcription (Chapter 1). Eukaryotic gen lation requires distinct multi-protein 
complexes to modulate chromatin structure, to imprint a transcriptional signature 
through covalent modifications (“histone/protein code”), to bind to DNA elements 
(enhancers, promoters), to communicate between the basal transcription machinery 
 unexplained. Initially, m
ge, 
ith TBP
lated and that th
fi
ge pro
ts for cleavage? What is/are the protease(s) responsible for cl
ing and process of TFIIA cleavage?
a
e regu
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and activators as well as to generate accurate transcripts. Recent technical 
developments like chromatin immunoprecipitations (ChIP) and ChIP-on-chip allow 
studies as to how promoters stage the interplay between these factors. The ongoing 
research in the transcription field is by a large amount focused on mapping this using 
massive data collections and global target site analyses.   
 TFIIA was identified as one of the general transcription factors in the initial 
screening of factors involved in assembly of the preinitiation complex and 
transcriptional activation, but later research has shown that depleting TFIIA gives but 
minor effects on general RNA pol II transcription, in contrast to depletion of any other 
general transcription factors (Chapter 2). Thus, TFIIA is probably not critical for 
transcription of all genes, and defining it as a general transcription factor may even be 
misleading. Nevertheless, TFIIA is essential in yeast and probably has an important 
role on a subset of promoters, for example on cell cycle regulating genes. The 
regulation of TFIIA levels has been shown to be involved in the cellular gene program 
change upon differentiation and viral infection, and cleavage of TFIIA, which has 
specifically evolved in higher eukaryotic organisms, may add another level of TFIIA 
regulation, evolved to fine-tune the transcriptional activity of the general transcription 
factor.  
 The interaction of the uncleaved form of TFIIA with TBP in TAC is 
remarkably strong, compared to the interaction between TFIIA and TFIID. This 
suggests that interactions specific for TAC are formed and that the uncleaved form of 
TFIIA may have a different affinity for TBP than the cleaved form. This hypothesis 
was tested by studying a large number of TBP surface mutants for their ability to form 
TAC (Chapter 3), and the study reveals that helix 2 in TBP is critically involved in 
TAC formation whereas the stirrup region contributes to the overall stability of TAC. 
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These conclusions are in contrast to earlier studies of the TFIIA-TFIID interactions, 
where the stirrup region was shown to be essential for formation of a DA complex and 
to support activated transcription in vivo1. In addition, single mutations in TBP had 
less severe effects on TAC assembly than on the previously assessed formation of a 
functional TFIIA-TFIID complex. An explanation for this is the formation of 
ble form of TFIIA with the wild-type TFIIA, but to our surprise the studies 
additional interactions between TBP and TFIIA in the TAC complex, and then 
specifically in the convex region of TBP.  
 The uncleaved and cleaved forms of TFIIA could therefore associate in 
different complexes and may have separate roles in regulation of transcription. 
However, the cleavage of TFIIA had never been paid much attention; the cleavage 
site had not been identified and the responsible protease(s) remained unknown. To 
characterize the cleavage site, the N-terminus of the TFIIAβ-subunit was determined 
by Edman degradation to be D278 (Chapter 4). Mutational studies of the adjacent 
region revealed that the molecular determinants for the cleavage event are a string of 
four residues N-terminal of D278, named the cleavage recognition sequence (CRS). 
The CRS appears critical for efficient cleavage of TFIIA and any single mutant almost 
entirely inhibited cleavage. These mutants allowed the functional comparison of an 
uncleava
revealed no differences between the two with regard to binding TBP, stabilizing of 
TBP binding to DNA and activation of transcription in vivo. Despite the fact that 
uncleaved and cleaved TFIIA may be present in different transcriptionally potent 
complexes, there appears to be no significant differences in functional characteristics, 
at least as far as ‘classical’ TFIIA function is considered. However, the transcriptional 
variation between uncleaved and cleaved TFIIA could be promoter-specific, and this 
issue should be pursued in the future.  
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Recent results from studying MLL cleavage, a human homologue of the 
Drosophila Trithorax protein, revealed a cleavage recognition site –Q[V/L]DG- which 
is virtually identical to the CRS in TFIIAαβ2,3. Taspase1 was identified as the 
protease responsible for MLL cleavage, and consistent with the conserved CRS, was 
successively found to cleave TFIIA as well (Chapter 5). Experiments performed both 
in vitro and in vivo demonstrated that Taspase1 cleaves TFIIA efficiently and 
specifically, and knock-down of Taspase1 in U2-OS cells reduces the efficacy of 
endogenous TFIIA cleavage, confirming that Taspase1 is the genuine protease 
responsible for TFIIA cleavage. Interestingly, Taspase1 is localized in the nucleus and 
associated with chromatin, implying that Taspase1 is active on DNA. Given that the 
substrates identified so far, MLL and TFIIA (and ALF) are transcription factors, it is 
tempting to speculate on a role for cleavage in transcriptional regulation. Studies have 
indeed shown that various Hox genes were affected differently upon Taspase1 RNAi 
treatment2, suggesting that uncleaved and cleaved MLL have different specificity in 
control of Hox gene expression. Cleavage might control and regulate the levels of 
transcription factors that are substrates of Taspase1, and in turn play a role in 
transcription regulation.  
N-terminal sequencing of Taspase1-cleaved, recombinant TFIIA revealed that 
the cleavage site was at D274/G275, consistent with the cleavage site of MLL, but 
contrasting previous data obtained from our in vivo experiments (Chapter 4). These 
discrepancies may be a result of a secondary cleavage event with either an endo- or an 
exopeptidase activity.  The conservation of the N-terminal residue of TFIIA, Asp, 
throughout evolution suggests that this residue is important. Furthermore, mutation of 
this residue reduces cleavage of TFIIA and inhibits cleavage of ALF.  
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One important difference between cleavable and uncleavable forms of TFIIA 
emerging from these studies was a difference in stability; prevention of cleavage by 
single mutations in the CRS increased the half-life by 3-4 fold, and cleavage of TFIIA 
appeared to be prerequisite for proteasome-dependent degradation (Chapter 4). Thus, 
these data support a link between cleavage and the turn-over of TFIIA. Cleavage of 
TFIIA creates an N-terminal Asp, which is a secondary destabilizing residue 
according to the N-end rule4. The N-terminal Asp, though highly conserved in TFIIA 
of all higher eukaryotes, is important but not essential for cleavage. It is therefore 
possible that the Asp is conserved mostly to render the cleavage product unstable and 
that TFIIAαβ represents a stable pro-N-degron, which upon cleavage by one or more 
protease activities exposes an unstable Asp-bearing N-degron (TFIIAβ). Secondary 
destabilizing residues are recognized by ATE1, which conjugates to it an Arg, turning 
it into a primary destabilizing residue and a substrate for an N-end rule E3 ligase. 
Upon testing the effect of ATE1 on TFIIA stability, we find that over-expression of 
ATE1 destabilises the cleaved subunits of TFIIA whereas the uncleavable form is 
non-affected, arguing that ATE1 affects the degradation of the TFIIA subunits 
subsequent to cleavage (Chapter 6). This was supported by studies in ATE1-knock-
out cel
more, the Asp-
bearing TFIIA fragment remained a part of the TFIIA complex on a Superose-6 size 
ls where endogenous TFIIA appears to be stabilized compared to that of wild-
type cells. A similar scenario is the caspase-mediated cleavage of DIAP1 (Drosophila 
IAP1) that converts the more stable full-length protein into a highly unstable Asn-
bearing N-degron and its subsequent degradation by the N-end rule pathway is 
essential for regulation of apoptosis5,6.  
There are some important aspects to keep in mind; the Edman sequencing of 
TFIIAβ yielded an N-terminal Asp, not N-terminal Arg-Asp. Further
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exclusi
est that the half-life of the cleaved subunits of 
TFIIA 
on column. Thus, if the conjecture of the involvement of the N-end rule 
pathway is correct, one must assume that the Asp-bearing C-terminal fragment is 
sterically unavailable for arginylation (and degradation) in the complex until for 
example dissociation of the complex or (de-)modification, leads to the fragment 
becoming an actual substrate of ATE1.  
 For the function of TFIIA cleavage, a number of scenarios can be imagined. 
There are several examples of proteins where cleavage represents an activating step. 
The well-known mammalian caspases can be activated through cleavage and they can 
themselves cleave and activate CAD, thereby initiating endonucleolytic chromosome 
degradation7. However, the fact that the uncleavable TFIIA performs similarly to the 
wild-type protein in all assays tested so far, makes this a rather unlikely possibility. 
The opposite setting where cleavage of TFIIA represents an inactivating step is 
possible but somewhat contra-intuitive, since most of the cellular TFIIA is in fact 
cleaved.  Another protein that undergoes proteolytical cleavage is MLL; cleavage has 
been suggested to confer subnuclear localization8, furthermore inhibiting MLL 
cleavage interferes with proper HOX gene expression. Uncleavable TFIIA mutants 
however localized to similar cellular compartments as wild-type TFIIA (results not 
shown). Whether the two forms of TFIIA have separate promoter preferences remains 
an open issue to be pursued. At this point, however, the cleavage does not seem to 
affect the transcriptional competence of TFIIA and the only apparent distinction is the 
difference in half-life.  
 The studies from chapter 4 sugg
is not dramatically short; this is also consistent with the steady-state levels of 
TFIIA in most cell lines, in which the major fraction of TFIIA is cleaved. It seems a 
more likely explanation that rather than resulting in a rapid protein removal, cleavage 
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of TFIIA places a ‘timer’ on TFIIA and labels it for destruction. Importantly, this 
would, in contrast to posttranslational (de)modifications like (de)phosphorylation, 
represent an irreversible step; upon cleavage, TFIIA has commenced its path to death 
and from this point has only a certain time to perform its role in the cell. It is possible 
that the two forms function indistinguishably, the main difference being that the 
cleaved form is primed for destruction. If this is true, regulation of the protease 
activity regulates the stability of the protein without significantly altering its function 
and the inhibition of TFIIA cleavage (by modification of TFIIA/the protease activity) 
could be pictured as a way to store a more stable form of TFIIA (i.e. TAC) (see figure 
1). Interestingly, this manner of regulating TFIIA is conserved also in ALF (chapter 6) 
and possibly has a more global function.  
                               
 
 
 
Figure 1. Model of function and regulation 
assemble with TBP into TAC and this is 
facilitated, directly or indirectly, by p300. 
activation of hitherto unknown embryo-
αβ/γ
cleaved by Taspase 1 into TFIIAα/β/γ that 
can assemble with TFIID and activate general 
substrate for proteasomal degradation, 
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TAC is responsible for the transcriptional 
specific promoters. TFIIA  can be 
transcription. Ultimately, TFIIAα/β/γ is a 
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Concluding remarks 
 Returning to the initial question; why is TFIIAαβ cleaved? Frequently in 
science, simple questions do not have simple answers, and whereas this work has 
succeeded in filling some gaps in our knowledge about TFIIA, the most intriguing 
question is still a matter of speculation and of favoring one theory over another. The 
function of cleavage may be merely to destabilize TFIIA but the fact that Taspase1 
associates with chromatin may reflect a role of cleavage more directly linked to the 
transcription process. Our data go against a direct requirement of transcriptional 
activity for cleavage to occur (chapter 4), but this cannot exclude the possibility that 
cleavage does occur at a certain transcription step, without changing the 
transcriptional competence of TFIIA. This regulation may be to ensure that TFIIA 
only undergoes a limited number of initiation rounds. Furthermore, the engagement of 
the cleaved and uncleaved TFIIA in two separate complexes, TFIID and TAC, may 
suggest that these two forms of TFIIA have distinct responsibilities in promoter 
regulation (see figure 1).  
 Cleavage of TFIIA appears to have evolve l 
regulative step in higher eukaryotes. TFIIA clea  
conserved stretch of four amino acids, which is es  
is cleaved by Taspase1, a chromatin associated r 
cleavage of MLL. The cleavage process is lik
potentially important are firstly p300; over-expression of p300 leads to accumulation 
 TFIIA) in differentiated cell lines like Cos7. Whether this is a 
irect effect on TFIIA or an indirect effect on for example the protease remains to be 
een. Secondly, our results suggest that phosphorylation sites adjacent to the cleavage 
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d from S. cerevisiae as an additiona
vage is mediated through a highly
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CKII has been implicated in the regulation of a number of transcription factors, 
reveal TATA-box binding protein surfaces required for activated transcription 
 development 10, 2491-504 (1996). 
2. Hsieh, J. J., Cheng, E. H. & Korsmeyer, S. J. Taspase1: a threonine aspartase 
293-303 (2003). 
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biology 5, 373-6 (2003). 
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Fragments That Confers Protein Stability and Subnuclear Localization. 
including IκBα, c-Jun, IRF-1, RNA pol II and the phosphatase FCP1 which is 
involved in recycling of RNA Pol II for transcription elongation9-12. CKII has also 
recently been shown to be involved in promoter selection and transcription 
reinitiation13. How these factors interplay through development to adjust the levels of 
TFIIA accordingly should offer an interesting direction for future experimenting.  
 Thus far, experiments with transcriptional assays in vivo have not succeeded in 
uncovering any functional differences in transcriptional competence between 
uncleavable and cleavable TFIIA; nonetheless, the strict conservation of the CRS 
within higher eukaryotes implies that whatever the role, it is essential for the 
organism. It follows that the work described here hopefully provides the necessary 
ground for identifying the function of TFIIA cleavage in higher eukaryotes.  
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Lange tijd werd het verschil in complexiteit tussen ‘lagere’ organismen en 
hoogst ontwikkelde en intelligente organismes zoals wij zelf, simpelweg veklaard 
door het gepostuleerde verschil in aantal genen. Volgens schattingen bevatte een 
redelijk ontwikkeld mens toch al gauw zo’n 100.000 verschillende genen in zijn of 
haar genoom, de veel simpelere fruitvlieg 15.000 en het genoom van de eencellige 
bakkersgist omvatte slechts 6.000 genen. De schok was dan ook groot toen de 
conclusies van het Human Genome Project inhielden dat de mens ‘slechts’ 20.000-
25.000 genen bevatte, net ietsje meer dat het fruitvliegje en maar 3 tot 4 keer de 
zoveel als gist.  
Het verschil in complexiteit diende dus op andere wijze te worden verkregen 
én verklaard; het huidige dogma stelt dan ook dat niet de quantiteit aan genen, maar 
de manier waarop deze genen gereguleerd worden veel complexer, dynamischer en 
subtieler is in de mens. Dit lijkt deels te danken aan een grotere variëteit aan 
zogenoemde transcriptiefactoren: alhoewel de meeste eukaryotische organismen 
dezelfde basis aan transcriptie regulerende functionaliteiten bevat (general 
transcription factors), bevatten hogere eukaryoten voor veel functies meerdere 
varianten, die elk hoogstwaarschijnlijk transcriptie net iets anders beinvloeden, 
eventueel op andere momenten, in andere celtypes, etc.  
Één zo’n general transcription factor is TFIIA, focus van deze thesis. Niet 
alleen bevat TFIIA een variant in hogere eukaryoten, ALF (TFIIA like factor), TFIIA 
zelf is in hogere eukaryoten (maar niet in bakkersgist) ook onderhevig aan 
posttranslationele proteolyse. Hierdoor bestaan 2 mogelijk cellulaire varianten van 
TFIIA, een ongekliefde (TFIIAαβ) vorm en een gekliefde vorm (TFIIAα/β), een 
vroege observatie die hardnekkig genegeerd werd door het wetenschappelijke veld. 
 163
 Experimenten waaruit geconcludeerd werd dat de aanwezigheid van gekliefd dan wel 
ongekl
278 essentieel was voor dit proces (vergelijkbare resultaten werden 
behaald
el, wat suggereerde dat deze 
eiwitte
iefd TFIIA afhankelijk is van de differentiatie status van de cel, zette het proces 
van klieving weer in de spotlight. De vraagstelling aan het begin van deze thesis was 
dan ook simpel: Waarom wordt TFIIA gekliefd?  
Om dit te onderzoeken zijn we begonnen om de exacte positie van klieving te 
bepalen. Edman degradatie op gezuiverd humaan TFIIA liet zien dat de N-terminus 
van TFIIAβ begint op aminozuur D278. Mutagenese van de regio rondom deze 
klievingssite toonde dat de identiteit van D278 weliswaar belangrijk was voor 
klieving, maar dat de identiteit van elk van vier opeenvolgende aminozuren N-
terminaal van D
 met betrekking tot de TFIIA variant, ALF (alhoewel het ALF residu dat 
correspondeert met TFIIA D278, D354, volstrekt essentieel voor klieving is). Deze 
onkliefbare mutanten verschaften uitstekende reagenten om eventuele verschillen 
tussen kliefbaar TFIIA en onkliefbaar TFIIA te bestuderen in cellen. 
Verbazingwekkend genoeg bleek er geen duidelijk verschil tussen de 2 vormen te 
vinden met betrekking tot affiniteit voor de tweede subunit van TFIIA (TFIIAγ), 
transcriptionele activatie van een minimale promoter, binding aan TBP of stimulatie 
van TBP associatie met DNA. Het enige aanwijsbare verschil was dat de onkliefbare 
TFIIA mutanten accumuleerden tot hoge levels in de c
n een langer halfleven hadden dan kliefbaar TFIIA.  
Pulse-Chase experimenten lieten zien dat onkliefbaar TFIIA inderdaad een 
duidelijk langer halfleven heeft dan kliefbaar TFIIA. Inhibitie van proteasomale 
degradatie liet verder zien dat alleen geklieft TFIIA een substraat is voor 
proteasomale degradatie en dat een van de kleinere subunits geconjugeerd wordt aan 
ubiquitine, een kenmerk van proteasomale degradatie. Deze data suggereerden dat 
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 TFIIA klieving noodzakelijk is voor regulatie van TFIIA levels in de cel. Het feit dat 
de N-terminus van TFIIAβ (D278), maar niet van TFIIAαβ (M1) een secundair 
onstabiel residue is volgens the N-end rule ondersteunde deze notie. Volgens het 
proteosomale degradatie mechanisme van de N-end rule dient een secundair 
onstabiele N-terminus alvorens het gedegradeerd kan worden, omgezet te worden in 
een primair onstabiel residu door fusie van een arginine (R), een proces gemedieerd 
door ATE1 (arginine tRNA transferase 1). Als een doel van TFIIA klieving inderdaad 
het genereren van een potentieel N-end rule substraat is dan zou deregulatie van 
ATE1 het halfleven van TFIIA dienen te beinvloeden. Inderdaad, deletie van ATE1 
leidde to accumulatie van zowel endogeen als exogeen TFIIA en herintroductie van 
ATE1 in deze cellen verkortte het halfleven van TFIIA. Vergelijkbaar, overexpressie 
van ATE1 in U2OS cellen verkortte het halfleven van kliefbaar TFIIA drastisch, maar 
niet het halfleven van onkliefbaar TFIIA. Mutatie van D278 tot een zeer stabiel N-
terminaal residue, namelijk methionine (M) zou degradatie van geklieft TFIIA moeten 
inhiberen, en complementair, mutatie van D278 in het primair unstabiele R zou 
degradatie kinetiek onafhankelijk moeten maken van ATE1. Met behulp van 
transfectie experimenten konden beide postulaties bevestigd worden. Tesamen lijken 
al deze datasets er sterk op te wijzen dat een belangrijk (zo niet het enige) doel  van 
TFIIA klieving de regulatie van het halfleven van TFIIA is.  
Een verdere open deur voor opvolgend onderzoek is de rol van fosforylatie is 
klieving en degradatie van TFIIA. Onze experimenten lieten zien dat de identiteit van 
3 residuen direct C-terminaal van D278 (namelijk T279, S280, S281) belangrijk is 
voor regulatie van de levels van geklieft TFIIA. Deze residuen zijn bekend als 
fosforylatie targets en mutagenese van de herkenningssequentie (E282-D284) voor 
potentiële fosforylatie van T279-S281 door CKII (Casein kinase II) had hetzelfde 
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 destabiliserende effect als mutagenese van TSS naar Alanine. Tenslotte bleek de 
fosforylatie imiterende T276D mutatie, maar niet de T276A mutatie, volledig 
onkliefbaar. Dit suggereert dat de fosforylatie status van T276 (toevallig ook een 
potentiële CKII site) een rol speelt in TFIIA klieving. 
Één belangrijke speler in het leven van TFIIA bleef lang ongrijpbaar. Tot een 
publicatie de protease verantwoordelijk voor klieving van het trithorax eiwit MLL 
(Mixed lineage leukaemia) identificeerde, Taspase1. Deze protease kliefde midden in 
een sequentie die identiek van aan de sequentie van de CRS in TFIIA, de residuen 
essentieel voor TFIIA cleavage. Zowel in vitro als in vivo experimenten lieten zien dat 
Taspase1 in staat is TFIIA te klieven. Edman degradatie van in vitro, Taspase1 
gemedieerd, geklieft TFIIA liet zien dat de N-terminus van TFIIAβ begon op dezelfde 
plek als in MLL, op G275 en dus niet begon op D278 zoals de in vivo resultaten 
stelden.  
Als een gevolg hiervan eindigt deze thesis zoals vaak met een aantal 
antwoorden, maar ook weer veel nieuwe vragen, hier een aantal ervan: Hoe zijn de 
verschillen tussen de in vivo en in vitro N-terminus van TFIIAβ te verklaren? Vindt er 
secundaire klieving leidend tot een instabiele N-terminus? Wat is de exacte 
physiologische rol van verschillende eiwitten waaronder Tapase1, ATE1, p300, E1A 
en CKII in regulatie van TFIIA klieving en halfleven? Op welke wijze speelt het 
transcriptieproces een rol in TFIIA klieving? p300, CKII en Taspase1 zijn chromatine 
geassocieerde eiwitten en alhoewel onze experimenten suggereren dat klieving niet 
noodzakelijk is voor transcriptie progressie en transcriptie progressie niet 
noodzakelijk is voor klieving, is het wel zeer mogelijk dat klieving en halfleven van 
TFIIA gerelateerd zijn aan het transcriptieproces (mogelijkerwijs door het plaatsen 
van een ‘timer’ op  TFIIA vóór, tijdens of na transcriptie). Zijn er daadwerkelijk 
 166
 functionele verschillen tussen ongeklieft en geklieft TFIIA (bijv. promoter 
specificiteit, diferentiatie specifieke functies), of is klieving simpelweg een 
irreversibele stap in de degradatie van TFIIA?  
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